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Summary 
The use of chemical control agents to control microbial spoilage in agriculture has been compromised 
with the emergence of increasing microbial resistance, together with a shift in regulation toward 
pesticides with a lower intrinsic toxicity and lower environmental impact. This has instigated the 
search for alternate so-called green-biocides with a reduced environmental impact together with 
alternate modes of action to conventional chemical control agents to combat the trend of resistance 
development.  
The antimicrobial peptides of focus in study may offer a potential solution. The tyrocidines and their 
analogues (Trcs) are a group of cyclodecapeptides [cyclo(D-Phe1-L-Pro2-L-(Phe3/Trp3)-D-
(Phe4/Trp4)-L-Asn5-L-Gln6-L-(Tyr7/Phe7/Trp7)-L-Val8-L-Orn9-L-Leu10] produced by the soil 
bacterium Bacillus aneurinolyticus. These cyclodecapeptides have shown potent antimicrobial 
activity toward a broad range of pathogens which affect the agricultural industries including Gram-
positive bacteria as well as fungi. In addition to a rapid membrane lytic activity, they have alternate 
cellular targets that reduces the likelihood of resistance development. Increased antimicrobial activity 
toward different targets is achieved by different analogues which contain a variable primary structure 
mainly due to variation in aromatic amino acid content at residues 3, 4 and 7 in the 
cyclodecapeptides. 
The first objective of this study was to elucidate the optimal conditions that would allow for the large 
scale production of target-specific subsets of these cyclodecapeptides that would enable their 
utilisation as green-biocides in the agricultural industry. Supplementation of defined ratios of Phe/Trp 
in the growth media shifted the cyclodecapeptide production profile to defined subsets of different 
analogues, as defined by changes in aromatic amino acids in their primary structures. Increased 
natural cyclodecapeptide production was achieved in excess of one gram per litre in flask cultures. 
Purification of culture extracts, either by manipulation of solubility of the cyclodecapeptides in 
solution or via column chromatography, achieved a peptide complex purity of >75% to utilise in 
agricultural applications. Further purification via high performance liquid chromatography yielded 
single peptides with purity >90%. The production and purification methodologies are of such a nature 
as to allow for future upscaling. 
Investigation of the relationship between the structure and oligomerisation of the six major 
cyclodecapeptides produced in the different subsets under various Phe/Trp supplemented conditions 
revealed a relationship between increased hydrophobicity and the tendency to form dimeric 
structures, the proposed membrane active units. Increased higher order structure formation, however, 
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was dependent on intermediate hydrophobicity and dimerization. This coincided with structures of 
the tyrocidine A (Phe3, Phe4 and Tyr7) and tyrocidine B (Trp3, Phe4 and Tyr7) analogues. 
Furthermore, glucose disrupted higher order structures of analogues containing Phe4 together with 
Tyr7 or Phe7. These properties correlated with increased antifungal activity toward Aspergillus 
fumigatus. Antifungal activity was found to be related to a balance in hydrophobicity and higher 
structure formation where interaction with hexose moieties in the target cell wall may play a role in 
the mode of action and possible pore formation in the target membrane. In contrast antibacterial 
activity toward Bacillus subtilis was found to be independent of dimerization and the variable 
characteristics of the different cyclodecapeptide analogues. Antibacterial activity was possibly more 
dependent on the conserved pentapeptide (VOLfP), as near equivalent activity was observed by 5 of 
the 6 analogues. Co-produced cyclodecapeptide pairs showed a propensity of forming heterodimers 
that mostly lead to additive antimicrobial activity. However, overt antagonism was observed in 
peptide combinations containing tryptocidines (Trp7) which are not naturally produced in increased 
quantities, while synergism was observed in for the naturally produced combinations of TrcA:PhcA 
(Phe3; Phe4) and TrcA:TrcB (Phe3; Phe4, Tyr7 and Trp3; Phe4, Tyr7) toward the fungal target, and 
TrcA:TrcB and TrcB:TrcC (Phe3; Trp4, Tyr7 and Trp3; Trp4, Tyr7) toward the bacterial target. 
Characteristics of intermediate hydrophobicity and dimerization in peptide pairs again resulted in 
increased activity toward the fungal target. These peptide mixtures, specifically TrcA and TrcB, are 
naturally produced in high quantities, indicating an evolutionary advantage to the producer strain. 
Formulation of the cyclodecapeptide mixtures in ethanol or dimethylformamide (DMF) revealed 
changes in oligomerisation, with reduced dimerization in ethanol relative to DMF. Furthermore, 
glucose and sucrose were observed to suppress antimicrobial activity when dissolved in ethanol, 
however, this was largely relieved when dissolved in DMF. The interaction of the cyclodecapeptides 
with sugar like moieties depended on a balance between the active conformation and target cell 
properties. Formulations of the natural peptide extract (Te) in 50% sucrose and DMF were found to 
be non-toxic towards toward adult bees and in field trials the Te-treated bees showed increased 
survival.  
These cyclodecapeptides offer an alternate solution to conventional chemical agents to treat 
pathogens in the agricultural and food industries. Optimized formulation of these cyclodecapeptides 
would possibly enhance their potential. In order to harvest the potential of these cyclodecapeptides, a 
concerted effort must be made in future investigations to gain knowledge on their mode of action, 
toxicity and behaviour as mixtures. 
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Opsomming 
Die gebruik van chemiese beheermiddels in landbou om mikrobiese bederf te beheer is onder druk 
deur toenemende mikrobiese weerstand en regulering van biosiedes ten gunste van dié met 'n laer 
intrinsieke toksisiteit en omgewingsimpak. Dit het die soektog na alternatiewe biosiede met 'n 
verminderde omgewingsimpak, naamlik die sogenaamde groen biosiede met alternatiewe 
werkingsmeganismes , as konvensionele chemiese biosiede, aangehelp om spesifiek om die tendens 
van toenemende weerstand te stuit. 
Die antimikrobiese peptiede wat die fokus is hierdie studie kan 'n potensiële oplossing bied. Die 
tirosidiene en hul analoë is 'n groep sikloddekapeptiede [cyclo(D-Phe1-L-Pro2-L-(Phe3/Trp3)-D-
(Phe4/Trp4)-L-Asn5-L-Gln6-L-(Tyr7/Phe7/Trp7)-L-Val8-L-Orn9-L-Leu10] wat vervaardig word deur die 
grondbakterium Bacillus aneurinolyticus. Hierdie siklodekapeptiede het 'n kragtige antimikrobiese 
aktiwiteit teenoor 'n wye verskeidenheid van patogene wat 'n invloed het in die landbousektor het, 
spesifiek Gram-positiewe bakterieë en swamme. Benewens 'n vinnige litiese membraan aktiwiteit, het 
hulle alternatiewe sellulêre teikens wat die moontlikheid van weerstand verminder. Verhoogde 
antimikrobiese aktiwiteit teenoor spesifieke teikens deur die analoë met verskillende primêre 
strukture is hoofsaaklik te wyte aan variasie in aromatiese aminosuur identiteite van residue 3, 4 en 7 
in die siklodekapeptiedes. 
Die eerste doel van die studie was om die optimale kondisies te vind vir grootskaalse produksie van 
teiken-spesifieke subgroepe van hierdie siklodekapeptiede wat hul benutting as groen biosiede in die 
landboubedryf moontlik kon maak. Die byvoeging van 'n gedefinieerde ratio van Phe/Trp in die groei 
media verskuif die siklodekapeptiede produksieprofiel na gedefinieerde subgroepe van verskillende 
analoë, soos gedefinieer deur die veranderinge in aromatiese aminosure in residu-posisies 3, 4 en 7. 
Verhoogde natuurlike siklodekapeptiedproduksie van groter as een gram per liter in fles kulture kon 
bereik word. Suiwering van kultuurekstrakte, hetsy deur manipulasie van die siklodekapeptied 
oplosbaarheid of deur middel van kolomchromatografie, het ŉ ekstrak suiwerheid van >75% 
peptiedkompleks gelewer vir aanwending in die landbousektor. Verdere suiwering via hoë 
doeltreffrendheid vloeistofchromatofrafie het enkel peptiede met >90% suiwerheid gelewer. Die 
produksie- en suiweringmetodes was ideaal vir toekomstige opskallering 
Die ondersoek van ses verteenwoordigende peptiede, uit die verskillende subgroepe  wat met 
verskillende Phe/Trp media aanvullings geproduseer is, het 'n verband tussen verhoogde 
hidrofobisiteit en die neiging om dimeriese strukture, die voorgestelde membraanaktiewe eenhede, 
onthul. Die verhoogde vorming van hoër orde dimeriese strukture was egter afhanklik van 
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intermediêre hidrofobisiteit, soos die van tirosidien A (Phe3, Phe4 en Tyr7) en tirosidien B (Trp3, Phe4 
en Tyr7). Verder is gevind dat glukose hoër orde strukture van analoë met Phe4 tesame met Tyr7 of 
Phe7 ontwrig. Hierdie eienskappe het met verhoogde antifungiese aktiwiteit teenoor Aspergillus 
fumigatus gekorreleer. Antifungiese aktiwiteit hou verband met 'n balans in hidrofobisiteit en die 
vorming van hoër strukture waar interaksie met heksoses in die teikenselwand 'n rol kan speel in die 
werkingsmeganisme en moontlike porieë wat vorm in die teikenmembraan. In teenstelling was die 
antibakteriese aktiwiteit met die Bacillus subtilis teiken onafhanklik van dimersasie en die 
veranderlike eienskappe van die verskillende sikliese dekapeptied analoë. Dit is moontlik afhanklik 
van die gekonserveerde pentapeptied (VOLfP), aangesien soortgelyke aktiwiteit gevind is vir vyf van 
die ses analoë. Die twee hoof siklodekapeptiede wat saam geproduseer word in subgroepe het geneig 
om heterodimere te vorm wat vir meeste peptiedpare tot additiewe antimikrobiese aktiwiteit. Daar is 
egter effense antagonisme waargeneem vir peptiedkombinasies wat triptosidiene (Trp7) bevat wat nie 
natuurlik geproduseer word nie. Sinergisme is gevind vir die natuurlik geproduseerde 
peptiedkombinasies van TrcA:PhcA (Phe3; Phe4)  en TrcA:TrcB (Phe3; Phe4, Tyr7 en Trp3; Phe4, Tyr7)  
teenoor die swam teiken, en TrcA:TrcB en TrcB:TrcC (Phe3; Trp4, Tyr7 en Trp3; Trp4, Tyr7) teenoor 
die bakteriële teiken. Die intermediêre hidrofobisiteit en dimerisasie is weer gevind vir aktiewe 
peptiedpare met die swam as teiken. Hierdie peptiedmengsels, spesifiek TrcA en TrcB word natuurlik 
geproduseer in groot hoeveelhede, wat dui op 'n evolusionêre voordeel vir die bakteriële 
produseerder. 
Formulering van die peptiedmengsels in etanol of dimetielformamied (DMF) het verskille in 
oligomerisasie getoon, met minder dimeriese peptiedspesies in etanol as in DMF. Verder is gevind 
dat glukose en sukrose antimikrobiese aktiwiteit onderdruk met etanol in peptiedpreparaat, terwyl 
DMF in die peptiedoplossing die aktiwiteit hertel het. Die interaksie van die siklodekapeptiede met 
heksoses blyk afhanklik te wees van die balans tussen die aktiewe struktuur en teikensel eienskappe. 
Formulering van die natuurlike peptied ekstrak (Te) in 50% sukrose en DMF is gevind om nie giftig 
teenoor volwassene bye te wees nie en in veldproewe het die Te-behandelde bye tot verhoogde 
oorlewing gelei in sommige korwe.  
Die siklodekapeptiede bied 'n natuurvriendelike alternatiewe oplossing vir konvensionele chemiese 
middels om bakteriële en swam patogene in die landbou- en voedselbedryf te behandel. 
Geoptimaliseerde formulering van hierdie siklodekapeptiede sal hul potensiaal verder kan uitbou. 
Ten einde die besondere potensiaal van die siklodekapeptiede ten volle te ontwikkel, moet 'n 
daadwerklike poging aangewend word in toekomstige ondersoeke om kennis te verkry oor hul manier 
van werking, toksisiteit, stabiliteit en gedrag as mengsels. 
Stellenbosch University  https://scholar.sun.ac.za
 vii 
 
 
 
 
 
 
 
 
 
“Carpe diem quam minimum credula postero” 
Seize the day, put very little trust in tomorrow 
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Preface 
The loss incurred due to microbial spoilage is a great concern to the agricultural and food 
industries. Microbial pathogens have typically been controlled through the use of chemical 
control agents and antibiotics. However, combination of emerging microbial resistance 
together with consumer opposition and regulation toward these chemical agents has instigated 
the need for so called green-biocides which have a reduced ecological impact together with 
lower potential for resistance development. The tyrocidines and their analogues, cyclic 
decapeptides produced by the soil bacterium Bacillus aneurinolyticus, show potential to serve 
as green-biocides. Potent antimicrobial activity toward bacterial and fungal pathogens which 
affect both the food and agricultural industries is achieved by different cyclodecapeptide 
analogues.  
The objective of this study was the development and evaluation of the future potential of the 
cyclodecapeptides produced by B. aneurinolyticus to serve as green-biocides. In this thesis an 
overview is given in Chapter 1 of the challenges facing agricultural production due to 
microbial spoilage and resistance, as well as the potential of antimicrobial peptides, 
specifically the tyrocidines and analogues to address this problem. The optimal conditions 
allowing for future large scale production of target-specific subsets of these 
cyclodecapeptides and economical downstream purification of the peptide mixtures and 
single peptides is covered in Chapters 2-4. The produced cyclodecapeptide 
mixtures/formulations were investigated to elucidate some parameters which may allow for 
optimisation to target different agricultural and/or food related pathogens/problem organisms 
(Chapters 5 and 6). Initial formulation parameters were evaluated together with the relative 
safety of their application within an agricultural setting by determining their in vivo toxicity 
toward honey bees (Chapter 7). A Summary of the findings in each of the different chapters is 
presented together with proposed future work (Chapter 8). The experimental chapters of this 
thesis were written as independent units so as to enable future publication. In some chapters 
repetitions were unavoidable, every attempt was made to keep this to a minimum.  
The first goal of this study was the increased natural production of these cyclodecapeptides to 
enabling their tailored application to target different pathogens in an agricultural 
environment. In order to achieve the goal of this study the following objectives were set: 
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 Manipulation of the natural cyclodecapeptide profile of B. aneurinolyticus to produce 
defined peptide subsets and single peptides. (Chapter 2).  
 Construction of a computational model of cyclodecapeptide production by 
B. aneurinolyticus (Chapter 3). 
 Optimise production and purification methodology of the tyrocidines and their 
analogues for future large scale production (Chapter 4). 
The second goal was to characterise the peptides in order to facilitate formulation of the 
peptides for in vivo applications. In order to achieve the goal of this study the following 
objectives were set: 
 Investigate the structure and oligomerisation relationships of the major 
cyclodecapeptide analogues produced in the different subsets (Chapter 5). 
 Correlation of the oligomerisation characteristics of co-produced cyclodecapeptides 
with their antimicrobial activity toward two representative target organisms (Chapter 
6). 
 Formulation of the natural cyclodecapeptide extracts and investigation of their in vivo 
toxicity toward honey bees as representative non-target species (Chapter 7). 
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Chapter 1 
Literature review: Tyrocidines, antimicrobial peptides 
with potential applications in agriculture and industry 
1.1 Introduction 
The loss of production in the agricultural and food sector due to microbial disease and 
spoilage severely impacts productivity and global food security as a whole. Plant diseases or 
food spoilage caused by bacteria, fungi and viruses result in approximately 16% pre-harvest 
losses of global food production annually [1]. Postharvest losses of between 16 to 50% are 
not uncommon, particularly in developing countries [2]. The demand for food production and 
global food security is ever increasing with a growing human population and changing 
climatic conditions, a need clearly exists to increase available food resources. It has been 
estimated that in order to meet future global food demand in the year 2050 global food 
production will have to increase by 50% [2,3]. Efforts to increase food production on ever 
decreasing available agricultural land have encountered the problem of increased 
vulnerability of higher yielding plant varietals to pathogens [4]. 
Numerous microorganisms result in pre-harvest and postharvest spoilage of food products 
that may also be linked to food-borne pathogenic outbreaks in humans. These range from 
bacteria such as Erwinia amylovora responsible for causing fire blight and black soft rot in 
various types of fruit and vegetables [5,6]. Bacterial species such as Corynebacterium 
michiganeses, C. sepdonicum, Xanthomonas campestris and numerous genres of the 
Pseudomonas species lead to fruit and vegetable spoilage by causing various forms of spots, 
rot and blight [5]. Furthermore, numerous fungi such as those of the order Pucciniales, which 
cause Rust, result in severe losses in cereal production [4]. While Botrytis cinerea, B. allii 
and Rhizoctonia solani represent but a few fungal species responsible for large pre and 
postharvest losses in vegetable and fruit production [3,4,6]. Further food spoilage may occur 
due to contamination with food-borne pathogens such as Listeria monocytogenes, 
Escherichia coli and Salmonella [7]. Food-borne diseases cause further reductions in the 
available food resources as well as posing a serious health and economic concern by causing 
diarrheal diseases. These could be life threatening, particularly in immunocompromised 
individuals [7-10]. 
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Through the use of chemical pesticides and antibiotics such as oxyteracyclin and 
streptomycin to control many of these pathogens as well as improved agricultural practises, 
food production has been doubled over the last four decades [6,11,12]. The emergence of 
multiple drug resistant pathogens [7,12], and a shift in regulation toward pesticides with a 
lower intrinsic toxicity and lower environmental impact has, however, driven the search for 
alternative pesticides [1,11]. The use of antibiotics in the agricultural industry has been 
implicated in the resistance development of multiple drug resistant human pathogens through 
the horizontal transfer of resistant genes between different bacterial genres [1,12]. Increased 
social awareness has resulted in the banning of other plant pesticides due to the negative 
environmental impact that arises as a consequence of their use [6]. A significant reduction in 
the available number of pesticides able to treat pathogenic microbial infections in plants has 
resulted, limiting the ability to combat plant pathogens that affect numerous plant species of 
significant food and economic importance [1,13]. A need therefore exists to develop novel so 
called green-biocides with a reduced ecological impact and alternate mode of action. 
1.2 Antimicrobial peptides 
Antimicrobial peptides may be a solution to the resistance and environmental problem. 
Antimicrobial peptides are found throughout the prokaryotic and eukaryotic kingdoms 
[14,15], and show a broad range of activity toward Gram-positive and Gram-negative 
bacteria, fungi and viruses [9,16-21]. They are an alternate class of antimicrobial agents 
which have a novel mechanism of action and alternate cellular targets compared to 
conventional antibiotics [15,20,22,23].  
Antimicrobial peptides typically contain an amphipathic secondary structure within which 
hydrophobic and cationic residues are spatially separated from one another [14]. This 
characteristic allows antimicrobial peptides to associate with hydrophobic membrane 
structures and cause disruptions to the membrane and/or cellular processes, consequently 
leading to cell death [9,14,18,24]. A number of these antimicrobial peptides contain a net 
positive charge which allows them to show selective toxicity toward the more negatively 
charged bacterial cell membrane, allowing them to be discriminated from the neutral 
membranes of plants and animals. Furthermore, their rapid membranolytic activity reduces 
the likelihood of the development of resistance [14].  
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Consequently the antimicrobial peptides show potential in the development of an novel class 
of therapeutic agents to treat resistant strains of pathogenic microorganisms, or to serve as 
green-biocides and preservatives [9,15,19,23,25]. This has set off the impetus to elucidate the 
precise mode of action, as well as the bioactivity of the antimicrobial peptides 
[15,16,18,21,23,24,26-30], including the tyrocidines (Trcs) [9,19,20,31,32], the antimicrobial 
peptides of interest in this project. 
Antimicrobial peptides consist of a wide variety of different molecules, with more than 880 
known natural peptides [14,15,18,33]. These have been broadly grouped into six different 
categories in a review by Epand and Vogel [24]. These include: linear peptides which form 
amphipathic and hydrophobic α-helices, cyclic β-sheet peptides, peptides containing unique 
amino acids, cyclic peptides containing thio-ether groups known as lantibiotics, peptaibols 
and macrocyclic knotted peptides consisting of lipopeptides that contain amino alcohols on 
the terminal ends [15,24]. Of these groups considerably the largest amount of attention has 
been focused on the α-helical peptides. This includes peptides such as the magainins which 
are derived from the skin of the African clawed frog Xenopus laevis [34] and alamethicin 
derived from the Trichoderma viride fungus [15,35]. 
A number of mechanisms of action have been proposed for these α-helical peptides which 
centre on their interaction and insertion into model membranes to form pores. One model is 
the barrel-stave model, whereby individual peptides bind and insert themselves through the 
membrane bilayer, without changing the phospholipid head group orientation to from pores 
and recruit additional peptides to increase the pore size [17,18,30,36]. The second being the 
toroidal pore model, where the peptide molecules bind and accumulate on the membrane 
surface in a parallel orientation until a certain critical concentration is reached when the 
peptides insert themselves perpendicularly into the membrane, remaining associated with the 
phospholipid head groups, resulting in disruption in both phospholipid head group orientation 
and membrane permeabilization [17,18,29,30,37]. However, both of these models have been 
disputed with flaws indicated in both of them [17,24]. Other models propose that the peptides 
carpet the membranes and cause vesicles to form [29,38] or aggregate within the membranes 
causing disruption [18,39]. Recently it has been proposed that some peptides lead to phase 
separation of lipids [40] or lipid demixing [41,42], without permeabilising membranes but 
leading to membrane dysfunction in terms of supporting protein functionality. 
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Newer evidence has come to light proposing that membrane binding may only be part of the 
picture. Some antimicrobial peptides may bind to the membrane only as a means to enter the 
cell and then act on intracellular targets thereby causing cell death by means other than cell 
lysis or other membrane disruptions [9,16,16,24]. Moreover, the importance of peptide 
concentration has been highlighted by in a review by Hancock and Rozek [18]. Most 
experiments that deal with the elucidation of the mechanism of action of antimicrobial 
peptides are done with model membranes and high peptide concentrations resulting in an 
erroneous and unnatural point of view being created. It is proposed that high peptide 
concentrations together with model membranes fail to capture the true nature and 
heterogeneity of biological membranes, as well as the true range of activities of the 
antimicrobial peptides [18]. 
Most antimicrobial peptides may have a more subtle effect than previously thought. The 
majority of experiments are performed with concentrations well in excess of the minimal 
effective bactericidal concentration (MBC) where most antimicrobial peptides breakdown the 
cytoplasmic membrane integrity [33]. Antimicrobial peptides such as indolicidin and 
bactenecin have been shown to not disrupt the membrane potential at their MBC yet still 
cause cell death [16-18,43,44]. It has been proposed that antimicrobial peptides may target the 
cytoplasmic membrane at high concentrations, but also have a preferred intracellular or 
membrane target as well as other secondary targets at lower concentrations [14,30,43,44]. 
These multiple targets of antimicrobial peptides has ensured they maintain their potency 
despite being evolutionally conserved throughout the biosphere [16,21]. Characteristics such 
as these make antimicrobial peptides attractive candidates for the development of novel 
antimicrobial agents.  
Considerably less is known about the mechanism of action of the β-sheet peptides which 
includes; loloatins [45,46], defensins [47], the Trcs and their structurally related 
streptocidines [48,49] and gramicidin S (GS) [23]. The amphipathic β-type secondary 
structures of these peptides allows them to interact with bacterial membranes and cause cell 
lysis [31,32,47,50], yet specificity and activity is due to a fine balance between 
amphipathicity and positive charge [26]. Increasing the size and hydrophobicity of GS 
analogues is show to increase both their activity as well as inherent haemolytic toxicity. The 
addition of positively charged residues to these larger structure, however, maintained their 
activity and concomitantly increased specificity toward the negatively charged bacterial 
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membrane while decreasing haemolytic toxicity [27,51-53]. Similarly, the introduction of a 
positive charge to the structures of three diverse peptides namely the α-helical indolicidin 
[54] and maganin2 [55], as well as the β-peptide lactoferricin B [56] resulted in increased 
activity and reduced haemolytic toxicity [26]. Furthermore, modifications of the structure of 
GS with D-amino acids leads to the disruption of the formation of β-sheet type structure 
which are proposed to be the active structure in their membranolytic activity. These 
modifications, however, resulted in increased antimicrobial activity suggesting that GS has 
other intracellular targets in addition to the cell membrane [15,53,57]. The latter correlates 
with the reported interaction of GS with various intracellular targets such as carbohydrates 
[58] and enzymes of certain metabolic pathways [59]. 
Manipulation of the native structures of the antimicrobial peptides by the introduction of 
positively charged residues has been used to increase their specificities for microbial 
membranes of numerous peptides including: GS [51-53,57], indolicidin [54], maganin 2 [55], 
lactoferricin B [56], as well as tyrocidine A [60,61]. This approach aims to reduce the 
inherent haemolytic toxicity of these peptides and concomitantly increase their therapeutic 
index. Ultimately the goal is the development of novel chemotherapeutic agents for treatment 
of pathogenic infections in humans and other mammalians.  
We, however, propose to use naturally produced Trcs and their analogues as a preventative 
measure aimed at agricultural applications and food bio-security. The losses in agricultural 
food production due to pathogenic spoilage of numerous crops of not only dietary but also 
economic importance severely effects social well-being of the human population [2,4]. This is 
of particular concern in third world countries where many individuals survive by subsistence 
farming, thus crop losses may potentially cause famine as well as financial hardship. 
Infections with food-borne pathogens and their associated negative effect due to food spoilage 
and morbidity may be prevented by pre-treatment of food stuffs or crops with antimicrobial 
peptides [9]. 
The potential of antimicrobial peptides as bio-control agents has been recognised. 
Agricultural research related to the use of microbial producers of antimicrobial peptides as 
bio-control agents was already in progress in the middle of the last century [62]. The natural 
abundance of antimicrobial peptides throughout all biospheres [14,63,64] led to them to be 
often considered as one of the most natural ways of maintaining a balanced ecosystem [62]. 
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The successfully protection of plants from typically fungal, as well bacterial pathogens, using 
microorganisms as natural bio-control agents has in many instances been achieved using 
bacteria which produce antimicrobial peptides in natural soil and water bodies [65-76]. The 
cyclic structure of many these naturally produces antimicrobial peptides makes them more 
resistant to degradation allowing them sufficient time to target slow growing fungal 
pathogens, while still remaining biodegradable to their basic amino acid building blocks 
which may serve as nutrients to plants [77]. 
The current increase in resistance of pathogens to conventional chemical control agents 
[7,12]; together with increased awareness of the negative ecological impact of chemical 
control agents [6], has driven the impetus of renewed interest in the use of natural bio-control 
as a means to curb the losses due to microbial spoilage and diseases in plants [66,69,72]. 
Different strains of the soil bacterium Bacillus subtilis have been shown to protect plants 
from phytopathogenic fungal pathogens through the production of a broad range of different 
cyclic β-sheet antimicrobial peptides including: iturin [70,75,76], iturin A and surfactin 
[65,78].The lipopeptide surfactin and fengycin are also shown to protect plant by inducing 
systemic resistance [74]. The bacterial producer of the antimicrobial peptide GS, which has a 
primary structure of 50% analogy to the Trcs, has also been shown to protect plants and their 
fruit from fungal pathogens [67,68,73]. Moreover, GS as well as the bacterial producer is 
shown to have a broad antibacterial activity [79] which would also allow for protection 
against a broader range of pathogens. 
The use of the bacterial producers of cyclic-antimicrobial peptides as bio-control agents thus 
shows significant promise. However, this approach has some limitation with regard to the 
range of applications where it is applicable, as well as the inherent unpredictability related to 
the growth and antimicrobial peptide production by microbes within an agricultural or 
industrial application. An alternate approach taken in this project entailed the increased 
production of the Trcs within a controlled environment, thereby increasing the control and 
scope of their application. 
1.3 The tyrocidines 
The Trcs and the cyclodecapeptide analogues have so far shown promising antimicrobial 
activity toward numerous pathogenic microorganisms which cause food spoilage and disease 
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including: the Gram positive bacteria L. monocytogenes [20,80], as well as a multitude of pre- 
and postharvest fungi such as: Botrytis cinerea, Fusarium spp and Penicillium spp [81-84]; 
while also including the human malaria parasite Plasmodium falciparum [19]. All of which 
directly or indirectly result in extensive morbidity and mortality in developing countries such 
as those of Southern Africa.  
The Trcs, as well as their structural analogues the tryptocidines and phenycidines, are isolated 
from the tyrothricin (Tcn) peptide complex which is primarily produced during the late 
logarithmic growth phase by the soil bacterium Bacillus aneurinolyticus, previously known as 
Bacillus brevis [9,85-87]. The Tcn complex is composed of two fractions, the first being a 
neutral fraction consisting of linear pentadecapeptides known as the gramicidins (Grms) and 
the second being a basic fraction consisting of cyclic decapeptides, namely the Trcs and 
analogues [25]. 
Despite being discovered 10 years after penicillin, Tcn was the first antibiotic to be used in 
clinical practices, yet due to its haemolytic toxicity [88] use was limited to topical 
applications [89-92]. They have also been proven safe for oral consumption [86,93-96] and as 
such have been extensively utilised as the active ingredient in throat lozenges containing 
1 mg Tcn under the trade name of Tyrozets® [97]. Tcn has also been used to successfully treat 
ulcers in the eye [98]. However, due to the perceived toxicity of the Trcs in the Tcn complex 
[95,96,99-101], attention has largely been focused on the β-lactam antibiotics as 
chemotherapeutic agents.  
1.3.1 Structure of the tyrocidines 
Investigations into the structure of the Trcs and their analogues have indicated that they are 
cationic antimicrobial peptides containing a fairly conserved cyclic decapeptide structure 
(Fig. 1.1), with variations mainly at positions three and four (Phe and Trp), seven (aromatic 
residues) and nine (ornithine, Orn or Lys) [9,25,32].This variability accounts for 24 of the 28 
Trcs previously characterised by Tang et al. [25]. The last four are formed due to variability at 
position eight (Val, Leu and Ile) [25] (Table 1.1). This variability indicates that there are 
possibly 72 different Trcs; hence there may be a large number of as yet uncharacterised Trcs.  
The structure of tyrocidine A has been determined to form a two stranded antiparallel β-sheet 
structure connected by a type II β-turn on the one end and slightly distorted type I β-turn on 
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the other end of the molecule [50,102-106]. The structure is stabilised by the formation of 
four intramolecular hydrogen bonds, as well as hydrophobic interactions between some of the 
side chains to yield an amphipathic curved structure [105]. Despite some variation in primary 
structure, particularity with regard to aromatic amino acid identity, the basic backbone 
structure is proposed to generally be conserved among the different Trc analogues [107]. The 
Trcs are proposed to oligomerize into higher ordered structures which associate with cell 
membranes, causing loss of structural integrity [9,20,32,50,105,106], as well as targeting 
alternate intracellular targets [108,109], both of which result in cell death [19,20,20,80,82]. 
 
 
 
 
 
 
Figure 1.1 Primary structure of tyrocidine A exemplifying the cyclic decapeptide structure of 
the Trcs and their analogues. Residues are referred to using standard three letter 
amino acid abbreviations with Orn representing ornithine. Residues are numbered 
according to their order of incorporation during biological synthesis, with variable 
amino acids represented in brackets. The tyrocidine analogues are formed when 
residue 7 is substituted by either phenylalanine or tryptophan to produce the 
phenycidines or tryptocidines respectively. Adapted from Tang [25]. 
1.3.2 Non-ribosomal production of the tyrocidines 
The Trcs and their analogues are cyclic non-ribosomal peptides (NRP) produced by a series 
of multi-domain enzymatic peptide synthetases (TycA, TycB and TycC). These are not 
encoded for by a single gene but by the 39.5kb tyrocidine biosynthesis operon containing the 
genes tycA, tycB and tycC, as well as tycD, tycE and tycF [110]. Through data base searches 
the two genes tycD and tycE, which show 36% sequence identity, are suggested to encode for 
two ABC transporters. Due to the observed function of similar proteins in Proteus mirabilis 
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[111], the proteins these genes encode for are putatively suggested to be responsible for 
resistance of the producer strain to the Trcs by actively transporting them out of the cell 
[110]. While tycF is proposed to encode for a putative thioesterase as it shares 34% identity 
with the thioesterase of the GS operon [110,112] (Fig. 1.2). 
Table 1.1 Summary of the different Trcs and analogous previously isolated and 
characterised from Tcn [25]. 
No Identity Abbreviations Sequence a 
Monoisotopic 
Molecular mass 
Abundance b 
1 - - VKLfP(L/I)fNQY 1249.7 <1 
2 Phenycidine A c PhcA VOLfPFfNQF 1253.8 2.8 
3 Tyrocidine A TrcA VOLfPFfNQY 1269.7 81 
4 Tyrocidine A1 TrcA1 VKLfPFfNQY 1283.7 36 
5 Tyrocidine E d TrcE VOLfPFyNQY 1285.7 <1 
6 Tyrocidine E' d TrcE' VOLfPYfNQY 1285.7 2.0 
7 Tryptocidine A TpcA VOLfPFfNQW 1292.7 14 
8 Phenycidine B d PhcB VOLfPWfNQF 1292.7 3.4 
9 Tyrocidine E1 TrcE1 VKLfPYfNQY 1299.7 1.0 
10 Tyrocidine E1 TrcE1 VKLfPFyNQY 1299.7 <1 
11 Tyrocidine B TrcB VOLfPWfNQY 1308.7 100 
12 Tyrocidine B' d TrcB' VOLfPFwNQY 1308.7 13 
13 Tyrocidine B1 TrcB1 VKLfPFwNQFY 1322.7 40 
14 Tyrocidine B1 TrcB1 VKLfPWfNQFY 1322.7 5.3 
15 - - (L/I)OLfPWfNQY 1322.7 1.7 
16 Tyrocidine D cd TrcD VOLfPYwNQY 1324.7 1.9 
17 - - VOLfP(L/I)fNQY 1325.7 1.1 
18 Tryptocidine B TpcB VOLfPWfNQW 1331.7 24 
19 - - VOLfPF(?)NQY 1336.7 4.1 
20 - - (L/I)KLfPWfNQY 1336.7 2.4 
21 Tyrocidine D1 TrcD1 VKLfPYwNQY 1338.7 1.6 
22 Tryptocidine B1 TpcB1 VOLfPWfNQW 1345.7 12 
23 Tyrocidine C TrcC VOLfPWwNQY 1347.7 92 
24 - - VKLfPF(?)NQY 1350.7 8.6 
25 Tyrocidine C1 TrcC1 VKLfPWwNQY 1361.7 28 
26 - - VOLyPWwNQY 1363.7 <1 
27 Tryptocidine C TpcC VOLfPWwNQW 1370.7 21 
28 Tryptocidine C1 TpcC1 VKLfPWwNQW 1384.7 2.1 
a Conventional one letter abbreviations used for amino acid sequences as obtained from Tang et al. [25] with O 
representing ornithine and lower case representing D-amino acids 
b Expressed relative to that observed for tyrocidine B 
c Renamed from tyrocidine E [25] 
d Named by the BIOPEP group [9] 
The three Trc peptide synthetases, TycA, TycB and TycC are composed of one, three and six 
modules respectively, correlating with the number and order of the amino acids each 
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incorporates into the Trc polypeptide chain [110]. Each of these modules is divided into a 
number of catalytic domains which is responsible for a specific step in the recognition, 
activation and addition of a single amino acid residue to the Trc polypeptide chain [113-115]. 
In the process a linear molecule is constructed through the tethering of intermediates to 
successive enzymatic modules. Ultimately the process culminates with the cyclization of the 
linear molecule by a carboxy-terminal thioesterase (TE) domain of the final enzymatic 
module [110,116,117] (Fig. 1.3). 
 
 
 
Figure 1.2 Entire tyrocidine biosynthesis operon composed of genes tycA to tycF, as well as 
the respective amino acids incorporated by each module in the backbone structure 
of tyrocidine A. As obtained from Mootz and Marahiel [110]. 
 
 
 
 
 
 
 
Figure 1.3 Process of tyrocidine synthesis [117]. The three genes tycA, tycB and tycC encode 
for the three multi-domain peptide synthetases TycA, TycB and TycC which 
incorporate one, three and six amino acids respectively. The number of amino 
acids incorporated coinciding with the number of modules of each synthetase. 
Modification of the bound amino acid residues by epimerization occurs at module 
one and four, where the epimerization by module one serves as an initiation of 
polypeptide synthesis. Figure from Linne et al. [113]. 
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The first step at every module is the binding of a specific amino acid residue within the 
binding pocket of an adenylation (A) domain [118] and activation using ATP to form an 
aminoacyl-AMP anhydride [110,115,119]. The activated amino acid is then transferred to a 
4’-phosphopantetheine moiety which is covalently bound to a highly conserved serine residue 
of a peptidyl carrier protein (PCP) to form a high energy thiol bond on the C-terminal of the 
amino acid [113,119]. The PCP then functions like a swinging arm, similar to fatty acid 
synthesis, to transport the activated amino acid to a highly specific downstream condensation 
(C) domain [115,119]. Peptide bond formation is catalysed by the latter C domain through the 
nucleophilic attack of the α-amino group of the new amino acid residue with the thio-
esterified α-carboxy group on the 4’-phosphopantetheine moiety of the upstream module 
containing the initial amino acid [120]. This results in growth of the polypeptide chain on the 
α-carboxy terminal as the growing polypeptide chain is transferred from one module to the 
next by each subsequent PCP [110,115,121] (Fig. 1.4). 
 
 
 
 
 
Figure 1.4 Mechanism of polypeptide elongation by the various domains of the 
nonribosomal peptide synthetases. (1) Amino acid (aa) selection and activation by 
the Adenylation (A) domain using ATP. (2) Transfer of the aminoacyl-AMP 
anhydride to a 4’-phosphopantetheine moiety which is covalently bound to a 
highly conserved serine residue of a peptidyl carrier protein (PCP) to form a high 
energy thio-ester bond on the C-terminal of the amino acid. (3) Nucleophilic 
attack and consequent transfer of the growing polypeptide to the N-terminal of the 
downstream PCP bound amino acid, catalysed by the Condensation (C) domain. 
(4) Transfer of the full length polypeptide chain to the thioesterase (TE) domain 
from the final PCP and consequent product release. Figure from Marahiel and 
Essen [120]. 
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The first module of the, TycA peptide synthetase, however, does not contain a C domain and 
is known as the initiation module [122]. TycA is responsible for the binding of L-Phe, the 
first amino acid residue, and its conversion to D-Phe via an Epimerization (E) domain 
[113,114,121,123]. The D-Phe isomer is then transferred by the PCP to the C domain on 
TycB and thus initiates product formation [113]. All of the subsequent modules contain a C 
domain and are referred to as elongation modules which are dependent on the first module for 
the initiation of product formation [122]. Further amino acid epimerization is performed by 
the E domain containing module 4, which is situated within the non-ribosomal peptide 
synthesis assembly line and merely adds the modified residue to the growing polypeptide 
chain [113,114]. 
Ultimately Trc synthesis culminates when the polypeptide chain reaches the final PCP and is 
transferred to a TE domain on the C-terminal of TycC. The TE domain then catalyses the 
transfer of the full-length polypeptide chain to its active site serine residue where it causes 
head to tail cyclization of the Trc molecule. Consequently the fully formed peptide is released 
from the non-ribosomal peptide synthetase machinery [114,115] (Fig. 1.4).  
1.3.3 Tyrocidine production and control 
The Trcs and Grms antimicrobial peptides are maximally produced after the vegetative 
growth phase, particularly during the early stationary phase [124-126]. The precise function 
of the antimicrobial peptides in the producer organism remains to be elucidated. Numerous 
authors have, however, proposed that the antimicrobial peptides may play a role in the 
process of sporulation [124,127-136] in addition to their antimicrobial action which provides 
a competitive advantage to the producer strain [126].  
This is based on the fact that when the producer strain was grown in a nitrogen deficient 
medium the addition of Trc was observed to induce sporulation [130,131,134,135]. 
Furthermore, the Trcs were observed to interact with DNA and inhibit RNA transcription 
[136-138], which is then reversed by the Grms [135,136,139,140]. The expression and 
production of the Trcs was observed to occur before that of Grms. After the production of the 
Trcs certain proteases were expressed which together with products of the protease digestion 
of casein peptide induced high levels of Grm production [124,129]. Grm then interacts with 
the σ subunit of RNA polymerase and inhibited the transcription of some genes [127], while 
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its interaction with the Trcs promotes the transcription of other genes [134,135]. The Trcs and 
Grms are proposed to act as cell cycle regulators through the timeous activation or repression 
of the expression of certain genes during the stationary growth phase and induction of 
sporulation [128,130,134]. However, the evidence in literature is ambiguous as others have 
reported the ability of the producer strain to produce viable spores and sporulate in the 
absence of Trc production [141]. 
The development of newer molecular techniques and an understanding of the genetic level of 
control of sporulation, as well as antimicrobial production have altered this perception. It 
would now seem that the previously mentioned relationship may possibly be an artefact of the 
greater genetic control. Both sporulation and antimicrobial production are induced under 
conditions where the producer is placed under metabolic stress such as nitrogen deficiency or 
oxygen limitation [108] or other forms of nutritional stress [142]. Initial work on Tcn 
production by Stokes and Woodward [143] found that Tcn production could be induced in 
stationary cultures, but not in submerged aerated cultures grown in media containing complex 
nitrogen sources. While Seddon and Fynn [108] reported a slower growth rate and increased 
Tcn production under conditions with low oxygen concentrations. Moreover, higher 
concentrations of Trc within the concentration range observed at the end of exponential 
growth were reported to inhibit NADH oxidase activity and consequently the electron 
transport chain [108]. These data all indicate the presence of some form of regulatory system 
which is activated and causes the expression of secondary growth phase genes, including the 
tyrocidine biosynthesis operon, under conditions of metabolic stress.  
Many of these genes that are activated at the onset of the stationary growth phase and that 
result in sporulation are under control of the SpoOA-AbrB regulatory circuit [144-148]. 
During the exponential growth phase the expression of many secondary growth phase and 
sporulation related genes are blocked by the binding of the 10.7 kDa AbrB protein to their 
promoter sequences [144,149-151]. However, upon receiving a metabolic stress signal a 
series of reactions known as the phosphorelay are activated which convert the un-
phosphorylated SpoOA transcriptional repressor to a phosphorylated transcriptional activator. 
Although the precise nature of the signal is unknown, the first step in the pathway is the 
autophosphorylation of the KinA or KinB proteins, which then transfer the phosphate 
molecule to a second messenger SpoOF. A further two phosphotransfer reactions cause the 
transfer of the phosphate molecule to SpoOB and finally SpoOA [142,146,148,150]. The 
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phosphorylated SpoOA then activates numerous genes associated with the stationary growth 
phase and sporulation by binding to the promoter sequence of the abrB gene. Thereby 
relieving repression of genes by the AbrB protein such as tycA, the first gene of the tyrocidine 
operon [142,144,147,152] (Fig. 1.5). 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Phosphorelay cascade of reactions responsible for the phosphorylation of SpoOA 
and activation of the genes controlled by the SpoOA-AbrB regulatory system. 
Autophosphorylation of KinA and/or KinB serves as the first step of the 
phosphorelay, the signal for which, however, is unknown. The phosphate 
molecule is then transferred via three transfer reactions: to firstly the second 
messenger SpoOF (OF), then to SpoOB (OB) and finally to SpoOA (OA). The 
phosphorylated SpoOA then activates the transcription of various genes related to 
the secondary growth phase and sporulation. Phosphorylated SpoOA binds to the 
OA box within the promoter of the abr gene and inhibits its transcription thereby 
relieving the repression of genes by the AbrB protein such the tyrocidine 
biosynthesis operon [148,150,155]. Cell cycle signal may further influence the 
phosphorelay at SpoOB via the GTP-binding protein Ibg [148]. Figure from Hoch 
[148]. 
Much of the knowledge gained about the control of sporulation as well as those controlling 
Trc expression were elucidated in B. subtilis as many of the necessary tools used to study 
genetic control in Bacillus are available in this species.[153] Using a tycA-lacZ fusion protein 
Marahiel et al. [153] demonstrated that the expression of the tyrocidine biosynthesis operon is 
under the solitary control of the AbrB protein. While other sporulation specific genes such as 
spoVG and aprE may be subject to additional levels of control as they maintained their post-
exponential phase induction in abrB mutants [150,153-155]. This control may be related to an 
additional regulatory role of the SpoOA protein aside from its interaction with AbrB as 
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spoOA abrB double mutants are unable to sporulate [149,153]. Moreover spoOA abrB double 
mutants are observed by Marahiel et al. [153] to result in seven fold higher levels of 
constitutive expression of tycA-lacZ fusion protein relative to wild-type cells [153,154]. 
Taken together it is evident that antimicrobial peptide production is closely linked to 
sporulation and other post exponential growth phase events. The antimicrobial peptides may 
have a secondary function as cell cycle regulators during the post-exponential phase of 
growth. However, control of their production, as well as sporulation, occurs on a genetic level 
via the same SpoOA-AbrB regulatory circuit which is triggered by environmental changes 
[149,152]. Furthermore, the AbrB protein may be but one of the factors involved in the 
regulation of antimicrobial production, other factors relating to SpoOA may play an 
additional role to regulate antimicrobial production in addition to binding AbrB. Nonetheless, 
with some understanding of the internal processes controlling natural Trc production in 
B. aneurinolyticus, some valuable insight is garnered which may allow for the manipulation 
of the culturing conditions of the producer organism to naturally increase Trc production. 
The previously stated potential of the Trcs to act as green-biocides targeting a range of 
industrially relevant pathogens, as well as isoform variable activity clearly indicate the 
necessity for the elucidation of the conditions that allow for the maximal production of the 
different Trc analogues produced by B. aneurinolyticus [25] (refer to Table 1.1). The 
conditions that govern Trc production by B. aneurinolyticus in relation to nitrogen and carbon 
nutrition [143,156,157], including urea supplementation [158], principally in submerged 
aerated cultures performed in fermentor vessels has been reported in literature. Increased Tcn 
production has largely been achieved in stationary cultures using complex nitrogen sources 
from tryptone or vegetable waste [159]. These studies have essentially focused on total Tcn 
production and not the identity of the specific antimicrobial peptides produced. For the Trcs 
to reach their true potential and application as green-biocides, increased production of 
selected Trc analogues or subsets of peptides needs to be achieved to target specific 
pathogens. 
1.3.4 Influence of the linear gramicidins in the tyrothricin complex 
The influence of the co-produced Grms on the activity and formulation of the previously 
mentioned Trc formulations will also need to be considered. As secondary metabolites these 
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peptides (Grms) are also produced after the logarithmic growth phase together with other 
gene products under the control of the SpoOA-AbrB regulatory circuit [144-148]. The Grms 
are NRP that are produced by four independent multi-domain peptide synthetases LgrA, 
LgrB, LgrC and LgrD which catalyse the incorporation of two, four, six, and four amino acid 
residues respectively into the final polypeptide structure. These peptide synthetases are 
encoded for by the gramicidin biosynthesis operon containing four large open reading frames 
which correspond with the four peptide synthetases [160]. The final structure of which is 
composed of a linear chain of 15 alternating hydrophobic L- and D-amino acid residues that 
are the result of seven E domains found on alternating synthetases. The first residue is 
formylated by a proposed N-formyltransferase domain situated on the N-terminal of the first 
module of the initial peptide synthetase, LgrA. Synthesis of the linear gramicidin polypeptide 
follows the same principals as described for the non-ribosomal synthesis of the Trcs barring 
that the last module of LgrD contains a reductase domain (R domain) on the C-terminal 
instead of TE domain found in Trc biosynthesis, which is responsible for product release 
[160]. Through the process of releasing the synthesised polypeptide chain the R domain 
converts a C-terminal Gly residue incorporated by the final module of LgrD into an aldehyde 
intermediate which is finally reduced by an aldoreductase LgrE via a NADPH-dependent 
reaction to a C-terminal ethanolamine [161]. 
This yields the Grms with the primary sequence fomyl-L-X1-L-Gly2-L-Ala3-D-Leu4-L-Ala5-
D-Val6-L-Val7-D-Val8-L-Trp9-D-Leu10-L-X11-D-Leu12-L-Trp13-D-Leu14-L-Trp15-
ethanolamine [162]. Variable position L-X1 is predominantly occupied by L-Val, however, in 
approximately 5% of the cases it may also be occupied by L-Ile. While the variable position 
L-X11 is predominantly occupied by L-Trp to yield the A analogue, it may also be occupied 
by either L-Phe or L-Tyr to yield either the B or C analogues respectively [163-166]. The 
linear gramicidins form a β-helix secondary structure with side chains of the amino acid 
residues pointing outwards [167,168]. The latter structures form homodimers that 
permeabilize membrane structures [167] resulting in high antibacterial activity [109,169,170] 
through the formation of ion channels which allow the rapid leakage of singly charged cations 
[167].  
The high membrane activity of the Grms, however, has also been attributed to the increased 
toxicity of the Tcn peptide complex [88,95,96,171]. They have also been found to antagonise 
the antimicrobial activity of the Trcs [31]. Hence, their contribution to the Tcn extracts needs 
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to be considered relative to the additional purification steps required to remove them from the 
Trcs in the different applications of the Trcs as green-biocides. 
1.3.5 Toxicity of the tyrocidines in the tyrothricin complex 
Hand-in-hand with the potent membranolytic activity of the Trcs, toxicity has also been 
reported for the Trcs, particularly in the Tcn complex which also contains the Grms. 
Haemolytic toxicity has been reported for the Trcs and Grms both in the Tcn complex and 
separated into the two fractions [96,99-101,171,172]. The haemolytic activity of the Trcs is 
initially more rapid. It is, however, inhibited after a short period by some undefined 
component of the red blood cells, leading to them being considerably less toxic than the Grms 
[88,101]. Similarly, increased toxicity of Grms is reported when applied intraperitoneally in 
mice and rats [95,96]. Some discrepancy exists in the reported leukocytic toxicity and 
intravenous application where the Trcs are reported to be more toxic [95], however, this may 
be due to decreased solubility of the Grms. 
The Tcn peptides have been safely utilised when applied topically [89-92] and has typically 
been effective at treating ulcers of the skin in humans or cutaneous infections [98,173-177]. 
Toxicity is, however, reported when applied to open wounds, which has been attributed to the 
haemolytic action of these peptides [95,171]. The relative safety of the Tcn peptides has also 
been demonstrated when taken orally in mammals [93,96,97,178,179]. Oral dosages as high 
as 1000 mg per kg body mass were not toxic to mice and rats [96]. While a maximum 
tolerated tyrothricin dosage of 0.8 mg per mouse was found after being successively fed three 
times a day for 10 days [94].  
Some authors have reported successful attempts at treating microbial infections in mice by 
oral administration of Tcn [86,94]. In other instances it was only able to slow down the rate of 
infection of pathogens which typically invade the upper gastro intestinal tract [94]. The use of 
Tcn to treat microbial infections by oral administration has largely been unsuccessful, despite 
high in vitro activity of the Tcn peptides toward the microbial targets [93,95]. Moreover, Tcn 
was found to be ineffective at treating infections away from the gastrointestinal tract when 
taken orally [94]. Taken together with the fact that mice orally treated with tyrothricin were 
observed to show no change in their intestinal microbiota [93,95], it would indicate the Tcn 
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peptides are not absorbed by the body and may be degraded and/or inactivated within the 
mammalian gastrointestinal tract. 
1.3.6 Tyrocidine targets and mode of action 
The antimicrobial activity of the Trcs, as with many other antimicrobial peptides, has largely 
been attributed to their ability to interact with hydrophobic cell membrane [31] causing 
permeabilization [180] and ultimately cell lysis [170]. The Trcs have been shown to associate 
into dimeric structures of increased amphipathicity which are stabilised by both hydrogen 
bonding and hydrophobic interactions [105,106] to form an arrow head like conformation 
[105].  
The Trcs, particularly at higher concentrations, are known to aggregate into higher order 
structures [9,181-185]. Consequently, the Trcs are suggested to oligomerize to form 
pore/channel like structures similar to those found in analogous GS [186] and other β-sheet 
peptides [187]. The dimeric unit of the Trcs has been shown to integrate into the surface 
layers of model membrane structures [105]. It has been suggested these may be the initial 
seeding units in the formation of pore/channel like structures within membrane targets [106]. 
However, due to the distinct curvature of the dimerised structures, the possibility of linking 
them into extended sheet-like structures is questioned [105]. At present the exact nature of 
how the Trcs cause membrane permeabilization, which leads to loss of integrity and cell lysis, 
remains unknown.  
Interaction of the Trcs with membrane structures occurs through a combination of 
hydrophobic interactions, Hydrogen bonding as well as ionic interactions [80]. While 
antifungal activity relied on cell wall binding as one of it possible targets as well as the cell 
membrane [81,82]. More subtle, non-lytic modes of antimicrobial action have also been 
suggested [19,20,82,188], these too would also depend on some form of initial membrane 
interaction and translocation to the intracellular space or contact with membrane bound 
enzymes. Antiplasmodial activity by the Trcs toward the malaria parasite occurs by targeting 
an alternate cellular target such as the food vacuole [188], as well as additional targets which 
may include a cell cycle regulator [19]. Moreover, the Trcs are shown to disrupt glucose 
metabolism in Gram-positive bacteria [99,109]. The Trcs therefore have additional targets 
other than just the cell membrane.  
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Considering the Trcs are known to bind DNA within the producer organism [137-139] and 
inhibit transcription in vitro [189], it is hypothesized that the Trcs may function through the 
inhibition of transcription and/or replication in addition to their membranolytic action [31]. 
This hypothesis of multiple cellular targets in addition to the cell membrane is supported by 
the possibility of multiple modes of action when targeting of different fungal pathogens 
[81,82]. Although calcium was observed to retard the cell wall/membrane antifungal activity 
of the Trcs, it brings to the fore disruption of other internal processes, including hyphal 
elongation to induce hyperbranching in the fungal pathogens thereby disrupting fungal growth 
[82]. Consequently, the Trc group are shown to not only consist of a range of different 
analogues, they also display multiple modes of action with variable targets, thereby reducing 
the likelihood of the development of resistant mutants.  
1.3.7 Tyrocidine structure-activity relationships 
Optimal antimicrobial activity of the Trcs toward different pathogens has been found to be 
related to both properties of the different target cell together with those of the different Trc 
analogues [9,19,20,80,82,188]. Differences in the primary structures of the Trcs, particularly 
those related to identity of the cationic residue at position 9 or variable aromatic amino acids 
at positions 3, 4 and 7 (refer to Fig. 1.1), lead to a variation in lipophilicity, side-chain surface 
area and mass-over-charge ratio which affect the activity of the peptides. These variations 
may cause changes to the conformation adopted by the different Trc analogues, altering the 
nature of their interaction with the target cells and thus influence antimicrobial activity. 
Analysis of the structure activity relationship (SAR) of the six major Trcs toward Gram-
positive bacterium L. monocytogenes found they displayed similar lytic activity, but differed 
in their ability to cause growth inhibition [20]. Growth inhibition and therefore activity was 
found to be dependent on both the variable aromatic residues. Increased antibacterial activity 
was observed by the more polar analogues containing Trp3 [20], while some correlation was 
observed for preference for Orn9 rather that Lys9 the variable cationic residue [80]. An 
investigation of the SAR of the Trcs, using an extended library of both natural and synthetic 
analogues by Leussa and Rautenbach [80], reported increased activity of a TrcA analogue 
containing a trimelylated Orn, indicating that the character of the cationic residue may play a 
major role in activity. These differences in antimicrobial activity could be because of 
differences in dimerization which are the proposed amphipathic active unit required for 
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antibacterial activity [105,106]. However, the membrane interaction by the cationic residue in 
relation to activity also determined by the properties of the target cell structure [80]. Increased 
antimicrobial activity of cationic antimicrobial peptides has largely been attributed to 
membrane binding and insertion of hydrophobic residues which are specially separated from 
cationic residues [14,24].  
The selectivity of natural antimicrobial peptides has been attributed to their positive charge 
causing preferential binding to the more negatively charged prokaryotic membrane structures 
[26]. One approach to increase the antimicrobial activity of the Trcs and related peptides such 
as GS while also decreasing their inherent haemolytic toxicity has entailed the manipulation 
of their native structures to alter their amphipathicity as well as increase positive charge 
[32,51-53,57,60,61,117,189,190]. This approach has largely been achieved through 
manipulation of the backbone structure of the TrcA analogue in the case of the Trcs. 
Qin et al. [60] reported increased activity toward B. subtilis while reducing haemolytic 
toxicity with synthetic TrcA analogue containing increased positive charge originating from a 
Glu6 to Orn6 substitution (sTrcAQ-O). Similarly, Marques et al. [32] reported two to eight 
fold increased antibacterial activity toward a range of Gram-positive bacteria by TrcA 
analogues containing increased positive charge by inclusion of Lys at position 6, similar to 
the sTrcAQ-O. Furthermore, through the substitution of D-Phe4 by D-Lys4 an analogue 
containing three cationic residues was created, inducing activity toward Gram-negative 
bacteria [32]. Substitution of only D-Phe4 with a cationic D-amino acid is reported by 
Kohli et al. [117] to increase selectivity, despite displaying decreased activity toward Gram-
positive bacteria relative to the native TrcA. These analogues also displayed some activity 
toward Gram-negative bacteria not observed by the natural Trcs. [117].  
Marques et al [32] reported a loss of antibacterial activity when amphipathicity of the 
structure was disrupted by substitution of hydrophobic pentafluorophenlyl residues on 
opposite sides of TrcA structure at positions 3 and 7. However, activity is regained when the 
substitution was only done at one of the two positions at a time. Similarly, increased 
antibacterial activity toward Gram-positive and Gram-negative bacteria is observed when Lys 
is included at positions 6 and/or 4 together with pentafluorophenlyl residue at position 3 [32]. 
Substitution of position 3 with Val is reported to result in a reduction in antimicrobial activity 
combined with reduced inhibition of active transport and transcription in vitro [189].  
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Leussa and Rautenbach [80] reported decreased antilisterial activity by sTrcAQ-O analogue 
in contrast to increased activity reported by Qin et al. [60] toward B. subtilis. Differences in 
antimicrobial activity are attributed to changes in the target cell structure [80]. The changes in 
antimicrobial activity observed with the synthetic analogues exemplify the importance of an 
amphipathic structure [32]. As exemplified by Danders et.al [189], increasing hydrophobicity 
may not necessarily correlate with increased activity, as was also reported by 
Marques et al [32]. Similarly, increase in positive charge did not necessarily result in 
increased antibacterial activity.  
Increased antimicrobial activity would depend on a balance between the differences in target 
cell structures as well as properties of the different Trcs originating from changes in their 
primary structures. A balance therefore exists between the strength of the membrane 
interaction and antimicrobial activity [80] which differs according to the target cell properties. 
This indicate a role in the placement of the different residues in higher order conformation 
adopted by the cyclodecapeptides [105,106]. 
Rautenbach et al. [19] found the more hydrophobic tyrocidine A, containing two Phe residues 
in the variable aromatic dipeptide moiety, to be most active against the human malaria 
parasite Plasmodium falciparum [19]. Further investigation of the antiplasmodial activity of 
an extended library of the Trc analogues by Leussa [188], in contrast found the more 
hydrophilic TpcC analogue (containing Trp as variable aromatic residues, Table 1.1) to also 
have increased activity. These differences in activity of these analogues are attributed to a 
difference in the non-lytic mode of action toward the malaria parasite occurs by targeting an 
alternate cellular target such as the plasmodial food vacuole [188]. 
Antifungal activity on the other hand was observed to be greatest with all the Trc analogues 
containing a Tyr residue at position 7 [81,82]. It would therefore seem apparent that the broad 
range of different natural Trcs that are produced enables the targeting of a multitude of 
different pathogens. Maximal activity toward different pathogens would consequently be 
achieved when increased amounts of selected analogues were present to target specific 
pathogens; most likely due to varying modes of antimicrobial action.  
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A group of non-ribosomally produced antimicrobial peptides, the tyrocidines from the tyrothricin
complex, have potential as antimicrobial agents in both medicine and industry. Previous work by
our group illustrated that the more polar tyrocidines rich in Trp residues in their structure were
more active toward Gram-positive bacteria, while the more non-polar tyrocidines rich in Phe
residues had greater activity toward Plasmodium falciparum, one of the major causative
pathogens of malaria in humans. Our group also found that the tyrocidines have pronounced
antifungal activity, dictated by the primary sequence of the tyrocidine. By simply manipulating the
Phe or Trp concentration in the culture medium of the tyrothricin producer, Bacillus
aneurinolyticus ATCC 10068, we were able to modulate the production of subsets of tyrocidines,
thereby tailoring the tyrothricin complex to target specific pathogens. We optimized the tailored
tyrothricin production using a novel, small-scale, high-throughput deep 96-well plate culturing
method followed by analyses of the peptide mixtures using ultra-performance liquid
chromatography linked to mass spectrometry. We were able to gradually shift the production
profile of the tyrocidines and analogues, as well as the gramicidins between two extremes in terms
of peptide subsets and peptide hydrophobicity. This study demonstrated that tyrothricin peptide
subsets with targeted activity can be efficiently produced by simple manipulation of the aromatic
amino acid profile of the culture medium.
INTRODUCTION
Since the advent of antimicrobial use, there has been a
progressive increase in drug resistance toward conventional
antibiotics. This has instigated the search for an alternative
class of antimicrobial agents with novel mechanisms of
action and rare resistance (Brown & Wright, 2005).
Antimicrobial peptides are potential candidates with
membrane-linked mechanisms of action as well as
possible cellular targets (Brown & Wright, 2005). Their
rapid membranolytic activity reduces the likelihood of
resistant mutants developing. Furthermore, reduced
toxicities of the antimicrobial peptides through greater
selectivity toward the more negatively charged bacterial
cell membrane allow them to discriminate between
pathogen targets and the neutral membranes of plants
and animals (Javadpour et al., 1996; Matsuzaki et al.,
1991, 1995; Qin et al., 2003). Consequently, antimicrobial
peptides show potential in the development of therapeutic
agents to treat resistant strains of pathogenic micro-
organisms or to serve as bio-pesticides and preservatives
(Brul & Coote, 1999; Cleveland et al., 2001; Keymanesh
et al., 2009).
A major limitation to the large-scale use of antimicrobial
peptides has been the cost and efficiency of their
production (Bradshaw, 2003; Gordon et al., 2005; Marr
et al., 2006; Yeaman & Yount, 2003). Automated chemical
synthesis to produce antimicrobial peptides remains very
costly (Hancock & Lehrer, 1998; Hancock & Sahl, 2006;
Marr et al., 2006), while use of transgenic organisms for the
production of antimicrobial peptides, either directly (De
Bolle et al., 1996; Franc¸ois et al., 2002; Yarus et al., 1996) or
as fusion proteins (Lee et al., 2000; Li, 2011; Moon et al.,
2007), is limited to ribosomally produced antimicrobial
peptides. Our attention has turned to a group of non-
ribosomal antimicrobial peptides, the tyrocidines, which in
the tyrothricin complex were the first antibiotics in clinical
use (Dubos & Cattaneo, 1939; Dubos, 1939), although their
use was limited to topical applications due to observed
haemolytic toxicity (Rammelkamp & Weinstein, 1942;
Abbreviations: GS, gramicidin S; LC, liquid chromatography; Phc,
phenycidine; Tpc, tryptocidine; Trc, tyrocidine; UPLC, ultra-performance
liquid chromatography; VGA, Val-gramicidin A.
Supplementary material is available with the online version of this paper.
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Rankin, 1944; Robinson & Molitor, 1942). The production
of non-ribosomal peptides such as the tyrocidines by
recombinant technology is, however, much more challen-
ging. The vast majority of the work on the synthesis of
non-ribosomal peptides has arguably been done on the
peptide surfactin, a promising biosurfactant (Arima et al.,
1968; Desai & Banat, 1997) and antimicrobial lipopeptide
produced by Bacillus subtilis (Hiraoka et al., 1992; Huang
et al., 2011; Sandrin et al., 1990). Efforts to increase
surfactin production have included the alteration of
growth medium composition, environmental factors,
product removal (Cooper et al., 1981; Ohno et al., 1995;
Sheppard & Mulligan, 1987) and the addition of carriers to
the growth medium (Drouin & Cooper, 1992; Yeh et al.,
2005). Genetic manipulation of B. subtilis has shown some
success via the induction of random mutations (Gong et al.,
2009; Liu et al., 2006; Mulligan et al., 1989) as well as
recombinant technology (Ohno et al., 1992).
The peptides in the tyrothricin complex, the basic
tyrocidines and neutral gramicidins (Dubos & Hotchkiss,
1941; Hotchkiss & Dubos, 1941; Tang et al. 1992) (refer to
Table 1), are produced by a series of multi-domain
enzymic peptide synthetases that are encoded by the
tyrocidine biosynthesis operon (Mootz & Marahiel, 1997)
or gramicidin biosynthesis operon, respectively (Kessler
et al., 2004). Most of the understanding of the genetic
control of tyrocidine production has been garnered from
expression systems in B. subtilis (Marahiel et al., 1987;
Mootz & Marahiel, 1997), as the tyrocidine producer strain
Bacillus aneurinolyticus, previously known as Bacillus brevis
(Dubos, 1939), has been found to be genetically less
accessible (Marahiel et al., 1987). Whilst a truncated
dipeptide version of the tyrocidines has been produced
successfully in Escherichia coli through the recombinant
expression of the first two modules of the tyrocidine
biosynthesis operon (Gruenewald et al., 2004), the
synthesis of a complete tyrocidine peptide in a recombin-
ant organism is yet to be achieved.
Employing recombinant technology to improve tyrothricin
production may not be necessary, as high natural
production of tyrothricin has been achieved by several
investigators (Appleby et al., 1947a, b; Baron, 1949; Lewis
et al., 1945; Stokes & Woodward, 1943), including our
group. The tyrocidines, as well as their structural analogues
the tryptocidines and phenycidines (Table 1), are produced
primarily during the late exponential growth phase by B.
aneurinolyticus (Dubos & Hotchkiss, 1941; Dubos &
Cattaneo, 1939; Dubos, 1939; Hotchkiss & Dubos, 1941).
The conditions that govern tyrocidine production by B.
aneurinolyticus relate to nitrogen, such as urea (Baron,
1949) and amino acid (Mach & Tatum, 1964; Ruttenberg &
Mach, 1966; Stokes & Woodward, 1943) supplementation,
and carbon nutrition (Stokes & Woodward, 1943). Whilst
shifts in tyrothricin production have been reported in the
literature (Mach & Tatum, 1964; Ruttenberg & Mach,
1966), the exact nature and control of this shift in
antimicrobial production remain to be elucidated.
Furthermore, Stokes & Woodward (1943) have reported
an inhibition of tyrothricin production with the supple-
mentation of certain amino acids to the culture medium.
These studies have largely focused on total tyrothricin
production and not the identity of the specific antimicro-
bial peptides produced.
These cationic tyrocidines and their analogues in the
tyrothricin complex have a fairly conserved cyclic decapep-
tide structure (Table 1), containing one pentapeptide
repeat of gramicidin S (GS) (Paladini & Craig, 1954;
Ruttenberg et al., 1965). Variations are mainly in the
variable pentapeptide moiety at the aromatic dipeptide
unit containing Trp and/or Phe or at the third variable
aromatic residue (generally Tyr) (King & Craig, 1955a, b;
Mach & Tatum, 1964; Paladini & Craig, 1954; Ruttenberg
& Mach, 1966; Ruttenberg et al., 1965; Tang et al. 1992).
However, despite the conserved structures of the tyroci-
dines, it has been found that specific tyrocidines were more
active against certain pathogens. The more polar Trc B and
C (Table 1), containing either Phe and Trp or two Trp
residues in the aromatic dipeptide moiety, respectively, are
more active against Gram-positive bacteria (Spathelf &
Rautenbach, 2009). The more non-polar Trc A, containing
two Phe residues, is most active against the human malaria
parasite Plasmodium falciparum 3D7 (Rautenbach et al.,
2007). Our group also found that the tyrocidines have
pronounced antifungal activity, dictated by the primary
sequence (Rautenbach et al., 2013). Whilst previous results
on the major tyrocidines are promising, this clearly
accentuated the need to elucidate the conditions that
would allow for the maximal production of the different
coproduced tyrocidines and analogues described previously
by Tang et al. (1992).
The aim of our study was to elucidate the optimal amino
acid supplementation for the manipulation of tyrothricin
production by B. aneurinolyticus ATCC 10068 to produce
pathogen-specific tailored tyrocidine subsets or to produce
extracts that could ease the downstream purification of
single peptides. We supplemented culture media with
selected amino acids central to the production and
variability of the different tyrocidines and analogues. A
small-scale high-throughput culturing methodology was
developed to vary the culture medium concentrations of
certain amino acids central to tyrocidine and gramicidin
production by the B. aneurinolyticus ATCC 10068 producer
strain. The peptide mixtures produced were then analysed
using ultra-performance liquid chromatography (UPLC)
linked to ES-MS to reveal the antimicrobial production
profile of the producer strain as affected by the specific
ratio of certain key amino acids in the culture media.
METHODS
Materials and reagents. B. aneurinolyticus ATCC 10068 was
obtained from the American Type Culture Collection. Micrococcus
luteus NCTC 8340 was obtained from the UK National Collection of
Type Cultures. Deep 96-well plates, tryptone, yeast extract, peptone,
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glucose, agar, HCl tryptone soy broth (TSB), LB broth, and the L-
amino acids Lys and Arg were from Merck. The L-amino acids Cys,
Phe, Tyr and Trp were from Sigma-Aldrich. Sterilization of media was
achieved by filtration using either a 0.22 mm sterile bottle top filtration
system from Whatman Klari-Flex or sterile syringes and 0.20 mm to
25 mm syringe filters from Lasec (Cape Town, South Africa). GS and a
commercially obtained tyrothricin extract (Sigma) were used as
positive controls in the antibacterial activity assays. Acetonitrile
(HPLC grade, far-UV cut-off) was from Romil. Acquity UPLC BEH
C18 (1.7 mm particle size, 2.1 mm6100 mm) UPLC columns and
Nova-Pak C18 (5 mm particle size, 60 A˚ pore size 150 mm63.9 mm)
analytical HPLC columns were supplied by Waters-Millipore.
Analytical-grade water was prepared by filtering water from a reverse
osmosis plant through a Millipore-Q water purification system.
Pre-culturing of the producer strain. Single colonies of the B.
aneurinolyticus ATCC 10068 producer strain were obtained from
freezer stocks by culturing using normal sterile techniques on pre-
culture plates (5.0 g peptone, 2.5 g yeast extract, 1.0 g glucose and
1.0 g skimmed milk powder, 15 g agar in 1.0 l water). Single colonies
were selected and incubated while shaking at 220 r.p.m. for 24 h at
37 uC in Falcon tubes containing 5 ml TGS (tryptone, glucose and
inorganic salts) culture media (Lewis et al., 1945). Amino acid
composition of the tryptone in TGS medium was determined by
HPLC using the Pico-Tag method (Bidlingmeyer et al., 1984) (Table
S1, available in Microbiology Online).
Analysis of growth rates of B. aneurinolyticus ATCC 10068. A
dilution series of single amino acids (Phe and Trp) ranging from 2.75
Table 1. Summary of identity, sequence and UPLC-MS data of the major peptides investigated in tyrothricin extracts from B.
aneurinolyticus ATCC 10068
High-resolution MS data (error ,5 p.p.m.) are given for both the [M+2H]2+ monoisotopic molecular ion and calculated experimental
monoisotopic Mr.
Peptide Abbreviation Sequence UPLC retention
time (min)
Major m/z
detected*
Mr
experimental*,D
(Mr theoretical)*
Tyrocidine A analogues (Ff)
Phenycidine Ad,§ Phc A Cyclo-(fPFfNQFVOL) 10.97 627.8367 1253.6578
(1253.6579)
Tyrocidine A Trc A Cyclo-(fPFfNQYVOL) 10.56 635.8347 1269.6538
(1269.6546)
Tyrocidine A1 Trc A1 Cyclo-(fPFfNQYVKL) 10.39 642.8423 1283.6690
(1283.6703)
Tryptocidine A Tpc A Cyclo-(fPFfNQWVOL) 11.13 647.3443 1292.6730
(1292.6706)
Tyrocidine B analogues (Wf)
Tyrocidine B Trc B Cyclo-(fPWfNQYVOL) 9.46 655.3398 1308.6640
(1308.6655)
Tyrocidine B1 Trc B1 Cyclo-(fPWfNQYVKL) 9.26 662.3489 1322.6822
(1322.6812)
Tryptocidine B Tpc B Cyclo-(fPWfNQWVOL) 9.82 666.8477 1331.6798
(1331.6815)
Tyrocidine C analogues (Ww)
Tyrocidine C Trc C Cyclo-(fPWwNQYVOL) 8.65 674.8451 1347.6746
(1347.6764)
Tyrocidine C1 Trc C1 Cyclo-(fPWwNQYVKL) 8.60 681.8536 1361.6916
(1361.6921)
Tryptocidine Cd Tpc C Cyclo-(fPWwNQWVOL) 9.07 686.3535 1370.6914
(1370.6924)
Linear gramicidin
Val-gramicidin A VGA HCO-VGAlAvVvWlWlWlW-
NHCH2CH2OH#
11.00 941.5469 1881.0782
(1881.0783)
Standard one-letter abbreviations for amino residues are used; O, ornithine. D-residues are shown in lower case and variable residues are shown in
italics. Sequence data obtained from Tang et al. (1992) and identities were confirmed in our own MS-MS studies [refer to Tables S2–S11 and
Spathelf (2010)].
*Monoisotopic m/z; Mr.
DExperimental Mr calculated using the following equation: Mr5(m/z62)–261.007825.
dPhc A and Tpc C previously known as tyrocidine E and D, respectively (Tang et al. 1992).
§Named in this study due to the Tyr7 to Phe7 modification.
N-terminal residue formylated (HCO).
#C-terminal residue blocked by ethanolamine (NHCH2CH2OH).
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to 27.5 mM was performed in quintuplicate (n55) in sterile flat-
bottom microtitre plates. A pre-culture of B. aneurinolyticus was
diluted four times into the wells of the microtitre plates using TGS
culture media with or without supplemented amino acids at
different concentrations. The inoculated plates were incubated at
37 uC and growth was monitored spectrophotometrically (595 nm)
every hour for a period of 16 h using a Bio-Rad microtitre plate
reader.
Analysis of effect of amino acids supplementation on tyro-
thricin yield. Concentrations of 5.5, 16.5 and 27.5 mM of amino
acids (Phe, Trp, Tyr, Cys, Lys and Arg) were prepared. Triplicate
sterile dilutions of the respective amino acids concentrations were
performed using TGS culture medium, and the dilutions were
inoculated with a pre-culture of B. aneurinolyticus and incubated for
10 days at 37 uC. They were then centrifuged for 5 min at 4500 g, and
the cell pellet freeze-dried and weighed. Tyrothricin was then
extracted using 50 % acetonitrile, and freeze-dried for determination
of crude yield and activity against M. luteus.
Antibacterial activity assays. M. luteus NCTC 8340 was cultured
on LB broth to an OD620 of ~0.8 and then subcultured in TSB and
grown to an OD620 of 0.6 for use in dose–response assays. The
microtitre broth dilution method described by du Toit & Rautenbach
(2000) and Lehrer et al. (1991) was used to test the antimicrobial
activity of the peptides. Stock solutions (106) of the analytically
weighed tyrothricin extracts and commercial tyrocidine were
prepared in 15 % ethanol (v/v) and diluted with media in order to
determine activity over a concentration range of 0.8–200 mg ml21. All
cultures were grown for 16 h at 37 uC in the presence of 1.5 % ethanol
(v/v) to compensate for the effect of ethanol in the peptide samples.
Growth was measured at 595 nm. The MIC was determined as the
first dilution where no growth was detected.
High-throughput deep-well production of tyrothricin. A fourfold
dilution of pre-cultured B. aneurinolyticus was prepared using TGS
culture medium. Aliquots of 10 ml were pipetted into sterile deep 96-
well plates containing 500 ml per well of TGS culture medium
supplemented with quadruplicate dilutions (2.75–27.5 mM) of amino
acids (Phe, Trp, Tyr, Cys, Lys and Arg). These microtitre plates were
subsequently covered and incubated for 96 h at 37 uC.
The cultures in the deep-well plates were then acidified with HCl to
pH 4.7 and allowed to stand at room temperature for 24 h. The deep-
well plates were subsequently centrifuged for 60 min at 2200 g. The
pellet in each well was resuspended in 200 ml of 100 % acetonitrile and
sonicated for 15 min. A further 200 ml of analytical-grade water was
then added to each well and the microtitre plate was sonicated for a
further 15 min followed by centrifugation for 30 min at 2200 g.
Thereafter, the respective extracts were pooled in analytically weighed
vials and freeze-dried to allow for analytical determination of extract
mass and analysis by UPLC linked to ES-MS.
ES-MS and UPLC-MS analysis of tyrothricin extracts. ES-MS
was performed using a Waters Quadrupole Time-of-Flight Synapt G2.
Samples were dissolved in 50 % (v/v) acetonitrile to 10.0 mg ml21,
centrifuged at 8600 g for 10 min to remove particulates and then
diluted to 1.00 mg ml21 using analytical-grade water. Injections of
3 ml samples were introduced via a Waters Acquity UPLC into a Z-
spray electrospray ionization source in positive mode for direct mass
analysis. The peptide identities were confirmed with high-resolution
MS (Table 1) and sequences via collision-induced dissociation (Tables
S2–S11). For UPLC analysis, 3 ml samples were separated on an
Acquity UPLC BEH C18 column at a flow rate of 0.450 ml min
21
using a 0.1 % trifluoroacetic acid (A) to acetonitrile (B) gradient
(100 % A from 0 to 0.5 min for loading, gradient was from 0 to 58 %
B from 0.5 to 12 min and then 58 to 90 % B from 12 to 13 min,
column wash was at 90 % B from 13 to 13.5 min, reconditioning was
done from 10 to 100 % A from 13.5 to 14 min and then 100 % A from
14 to 17 min). Analytes were subjected to a capillary voltage of 3.0 kV
and cone voltages of 15 V at a temperature of 120 uC at the source.
Data acquisition was performed by scanning the second analyser
(MS2) through the mass/charge ratio (m/z) range of 400–2000. Data
were then analysed using TARGETLYNX 4.1 (MASSLYNX mass spectro-
metry software; Waters).
HPLC analysis of peptide extracts. Extracts obtained in 50 %
acetonitrile (1 mg ml21, 10 ml injection) were analysed by reverse-
phase HPLC using methodology described previously by Rautenbach
et al. (2007).
RESULTS
Effect of amino acids supplementation on the
growth and tyrothricin production of B.
aneurinolyticus ATCC 10068
Having established the effects of certain key amino acids on
the growth and antimicrobial peptide production of the
producer strain, the ability of Phe and Trp, as well as selected
amino acids (Tyr, Cys, Lys and Arg), to manipulate
antimicrobial production was evaluated. Only supplementa-
tion of Phe and Trp had an effect on the tyrothricin
production profile; however, these amino acids had a
negative impact of the initial growth (primary growth
phase) of B. aneurinolyticus ATCC 10068 when compared
with growth in normal TGS medium (Table 2, Fig. 1). A
secondary growth phase (diauxie) was observed in cultures
where the growth medium was supplemented with Phe and
Trp (Fig. 1, Table 2). The pronounced inhibitory effect of
Trp supplementation on the initial growth was concentra-
tion dependent, as is evident from the delayed growth of the
producer strain with increasing concentrations of Trp (Table
2). This effect, however, was overcome as increased biomass
was observed after 96 h (results not shown), which was
sustained during the 10 days of culturing (Table 2, Fig. 1). In
contrast, supplementation with Phe initially only had a
slight dampening effect on the growth of the producer strain
(Fig. 1). After 96 h (results not shown) and 10 days (Table
2), increased biomass was obtained at the higher Phe
concentrations.
The relative antibacterial activity of the extracts obtained
from the cultures supplemented with increased amino acid
concentrations was generally less than that of the
commercial tyrothricin extract, as well as that of non-
supplemented control. However, the 5.5 mM Phe and Trp,
as well as 16.5 mM Phe, supplementation yielded high-
activity extracts, whilst the 27.5 mM Phe- and other two
Trp-supplemented cultures showed large decreases in
activity despite an increase in the extract masses (Table 2).
Manipulation of antimicrobial production of B.
aneurinolyticus
Using the novel, small-scale, high-throughput, deep 96-
well plate culturing method the producer strain was
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Table 2. Effect of supplementation of growth medium of B. aneurinolyticus with either Phe or Trp compared with the non-supplemented growth control
Condition (mM Phe
or Trp)
Lag time
(h)
First growth
rate±SEM (m) (n55)*
Second growth rate±SEM
(m) (n55)*
Per cent growth after
16 h±SEM (n55)D
Dry cell mass
(g l”1)d (n52)
Extract mass (g l”1)d
(n52)
Per cent IU±SEM§ (MIC)
(n512)
Growth control 5 0.92±0.02 2 100±6.6 6.91±0.29 2.29±0.01 102±2 (6.25)
Phe
2.75 5 0.89±0.03 0.32±0.02 91.9±3.5 2 2 2
4 5 0.85±0.01 0.23±0.03 160±28 2 2 2
5.5 5 0.82±0.03 0.22±0.03 198±30 6.14±1.91 2.18±0.36 91±3 (3.125)
11 5 0.83±0.02 0.22±0.03 206±34 2 2 2
16.5 5 0.78±0.02 0.15±0.03 178±33 10.1±0.41 2.85±0.06 99±3 (6.25)
22 6 0.79±0.02 0.15±0.02 136±28 2 2 2
27.5 6 0.75±0.01 0.15±0.01 100±6.0 10.6±0.57 2.19±0.16 69±10 (12.5)
Trp
2.75 6 0.75±0.02 0.24±0.04 57.5±1.8 2 2 2
4 7 0.62±0.02 0.24±0.04 49.0±2.4 2 2 2
5.5 7 0.59±0.01 0.25±0.02 48.8±4.6 7.20±3.45 2.10±0.48 89±5 (6.25)
11 8 0.46±0.02 0.14±0.01 46.2±2.2 2 2 2
16.5 8 0.39±0.01 0.13±0.01 38.3±1.1 7.95±2.14 2.73±0.68 62±12 (12.5)
22 12 0.33±0.02 0.13±0.01 23.7±0.3 2 2 2
27.5 14 0.09±0.01 2 9.10±0.1 7.96±1.38 2.90±0.58 10±3 (25.0)
*Growth rate (m) was determined as the Dln OD595/D time during the exponential growth phase over 16 h.
DAs determined from OD595 of culture after 16 h at 37 uC; calculated in terms of growth controls.
dDetermined after 10 days of cultivation at 37 uC.
§Per cent inhibition units (IU) defined as the percentage of the activity against M. luteus in terms of the MIC of commercial tyrothricin at 6.25 mg ml21 (mean of 12 determinations).
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cultured in culture medium supplemented with the
selected L-amino acids. The extracts obtained by growing
B. aneurinolyticus ATCC 10068 in the TGS medium or L-
amino acid-supplemented TGS medium were analysed by
analytical HPLC and UPLC-MS (Fig. 2). In TGS medium
the Trc A and B analogues (Ff and Wf) and Orn variants
dominated the tyrothricin profile, whilst the Trc C
analogue (Ww), Lys variants from the tyrocidine group
and VGA from the gramicidin group were also observed in
appreciable, but lower amounts (Table 1). The Orn
variant-dominated production profile was found, regard-
less of amino acid supplementation. Moreover, the
addition of Lys (or Arg) to culture medium did not shift
the production profile towards the Lys-containing peptides
(results not shown). We did not detect the Lys variants of
Tpc A or Tpc C and detected only trace amounts of the Lys
variants of Phc A and Tpc B, as well as the Ile variant of
gramicidin A and Val-gramicidin B within the extracts.
This result may possibly be accounted for when consider-
ing the endogenous low levels of the Lys variants and minor
gramicidins, as well as the low solubility of gramicidins in
polar solvents such as water (Hotchkiss & Dubos, 1941) and
50 % acetonitrile as used in the extraction and UPLC-MS
methodology. Due to the extremely low amounts of these
and other rare peptides in the extracts, we focused our
analyses on the 10 major tyrocidines and analogues, and
VGA as representative of the gramicidins, in our global
analyses of the tyrothricin production profile.
From all the amino acids tested, only Phe- or Trp-
supplemented cultures significantly altered the antimicro-
bial production profile of the producer strain relative to the
non-supplemented control (Fig. 3). According to the
amino acid analyses of tryptone used in our media, the
TGS medium contained 3.4 mM Phe and 1 mM Trp in
free form, and 1.9 mM Phe and 0.2 mM Trp in the less-
available peptide/protein form (Table S1). A complete shift
of the antimicrobial peptide production profiles occurred
at the pivotal supplement concentrations of 5.5 mM Phe
(total 10.8 mM Phe in medium) and 11 mM Trp (total
12.2 mM Trp in medium) (Fig. 4). Phe supplementation
shifted the antimicrobial production profile toward the
production of the Trc A analogues (denoted Ff), while
VGA production was concomitantly inhibited with
increasing concentrations of Phe (Fig. 4a). This correlated
with the antibacterial activity of the 10 day extracts, as at
the supplementation concentration of 5.5 mM Phe, the
extract yielded an MIC of 3.125 mg ml21, a higher activity
than the growth control extract and commercial tyrothri-
cin. However, at the highest Phe concentration of
27.5 mM, a reduction in activity was observed (fourfold
increase in the MIC), as well as a decrease in activity units.
In contrast, Trp supplementation shifted the antimicrobial
production profile towards the production of the Trc C
analogues (denoted Ww), as well as increasing VGA
production (Fig. 4b). Trp supplementation led to a
reduction in antimicrobial activity with increased Trp
concentrations. The 5.5 mM Trp-supplemented culture
extract yielded a MIC of 6.25 mg ml21 equivalent to that of
both the controls. However, the MIC doubled with the
extracts from 16.5 and 27.5 mM Trp supplementation,
correlating with the reduced activity units of 62 % and
10 %, respectively (Table 2).
Having established the effect on the antimicrobial produc-
tion profile of the producer strain through supplementation
of the growth media with both Phe and Trp alone, the effect
of supplementation with different combinations of Phe and
Trp was evaluated. The concentration of supplemented Phe
was varied from 2.75 to 27.5 mM, together with fixed
concentrations of Trp of 5.5, 11 or 16.5 mM, respectively
(Fig. 5). Supplementation with a combination of Phe
together with Trp led to a shift in the antimicrobial peptide
production profile toward predominantly the Trc B
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Fig. 1. Growth curves of B. aneurinolyticus in cultures supplemented with different concentrations of Phe (a) and Trp (b)
showing pronounced diauxie. Each time point is the mean of quintuplicate determinations.
Manipulation of tyrothricin production
http://mic.sgmjournals.org 2205
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
analogues. A supplement concentration of 5.5 mM Trp
led to domination of the Ww subset, with the Ww to Wf
analogue shift observed with addition of 2.5 mM Phe, Wf
to Ff at 11 mM Phe, and only at 27.5 mM Phe did the Ff
subset equal the Ww subset (Fig. 5a). As expected, these
shifts in antimicrobial peptide subset production only
occurred at much higher concentrations of Phe when
higher Trp concentrations were supplemented in the
media (Fig. 5b, c).
When all the Trp and Phe supplementation data and total
concentrations of these amino acids in the media were
considered in combined graphs (Fig. 6a, b), the production
trends again showed that ~75 % Phe (,0.2 Trp : Phe) was
needed for Ff .Ww and .80 % Phe was needed for Ff
.Wf. The Wf subset was sensitive to the Phe and Trp
contribution and dominated only in the narrow 60–80 %
Phe concentration range (Fig. 6). Conversely, a .40 % Trp
contribution or a ratio of Trp : Phe .0.8 led to the
dominance of the Trc C analogues (Ww), at the expense of
both the Trc A (Ff) and B (Wf) analogues (Fig. 6). VGA
production increased initially, following the Trc C
analogue increase, but then the VGA concentration
remained relatively constant with increasing Trp contri-
bution (results not shown).
DISCUSSION
Two key amino acids (Phe and Trp) had a major effect on
the growth and total tyrothricin production. The diauxic
growth observed in the cultures supplemented with amino
acids is similar to that observed by Vandamme & Demain
(1976) in B. brevis ATCC 9999, the GS producer strain.
They found B. brevis initially grew at the expense of amino
acids supplemented in the growth medium; only after a
diauxic lag was the available carbon source utilized and
antimicrobial peptide production initiated.
The initial lag in the growth of the cultures supplemented
with Trp which was far less evident in the Phe-
supplemented cultures may possibly be due to the toxic
effects of Trp, which were overcome over an extended
growth period. Stokes & Woodward (1943) reported an
inhibition of tyrothricin production in submerged, aerated
cultures supplemented with 0.5 % (w/v) of Trp, which
equated to a molar concentration of 24.5 mM. In the
present study, biomass production was initially lower, but
this was overcome after 96 h of culturing where biomass
and extract masses were similar to that of the control after
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Fig. 2. UPLC-MS chromatograms depicting the separation of a
mixture of the different tyrocidines, their analogues and VGA in this
study. The retention time for each of the peaks is given in the top
figure and the y-axis depicts the ES-MS signal. The small fronting
Trc B peak and trailing Trc B1 peak are the minor Trc B/B1
analogues with an inverted aromatic dipeptide unit (Trc B9 and B19,
respectively). Details of the primary structures are given in Table 1.
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the culmination of the culturing period at 10 days (Table
2). However, if the antimicrobial activity determined in the
27.5 mM Trp extract is considered, our results correlate
well with those of Stokes & Woodward (1943). In contrast,
the antimicrobial activity in the extracts of all the Phe-
supplemented cultures was particularly high, directly
correlating with the good biomass yields.
Analysis of the tyrothricin extracts by UPLC-MS revealed
only Phe and Trp supplementation significantly altered the
tyrothricin production profile B. aneurinolyticus. These
results are similar to those of Demain & Matteo (1976)
who found that Phe did not stimulate growth, but it did
stimulate GS production in B. brevis ATCC 9999 by acting
as a precursor for the initiation module, which is similar to
the module for tyrocidine initiation. In contrast, we found
Phe supplementation stimulated growth and also produc-
tion of Ff tyrocidine subsets more than the linear
gramicidins (i.e. VGA) in B. aneurinolyticus (Table 2, refer
to Fig. 4). In the non-supplemented culture medium the
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Fig. 3. Analytical HPLC chromatograms visualized at 254 nm depicting the peptide production profiles of the extracts obtained
from cultures of B. aneurinolyticus ATCC 10068 grown in non-supplemented medium (a) or altered by supplementation of the
medium with 5.5 mM Phe (b) or 5.5 mM Trp (c).
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Fig. 4. Peptide production profiles of the extracts obtained from cultures of B. aneurinolyticus ATCC 10068 grown in medium
supplemented with 2.75–27.5 mM of either: (a) Phe, resulting in predominantly the production of the Trc A analogues (Ff), or
(b) Trp, resulting in predominantly the production of the Trc C analogues (Ww) together with VGA, relative to the non-
supplemented control. The contribution of each analogue was calculated as a percentage of the sum of the total UPLC peak
areas observed for the different peptides. The dotted lines show the pivotal Phe or Trp concentrations where one peptide
subset dominated in the tyrothricin extract.
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producer strain predominantly produced Trc A and B
analogues as well as low levels of VGA. Supplementation of
the growth medium with either Trp or Phe above the
pivotal concentrations of 5.5 and 11 mM, respectively,
shifted the antimicrobial production profile between two
extremes of the Phe-containing peptides and Trp-contain-
ing peptides (Fig. 4). In general, Phe supplementation
shifted the production towards peptides with high Phe
content and Phe in position 4 of the tyrocidine structure
(Ff, Trc A and analogues). Phe supplementation sup-
pressed not only the production of the Trc B and C
analogues, but also that of VGA. This shift is beneficial as
we found purification of Trc A analogues to be quite
difficult in the presence of gramicidins. In contrast, Trp
supplementation enhanced the production of the Trc C
analogues (Trp in position 4), similar to what was observed
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Fig. 5. Peptide production profiles of the extracts obtained from cultures of B. aneurinolyticus ATCC 10068 grown in medium
supplemented with 2.75–27.5 mM Phe together with either: (a) 5.5, (b) 11 or (c) 16.5 mM Trp; relative to the non-
supplemented control. The contribution of each analogue was calculated as a percentage of the sum of the total UPLC peak
areas observed for the different peptides. The dotted lines show the Phe concentration that led to production change from one
peptide subset to another.
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for all (two opposing sigmoidal curves were fitted to Wf in b), except for Wf in (a) where only a third-order polynomial could be
fitted.
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by Ruttenberg & Mach (1966), but also the production of
gramicidin A, which also contains a Trp in the variable
aromatic residue position (Figs 2, 3 and 4).
Supplementation of both Trp and Phe led to a major loss in
the peptides with high Phe content at .20 % Trp in
supplement, and peptides with both Trp and Phe in their
structure (Wf, Trc B analogues) increased as the Trp : Phe
ratio approached 1 : 1 (Fig. 6b). The supplementation of
5.5 mM Trp to the culture medium gave an ~55 % molar
content of Trp, and hence both the Ww and Wf subsets
were produced. Further Trp concentration increase to
.60 % Trp led predominantly to the production of the C
analogues (Ww) together with the Trp-rich VGA (Figs 5c
and 6a). These studies also clarify the predominance of Trc
A (Ff) and B analogues (Wf) produced by B. aneurinolyticus
in the non-supplemented TGS culture medium. The only
source of amino acids in the non-supplemented TGS
medium is from the trypsin-digested casein in the tryptone
added to the media. From the amino acid analysis of the
tryptone it was calculated that there was .80 % free Phe
molar content in terms of total Trp+Phe concentration in
the non-supplemented medium and hence production of
the Ff subset (Trc A analogues) predominates, with some
Wf subset production. The latter is most probably due to
the availability of ~100 % free Trp versus 64 % free Phe.
These peptide subset shifts are probably due to a balance
between the aromatic amino acid affinity of the peptide
synthetases and increased availability of Phe or Trp. Mootz
& Marahiel (1997) found the adenylation domain of the
related tyrocidine producer strain B. aneurinolyticus ATCC
8185, responsible for incorporation of either Phe or Trp at
position 4, had an affinity approximately fivefold higher for
Trp (Mootz & Marahiel, 1997). Therefore, the proportion
of each of the antimicrobial peptides produced due to the
incorporation of the variable residues was dependent not
only on amino acid availability within the growth media
(Ruttenberg & Mach, 1966) and subsequent transport into
the cells, but also on the affinity of the peptide synthetases
for the respective residues (Mootz & Marahiel, 1997).
Knowledge of the identity of the different antimicrobial
peptides produced under the different conditions also
explained the variation in antibacterial activity of our
different extracts (Table 2). Increased Trp supplementation
led to not only an increase in the production of the Trc C
analogues (Ww), but also that of VGA (Fig. 4b). Aranda &
de Kruijff (1988) reported the disruption of model
membranes by the tyrocidines to be antagonized by
VGA. Hence, increased VGA production, particularly in
the 16.5 and 27.5 mM Trp-supplemented cultures,
accounts for the significant loss in activity observed with
increasing Trp supplementation (Table 2).
When considering the Phe-supplemented cultures, both
the 5.5 and 16.5 mM Phe extracts showed potent activity
that may relate to an optimal Ff to Wf tyrocidine
combination and very low VGA in the extracts. However,
there was a drop in the extract mass as well as activity with
supplementation of 27.5 mM Phe (Table 2). Spathelf &
Rautenbach (2009) reported that the Trc B analogues (Wf)
had greater antibacterial activity than the Trc A analogues
(Ff). Therefore, the observed loss in activity may possibly
be accounted for when considering the shift in antimicro-
bial production away from the production of a combina-
tion of the Trc A (Ff) and B (Wf) analogues at lower
concentrations of Phe, toward the sole production of the
Trc A analogues at increased Phe concentrations. The drop
in extract mass observed at the increased Phe concentration
could be due to growth inhibition at high amino acid
concentrations or aggregation of the hydrophobic Ff
peptides at high concentrations leading to loss during
extraction. However, these hypotheses remain to be
investigated, as well as possible interactions between the
different tyrocidine analogues and VGA, which may affect
their activity in extracts.
CONCLUSION
Our studies showed that the availability of the aromatic
amino acids, Phe and Trp, had a major role in the highly
controlled antimicrobial peptide production profile of B.
aneurinolyticus ATCC 10068. We have also demonstrated
clearly that selected analogues could be produced by simply
changing the availability and ratios of Phe and Trp within
the culture medium. From these studies it is possible to
design large-scale production cultures to produce tailored
antimicrobial peptide complexes such as the Trc B and C
analogues targeting Gram-positive bacteria (Spathelf &
Rautenbach, 2009), and Trc A analogues targeting the
human malaria parasite, P. falciparum (Rautenbach et al.,
2007).
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SUPPLEMENTARY DATA 
METHODS 
Amino acid analysis of tryptone 
Vacuum-dried samples of 1.5% tryptone in water were analysed for amino acid composition after a 
shortened 1 hour gaseous phase hydrochloric acid  hydrolysis (6M HCl, 1% phenol, 150oC) or 24 hour 
liquid hydrolysis using methane sulfonic acid  (4M MSA,  0.2% tryptamine) at 110oC (Cohen et al.. 
Pico-Tag® manual). Amino acid analyses were done via HPLC using a pre-column derivatisation of 
samples with phenylisothiocyanate  (PITC), according to the Pico-Tag® method (Bidlingmeyer et 
al.1984, Cohen et al.. Pico-Tag® manual).  
ESMS sequencing of peptides 
MS-MS sequencing of the six major tyrocidines (Trc A, A1, B, B1, C, and C1) and TrpC were 
performed using a Waters Q-TOF Ultima mass spectrometer fitted with an electrospray ionisation 
source. Capillary voltage was 3.5 kV with the source temperature and cone voltage set at 100 ºC and 35 
V, respectively. MS-MS analyses were performed by injecting 30 µL of peptide solution (100 µg/mL in 
acetonitrile/ water, 1:1, v/v) into the mass spectrometer and subjecting the selected molecular species to 
decomposition at collision energy of 40 eV. Data was collected in MS2 through m/z = 100-1999. 
For sequence analysis of TpcA, TpcB and PhcA we utilised a Waters Q-TOF Synapt mass spectrometer 
fitted with a Z-spray electrospray ionisation source.  Capillary voltage was 3.5 kV with the source 
temperature and cone voltage was set at 120 ºC and 15 V, respectively. MS–MS analyses were 
performed by injecting 2 µL peptide solution (200 µg/mL in acetonitrile/water, 1:1, v/v) was introduced 
into spectrometer via a Waters Acquity UPLCTM. CID of selected molecular ions was performed with 
collision energy of argon gas at a gas pressure of 10-15 psi in MS2 with the collision energy ramp from 
15 to 60 eV. The second analyzer was scanned from m/z = 40 to 1400. Fragment ions are named 
according to the principal established by Roepstorff and Fohlmann ( 1984), as revised by Biemann and 
Martin (1988).  
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RESULTS  
Amino acid composition of tryptone used in culture medium 
Table S1 Amino acid concentrations of the 1.5% tryptone used in culture medium in comparison 
with literature values obtained for 1.5% casein. The tryptone amino acid concentrations are 
the average of 3-8 determinations. 
Amino acid 
Casein: total  
[Amino acid] 
±SEM (mM)$ 
Tryptone: total  
[amino acid] 
±SEM (mM) 
Tryptone: free  
[amino acid]  
± SEM (mM) 
Alanine 5.5 ±  0.2 5.5 ±  0.1 2.6 ±  0.2 
Arginine 3.5 ±  0.1 3.2 ±  0.1 3.4 ±  0.2 
Aspartic acid 8.4 ±  0.2 7.1 ±  0.1 0.6  ± 0.05 
Cystine 0.5 ±  0.1  ND 0.7 ±  0.1 
Glutamic acid 22.5 ±  0.6 17.3 ±  0.3 2.2 ±  0.1 
Glycine 4.5 ±  0.6 4.9  ± 0.05 1.0 ±  0.1 
Histidine 3.1 ±  0.1 2.3 ±  0.1 0.5  ± 0.04 
Isoleucine 6.9 ±  0.1 6.4 ±  0.2 1.8 ±  0.2 
Leucine 10.9 ±  0.2 10.4 ±  0.3 7.3 ±  0.4 
Lysine 8.5 ±  0.2 9.8 ±  0.1 9.3 ±  0.7 
Methionine 3.0 ±  0.1 2.8 ±  0.1 1.6 ±  0.2 
Phenylalanine 4.8 ±  0.2 5.3 ±  0.1 3.4 ±  0.2 
Proline 15.3 ±  0.2 13.1 ±  0.2 0.5 ± 0.01 
Serine 9.1 ±  0.3 8.0   ±  0.2* 1.5 ±  0.2 
Threonine 6.1 ±  0.3 4.6   ±  0.1* 1.5 ±  0.1 
Tryptophan 1.0 ±  0.1 1.2 ±  0.1 1.0 ±  0.1 
Tyrosine 5.5 ±  0.2 3.1   ±  0.4* 0.8 ±  0.1 
Valine 9.1 ±  0.1 7.8 ±  0.3 2.6 ±  0.4 
 
$
  Literature values from Gordon et al. (1949); Sundararajan & Sarma (1957);  
Ellinger & Boyne (1965) 
*  Corrected respectively for 17% (Ser), 13% (Thr) and 11% (Tyr) loss during hydrolysis.  
 ND, not determined 
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MS-MS sequencing of tyrocidines and analogues in this study 
Table S2  Summary of fragment assignment of the major product ions generated by CID of the 
m/z=1270.7 molecular ion of tyrocidine A 
m/z 
observed 
Proposed  
ring opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
1270.67 -
 
[M+H]+ 1270.66 cyclo(P2F3f4N5Q6Y7V8O9L10f1) 
1105.60 Phe1-Pro2 b9 -NH3 1105.56 P2F3f4N5Q6Y7V8O9L10 
1010.54 Phe1-Pro2 b8 1010.51 P2F3f4N5Q6Y7V8O9 
896.45 Phe1-Pro2 b7 896.43 P2F3f4N5Q6Y7V8 
797.35 Phe1-Pro2 b6 797.36 P2F3f4N5Q6Y7 
634.31 Phe1-Pro2 b5 634.30 P2F3f4N5Q6 
506.25 Phe1-Pro2 b4 506.24 P2F3f4N5 
406.18 any Internal fragment 406.17 N5Q6Y7 
392.21 Phe1-Pro2 b3 392.20 P2F3f4 
390.18 any Internal fragment 390.18 f4N5Q6 
245.14 Phe1-Pro2 b2 245.13 P2F3 
243.15 any Internal fragment 243.11 N5Q6 
217.14 Phe1-Pro2 a2 217.12 P2F3 
115.09 Val8-Orn9 b1 115.09 O9 
 Table S3  Summary of fragment assignment of the major product ions generated by CID of the 
m/z=1284.7 molecular ion of tyrocidine A1 
m/z 
observed 
Proposed 
ring opening 
Proposed  
fragment type 
m/z 
calculated Sequence 
1284.69 - [M+H]+ 1284.68 cyclo(P2F3f4N5Q6Y7V8K9L10f1) 
1137.63 Phe1-Pro2 b9 1137.61 P2F3f4N5Q6Y7V8K9L10 
1024.54 Phe1-Pro2 b8 1024.53 P2F3f4N5Q6Y7V8K9 
896.46 Phe1-Pro2 b7 896.43 P2F3f4N5Q6Y7V8 
797.36 Phe1-Pro2 b6 797.36 P2F3f4N5Q6Y7 
634.31 Phe1-Pro2 b5 634.30 P2F3f4N5Q6 
506.25 Phe1-Pro2 b4 506.24 P2F3f4N5 
406.18 any Internal fragment 406.17 N5Q6Y7 
392.21 Phe1-Pro2 b3 392.20 P2F3f4 
390.19 any Internal fragment 390.18 f4N5Q6 
364.20 Phe1-Pro2 a3 364.19 P2F3f4 
245.14 Phe1-Pro2 b2 245.13 P2F3 
243.15 any Internal fragment 243.11 N5Q6 
217.14 Phe1-Pro2 a2 217.12 P2F3 
120.09 
any Internal 
fragment-CO 120.07 f1 or F3 or f4 
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Table S4  Summary of fragment assignment of the major product ions generated by CID of the 
m/z=1309.7 molecular ion of tyrocidine B  
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
1309.69 - [M+H]+ 1309.67 cyclo(P2W3f4N5Q6Y7V8O9L10f1) 
1144.62 Phe1-Pro2 b9 -NH3 1145.60 P2W3f4N5Q6Y7V8O9L10 
1049.53 Phe1-Pro2 b8 1049.52 P2W3f4N5Q6Y7V8O9 
935.47 Phe1-Pro2 b7 935.44 P2W3f4N5Q6Y7V8 
836.37 Phe1-Pro2 b6 836.37 P2W3f4N5Q6Y7 
673.33 Phe1-Pro2 b5 673.31 P2W3f4N5Q6 
545.27 Phe1-Pro2 b4 545.25 P2W3f4N5 
431.22 Phe1-Pro2 b3 431.21 P2W3f4 
406.18 any Internal fragment 406.17 N5Q6Y7 
390.19 any Internal fragment 390.18 f4N5Q6 
284.14 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.12 any Internal fragment 243.11 N5Q6 
159.10 any Internal fragment-CO 159.08 W
3
 
 
Table S5  Summary of fragment assignment of the major product ions generated by CID of  
the m/z=1323.7 molecular ion of tyrocidine B1  
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
1323.72 - [M+H]+ 1323.69 cyclo(P2W3f4N5Q6Y7V8K9L10f1) 
1176.62 Phe1-Pro2 b9 1176.62 P2W3f4N5Q6Y7V8K9L10 
1063.56 Phe1-Pro2 b8 1063.54 P2W3f4N5Q6Y7V8K9 
935.44 Phe1-Pro2 b7 935.44 P2W3f4N5Q6Y7V8 
836.37 Phe1-Pro2 b6 836.37 P2W3f4N5Q6Y7 
673.33 Phe1-Pro2 b5 673.31 P2W3f4N5Q6 
545.26 Phe1-Pro2 b4 545.25 P2W3f4N5 
431.22 Phe1-Pro2 b3 431.21 P2W3f4 
406.18 any Internal fragment 406.17 N5Q6Y7 
390.19 any Internal fragment 390.18 f4N5Q6 
284.15 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.12 any Internal fragment 243.11 N5Q6 
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Table S5  Summary of fragment assignment of the major product ions generated by CID of the 
m/z=1348.7 molecular ion of tyrocidine C 
m/z 
observed 
Proposed  
ring opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
1348.63 - [M+H]+ 1348.68 cyclo(P2W3w4N5Q6Y7V8O9L10f1) 
1184.61 Phe1-Pro2 b9 -NH3 1184.61 P2W3w4N5Q6Y7V8O9L10 
1088.51 Phe1-Pro2 b8 1088.53 P2W3w4N5Q6Y7V8O9 
957.41 Phe1-Pro2 b7 -NH3 957.45 P2W3w4N5Q6Y7V8 
875.38 Phe1-Pro2 b6 875.38 P2W3w4N5Q6Y7 
844.43 Val8-Orn9 b6 844.45 O9L10F1P2W3w4 
712.31 Phe1-Pro2 b5 712.32 P2W3w4N5Q6 
584.25 Phe1-Pro2 b4 584.26 P2W3w4N5 
470.21 Phe1-Pro2 b3 470.22 P2W3w4 
406.17 any Internal fragment 406.17 N5Q6Y7 
284.14 Phe1-Pro2 b2 284.14 P2W3 
256.14 Phe1-Pro2 a2 256.13 P2W3 
243.10 any Internal fragment 243.11 N5Q6 
 
Table S6  Summary of fragment assignment of the major product ions generated by CID of the 
m/z=1362.7 molecular ion of tyrocidine C1    
m/z 
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
1362.73 - [M+H]+ 1362.68 cyclo(f1P2W3w4N5Q6Y7V8K9L10) 
1198.65 Phe1-Pro2 b9 -NH3 1198.62 P2W3w4N5Q6Y7V8K9L10 
1102.58 Phe1-Pro2 b8 1102.55 P2W3w4N5Q6Y7V8K9 
974.49 Phe1-Pro2 b7 974.45 P2W3w4N5Q6Y7V8 
858.51 Phe1-Pro2 b6 -NH3 858.38 P2W3w4N5Q6Y7 
712.33 Phe1-Pro2 b5 712.32 P2W3w4N5Q6 
584.29 Phe1-Pro2 b4 584.26 P2W3w4N5 
470.23 Phe1-Pro2 b3 470.22 P2W3w4 
406.19 any Internal fragment 406.17 N5Q6Y7 
284.15 Phe1-Pro2 b2 284.14 P2W3 
256.10 Phe1-Pro2 a2 256.13 P2W3 
243.10 any Internal fragment 243.11 N5Q6 
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 Table S7  Summary of fragment assignment of the major product ions generated by CID of 
m/z=627.3 molecular ion of tryptocidine A  
m/z  
observed 
Proposed 
ring opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
647.34 - [M+2H]2+ 647.34 cyclo(f1P2F3f4N5Q6W7V8O9L10) 
1194.60 Val8-Orn9 b9 1194.61 O9L10f1P2F3f4N5Q6W7 
1033.53 Phe1-Pro2 b8 1033.53 P2F3f4N5Q6W7V8O 
1008.53 Val8-Orn9 b8 1008.53 O9L10f1P2F3f4N5Q6 
820.41 Phe1-Pro2 b6 820.38 P2F3f4N5Q6W 
634.30 Phe1-Pro2 b5 634.30 P2F3f4N5Q6 
619.36 Val8-Orn9 b5 619.36 O9L10f1P2F3 
506.24 Phe1-Pro2 b4 506.24 P2F3f4N5 
392.20 Phe
1
-Pro2 
any 
b3;  
Internal fragment 392.20 
P2F3f4 
f1P2F3 
245.13 Phe
1
-Pro2 
any 
b2 
Internal fragment 245.13 
P2F3  
f2P2 
228.14 Val8-Orn9 b2 228.17 O9L10 
115.09 Val8-Orn9 b1 115.09 O9 
 
 Table S8  Summary of fragment assignment of the major product ions generated by CID of 
m/z=666.9 molecular ion of tryptocidine B  
m/z 
observed 
Proposed ring 
opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
666.80 - [M+2H]2+ 666.85 cyclo(f1P2W3f4N5Q6W7V8O9L10) 
1233.62 Val8-Orn9 b9 1233.62 O9L10f1P2W3f4N5Q6W7 
1047.54 Val8-Orn9 b8 1247.54 O9L10f1P2W3f4N5Q6 
859.40 Phe1-Pro2 b6 859.39 P2W3f4N5Q6W7 
805.42 Val8-Orn9 b6 805.44 O9L10f1P2W3f4 
673.32 Phe1-Pro2 b5 673.31 P2W3f4N5Q6 
545.20 Phe1-Pro2 b4 545.25 P2W3f4N5 
472.31 Val8-Orn9 b4 472.29 O9L10f1P2 
431.18 Phe
1
-Pro2 
any 
b3 
internal fragment 431.21 
P2W3f4 
f1P2W3 
375.25 Val8-Orn9 b3 375.24 O9L10f1 
284.14 Phe1-Pro2 b2 284.14 P2W3 
115.08 Val8-Orn9 b1 115.08 O9 
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Table S9  Summary of fragment assignment of the major product ions generated by CID of 
m/z=1371.7 molecular ion of tryptocidine C  
m/z 
observed 
Proposed 
ring 
opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
1371.70 - [M+H]+ 1371.67 cyclo(f1P2W3w4N5Q6W7V8O9L10) 
1207.62 Phe1-Pro2 b9 -NH3 1207.62 P2W3w4N5Q6W7V8O9L10 
1111.56 Phe1-Pro2 b8 1111.55 P2W3w4N5Q6W7V8O9 
997.48 Phe1-Pro2 b7 997.47 P2W3w4N5Q6W7V8 
881.39 Phe1-Pro2 b6  -NH3 881.39 P2W3w4N5Q6W7 
712.33 Phe1-Pro2 b5 712.32 P2W3w4N5Q6 
584.27 Phe1-Pro2 b4 584.26 P2W3w4N5 
470.22 Phe1-Pro2 b3 470.22 P2W3w4 
429.20 any internal fragment 429.19 N5Q6W7 
284.15 Phe1-Pro2 b2 284.14 P2W3 
256.15 Phe1-Pro2 a2 256.13 P2W3 
243.10 any internal fragment 243.11 N5Q6 
Table S10  Summary of fragment assignment of the product ions generated by CID of m/z=627.8 
molecular ion of phenycidine A  
m/z 
observed 
Proposed ring 
opening 
Proposed 
fragment type 
m/z 
calculated Sequence 
627.80 - [M+2H]2+ 627.83 cyclo(f1P2F3f4N5Q6F7V8O9L10) 
1155.60 Val8-Orn9 b9 1155.60 O9L10 f1P2F3f4N5Q6F7 
1008.53 Val8-Orn9 b8 1008.53 O9L10 f1P2F3f4N5Q6 
994.52 Phe1-Pro2 b8 994.52 P2F3f4N5Q6f7V8O9 
880.46 Phe1-Pro2 b7 880.44 P2F3f4N5Q6f7V8 
781.37 Phe1-Pro2 b6 781.37 P2F3f4N5Q6f7 
766.40 Val8-Orn9 b6 766.43 O9L10 f1P2F3f4 
634.30 Phe1-Pro2 b5 634.30 P2F3f4N5Q6 
619.34 Val8-Orn9 b5 619.36 O9L10 f1P2F3 
506.18 Phe1-Pro2 b4 506.24 P2F3f4N5 
472.28 Val8-Orn9 b4 472.28 O9L10f1P2 
392.20 Phe
1
-Pro2 
any 
b3 
internal fragment 392.20 
P2F3f4  
f1P2F3 
245.12 Phe
1
-Pro2 
any 
b2 
internal fragment 245.13 
P2F3 
f1P2 
 
Stellenbosch University  https://scholar.sun.ac.za
  8 
SUPPLEMENTARY MATERIAL REFERENCES  
Biemann K. (1988). Contributions of mass spectrometry to peptide and protein structure. Biol Mass 
Spectrom 16, 99-111. 
Bidlingmeyer B. A., Cohen S. A., Tarvin T. L. (1984).  Rapid analysis of amino acids using pre-
column derivatization. J. Chromatogr—Biomed. Appl 336, 93-104 
Cohen S. A., Meys M., Tarvin T. L. The Pico-Tag® Method: A manual of advanced techniques for 
amino acid analysis, distributed by Waters®, Millipore 
Ellinger G.M. & Boyne E. B.  (1965). Amino acid composition of some fish products and casein.  Br. 
J  Nutr 19, 587-592 
Gordon W. G., Semmett W. F., Cable R. S. & Morris M. (1949). Amino acid composition of α-
casein and β-Casein2. J Am Chem Soc 71, 3293-3297. 
Roepstorff P. & Fohlman J. (1984). Proposal for a common nomenclature for sequence ions in mass 
spectra of peptides. Biomed Mass Spectrom 11, 601. 
Sundararajan T. & Sarma P. (1957). Preparation and amino acid composition of enzymically 
dephosphorylated casein. Biochem J 65, 261-266. 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 3.1 
 
Chapter 3   
A model for incorporation of aromatic amino acids in the 
three variable residue positions for the different 
tyrocidines and analogues 
3.1 Introduction 
The tyrocidines are cyclic decapeptides produced by Bacillus aneurinolyticus in the late 
logarithmic growth phase [1-4]. These peptides are produced by a series of peptide synthetases 
that are encoded by the tyrocidine biosynthesis operon [5]. The peptide synthetases are a series 
of multi-domain enzymes that bind specific amino acids at their adenylation domains and 
systematically grow a polypeptide chain through the orderly addition of these amino acid 
residues. Ultimately, in the case of the tyrocidines, this process culminates in the cyclisation of 
the linear polypeptide chain by a terminal thioesterase [5-7]. 
Vosloo et al. [8] have previously established that the production of different tyrocidine 
analogues may be accomplished through supplementation of the growth medium of 
B. aneurinolyticus with certain amino acids. Promiscuity of certain of the peptide synthetases 
gives rise to the variability in the structure of the tyrocidines. Of particular interest in this study 
are the amino acids which are incorporated at the position 3 and 4 which may be either Phe or 
Trp, known as the variable dipeptide unit. Variability at the variable dipeptide unit accounts 
for the production of the A (Phe3, Phe4), B (Trp3, Phe4) and C (Trp3, Trp4) analogues. Variation 
at position 7 of either Tyr, Phe or Trp results in the production of the tyrocidines, phenycidines 
or tryptocidines respectively [8,9] (Fig. 3.1).  
As such, it was observed that of the range of amino acids evaluated (Phe, Trp, Tyr, Cys, Lys 
and Arg); only supplementation with Phe and Trp significantly altered the tyrothricin 
production profile. Supplementation with Phe caused the predominant production of the A 
analogues. Supplementation with Trp resulted in the predominant production of the C 
analogues. The B analogues, however, where produced at intermediate ratios of Phe/Trp 
supplementation [8]. 
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Figure 3.1 Structure of the tyrocidine analogues depicting variable residues at positions 3, 4 
and 7 in italics and D residues in lower case. (A) Phenycidine A with Phe at variable 
positions 3, 4 and 7. (B) Tyrocidine B with Trp, Phe and Tyr at variable positions 
3, 4 and 7 respectively. (C) Tryptocidine C with Trp at variable positions 3, 4 and 
7. 
Vosloo et al. [8] established the shift in peptide production profile produced between the 
different A (Phe3, Phe4), B (Trp3, Phe4) and C (Trp3, Trp4) analogues, but the identities of these 
peptides, particularly concerning the identity of the residue in position 7, was not analysed. A 
more in depth view, where the exact identities of the different peptide analogues produced by 
B. aneurinolyticus under the different Phe and Trp supplemented growth conditions, is now 
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considered. From these data a competitive binding computational model was constructed which 
can be used to predict the occupancy at the three variable aromatic amino acid positions in the 
structure of the tyrocidines and their analogues. To our knowledge, this is the first study of its 
kind. The tyrothricin producer strain were initially referred to as the Dubos strain of 
Bacillus brevis [10], this strain was subsequently renamed Bacillus aneurinolyticus by 
Shida et al. [11] these authors subsequently suggested further reclassification of the strain to 
Brevibacillus parabrevis [12]. However, this organism will be referred to as 
Bacillus aneurinolyticus in keeping with the bacterial specie name used in the preceding 
published study [8] on which this work was based.  
3.2 Materials  
Bacillus aneurinolyticus ATCC 10068 was obtained from the American Type Culture 
Collection (Manassas, VA, USA). Deep 96-well plates, tryptone, yeast extract, peptone, 
glucose, agar, hydrochloric acid (HCl) and the L-amino acids lysine and arginine were from 
Merck (Darmstadt, Germany). The L-amino acids cysteine, phenylalanine, tyrosine and 
tryptophan were obtained from Sigma-Aldrich (Steinheim, Germany). Media was sterilized by 
means of filtration using either 0.22 µm pore size sterile bottle top filtration system from 
Whatman Klari-Flex (Piscataway, USA) or sterile syringes and 0.20 -25 µm syringe filters 
from Lasec (Cape Town, South Africa). Acetonitrile (HPLC-grade, far UV cut-off) was from 
Romil Ltd (Cambridge, UK). An Acquity UPLC® BEH C18 (1.7 µm particle size, 2.1 mm x 
100 mm) ultra-performance liquid chromatography (UPLC) column was from Waters-
Millipore (Milford, USA). Analytical grade water was prepared by filtering water from a 
reverse osmosis plant through a Millipore-Q® water purification system (Milford, USA). 
3.3 Methods  
3.3.1 Pre-culturing of the tyrothricin producer strain 
As was previously described [8]  using standard, sterile, microbiological culturing techniques, 
single colonies of B. aneurinolyticus were obtained from pre-culture plates (5.0 g peptone, 
2.5 g yeast extract, 1.0 g glucose and 1.0 g skimmed milk powder, 15 g agar in 1.0 L water) 
that were seeded from freezer stocks. From these, single colonies were selected and incubated 
in Falcon® tubes containing 5 mL aliquots of TGS (tryptone, glucose and inorganic salts) 
culture media [13] while shaking at 220 rpm for 24 hours at 37 °C. Using the Pico-Tag® method 
[14], the final amino acid composition of the tryptone in TGS medium was previously 
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determined by high performance liquid chromatography (HPLC) and reported to contain 
5.3±0.1, 1.2±0.1 and 3.1±0.4 mM of Phe, Trp and Tyr respectively [8]. 
3.3.2 Medium throughput deep well production of tyrothricin  
Culturing of the tyrothricin producer strain B. aneurinolyticus, in deep 96-well plates was 
performed as previously described [8]. In essence; a pre-culture of B. aneurinolyticus was 
diluted four times using TGS culture medium, of which 10 µL was added to quadruplicate 
repeats of 500 µL TGS medium per well of the sterile deep 96-well plates containing either 
TGS medium alone or spiked with amino acids. The TGS medium was spiked with amino acids 
(Phe and/or Trp) ranging in concentration from 2.75 to 27.5 mM over seven steps of each amino 
acid prepared in TGS medium.  
These plates were covered and incubated at 37 °C for 96 hours, following which they were 
acidified to pH 4.7 using HCl and allowed to stand at room temperature for 24 hours. The cell 
pellet in each well was subsequently obtained by centrifugation of the plates at 2200 × g for 60 
minutes. The pellet was subsequently suspended in 200 µL of 100% acetonitrile, sonicated for 
15 minutes, a further 200 µL of analytical grade water added followed by further sonication 
for 15 minutes. The supernatant was then obtained by centrifugation for 30 minutes at 2200 × g, 
pooled in analytically weighed vials. These were subsequently freeze dried and analysed via 
UPLC linked to ESMS (UPLC-MS). 
3.3.3 ESMS and UPLC-MS analysis of tyrothricin extracts  
Electrospray mass spectrometry (ESMS) was performed using a Waters Quadrupole Time-of-
Flight Synapt G2 mass spectrometer, as previously described [8]. Particulate matter was 
removed by centrifugation at 8600 × g for 10 minutes. The extracts were diluted to a final 
concentration of 1.00 mg/mL and dissolved in 5% (v/v) acetonitrile in water. The extracts were 
separated via a Waters Acquity UPLCTM and introduced into the mass spectrometer using a Z-
spray electrospray ionisation source in positive mode. Subsequently, the identities of the 
respective peptides were confirmed by means of high resolution mass spectrometry and 
sequenced via collision induced dissociation [8]. 
Using a 0.1% trifluoroacetic acid (A) to acetonitrile (B) gradient (100% A from 0 to 0.5 minutes 
for loading, a linear gradient was run from 0 to 58% B over 0.5 to 12 minutes followed by a 
linear gradient from 58 to 90% B over 12 to 13 minutes) 3 µL per sample was separated on an 
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Acquity UPLC® BEH C18 column at a flow rate of 0.450 mL/min. Analytes were subjected to 
a capillary voltage of 3.0 kV and cone voltage of 15 V at a temperature of 120 ºC at the source. 
Data acquisition was performed by scanning the second analyser (MS2) through the mass over 
charge ratio (m/z) range of 400 to 2000. Data were then analysed using TargetLynxTM 4.1 
(MassLynx Mass Spectrometry software, Waters, Milford, USA) [8]. 
3.3.4 Mathematical model analysis of the shift in the tyrocidine production 
profile  
The shift in the tyrocidine production profile was influenced by variability at either: the 
variable dipeptide unit at positions 3 and 4, or at position 7. Having established that we were 
able to shift the tyrocidine production profile through the titration of the growth medium with 
Phe and Trp, a number of mathematical equations were derived to describe the amino acid 
occupation at these variable positions.  
The concentration of an amino acid x, at a specific site a in a peptide, could be calculated by 
integrating its production rate 𝑉𝑥𝑎 over the period of production. Therefore, the concentration 
observed at time t, 𝑥𝑎 (𝑡) is equal to: 
𝑥𝑎(𝑡) =  ∫ 𝑉𝑥𝑎
𝑡
0
𝑑(𝑡) +  𝑥𝑎(0)        (1) 
To analyse the relative concentrations of amino acids (x; y) at a specific site these integrals 
must be compared. At the beginning of the experiment no peptide was produced hence  
𝑥𝑎(0) =  𝑦𝑎(0) = 0. 
𝑥𝑎(𝑡)
𝑦𝑎(𝑡)
=  
∫ 𝑉𝑥𝑎
𝑡
0 𝑑(𝑡)
∫ 𝑉𝑦𝑎
𝑡
0 𝑑(𝑡)
 , and if assumed  
𝑉𝑥𝑎
𝑉𝑦𝑎
= 𝑟       (2) 
𝑥a(t)
𝑦a(t)
= 
∫ r ∙ Vya
t
0 d(t)
∫ Vya
t
0 d(t)
= 𝑟          (3) 
If the ratio of the incorporation rates of x and y is constant then the concentration ratio of the 
amino acids is equal to the production ratio. As amino acids x and y are in competition with 
one another for inclusion in the peptide; a simple competitive binding mechanism was used to 
describe the rate of inclusion with a Michaelis Menten type equation: 
𝑉𝑥𝑎 =
𝑉𝑥𝑎∙
𝑥
𝐾𝑥𝑎
1+
𝑥
𝐾𝑥𝑎
+
𝑦
𝐾𝑦𝑎
  and 𝑉𝑦𝑎 =
𝑉𝑦𝑎∙
𝑦
𝐾𝑦𝑎
1+
𝑥
𝐾𝑥𝑎
+
𝑦
𝐾𝑦𝑎
 with ratios,      (4) 
𝑉𝑥𝑎
𝑉𝑦𝑎
=
𝑉𝑥𝑎∙
𝑥
𝐾𝑥𝑎
𝑉𝑦𝑎∙
𝑦
𝐾𝑦𝑎
= 𝑐 ∙
𝑥
𝑦
           (5) 
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Combining eq. 3 with 5 lead to the simple expression: 
𝑥a(t)
𝑦a(t)
= 𝑐 ∙
𝑥
𝑦
           (6) 
Thus, the expected ratio of amino acids included at a specific site of the peptide is linear with 
the concentration ratio of the free amino acids. As a first approximation one could consider that 
the cytosolic ratio of concentrations of amino acids reflects the concentration ratio in the 
medium. 
It is often more convenient to work with fractions or percentage occupation of a given amino 
acid per site than with ratios. As such, Eq. 6 is rearranged to a fractional relation, and allowing 
for a potential cooperative effect(s) this leads to: 
xa(t)
xa(t)+ya(t)
=
𝑐1 ∙(
𝑥
𝑦
)𝑛
1+𝑐1 ∙(
𝑥
𝑦
)𝑛
           (7) 
with 𝑐1 =  
𝑉𝑥𝑎∙(𝐾𝑦𝑎)
𝑛
𝑉𝑦𝑎(𝐾𝑥𝑎)𝑛
          (8) 
The analysis became slightly more complicated when three amino acids compete at a site, but 
with similar assumption as before we derived: 
xa(t)
xa(t)+ya(t)+za(t)
=
𝑉𝑥𝑎
𝑉𝑥𝑎+𝑉𝑦+ 𝑉𝑧𝑎
=
𝑉𝑥𝑎∙(
𝑥
𝐾𝑥𝑎
)𝑛
𝑉𝑥𝑎∙(
𝑥
𝐾𝑥𝑎
)𝑛+𝑉𝑦𝑎∙(
𝑦
𝐾𝑦𝑎
)𝑛+𝑉𝑧𝑎∙(
𝑥𝑧
𝐾𝑧𝑎
)𝑛
  
xa(t)
xa(t)+ya(t)+za(t)
=
𝑐1 ∙(
𝑥
𝑦+𝑐2∙𝑧
)𝑛
1+𝑐1 ∙(
𝑥
𝑦+𝑐2∙𝑧
)𝑛
         (9) 
with C1 as in Eq. 7 and 𝑐2 =
𝑉𝑧𝑎∙(𝐾𝑦𝑎)
𝑛
𝑉𝑦𝑎(𝐾𝑧𝑎)𝑛
                                                                                           (10) 
Eq. 9 reduces to Eq. 7 when z is zero, otherwise the competitive effect of z was weighed 
according to C2. 
The previously derived mathematical equations describe the occupancy of position 3 and 4 by 
either Phe or Trp (Eq. 7); as well as occupancy of position 7 by the three aromatic amino acids 
Phe, Trp or Tyr (Eq. 9). As such, using the observed experimental data a competitive binding 
computational model was constructed. 
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3.4 Results 
The data of four independent culture batches were subsequently used to not only determine the 
exact identity of the peptides produced utilising UPLC-MS, but also construct a competitive 
binding model which could be used to predict the identity and proportions of the peptides 
produced at given concentrations of the variable aromatic amino acids. Refer to Fig. 3.2 for 
representative examples of UPLC-MS analyses of the Trp and Phe supplemented culture 
extracts. 
 
 
 
 
 
 
 
 
Figure 3.2 UPLC-MS chromatograms depicting the shift in the peptide production profile 
when the growth media was supplemented to contain a total of: (A) 32.8 mM Phe 
and 1.2mM Trp to produce a range of tyrocidine A analogues (Phe3, Phe4) or (B) 
28.7 mM Trp and 5.3 mM Phe to produce the tryptocidine analogues (Trp7). 
3.3.1 Phe supplementation 
Supplementation of the culture media with Phe resulted in the predominant production of a 
range of the A analogues (Phe at both positions of the variable dipeptide positions) and 
correlated well to the previous study by Vosloo et al. [8] (Fig. 3.3 A). Production of 
tyrocidine A> tryptocidine A> phenycidine A predominated; all of which contain Phe3, Phe4; 
but Tyr7, Trp7 or Phe7 respectively at the variable aromatic site. Moreover, as the concentration 
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of Phe supplementation increased, a concomitant increase in the prevalence of the 
phenycidine A analogue was observed (Fig. 3.3 A). 
3.4.2 Trp supplementation  
A significant shift in the peptide production profile of B. aneurinolyticus toward the production 
of the tryptocidine analogues containing Trp7 was observed, when Trp was supplemented to 
the growth medium (Fig. 3.3 B). Initially an increase in production of the tryptocidine B 
analogue was observed. However, above the supplemented Trp concentration of 4 mM 
(5.3 mM Phe and 5.2 mM Trp total in medium) the contribution of tryptocidine B analogue 
decreased and that of the tryptocidine C analogue increased (Fig. 3.3 B). 
3.4.3 Supplementation with a combination of Phe and Trp  
Having shifted the peptide production profile between two extremes in terms of the A and C 
analogues through supplementation of either Phe or Trp, the influence of the co-
supplementation of Phe and Trp was assessed. Production of the tryptocidine analogues 
containing Trp7 predominated in conditions when Trp was supplemented to the growth medium 
at fixed concentrations of 5.5, 11 or 16.5 mM (6.7, 12.2 or 17.7 mM Trp total in medium), 
irrespective of the co-supplemented Phe concentration. Supplementation of varied 
concentrations of Phe between 2.75 to 27.5 mM merely served to shift the peptide production 
profile between the different tryptocidine analogues (Fig. 3.3 C).  
Substitution of Trp by Phe with increasing concentrations of the Phe only occurred at the 
variable aromatic dipeptide unit, but not at the variable aromatic residue 7 which was occupied 
by Trp7 at all the Trp and Phe co-supplementation concentrations. Supplementation of the 
growth medium with 5.5 mM Trp (6.7 mM Trp total in medium) initially shifted the peptide 
production profile toward the predominant production of the tryptocidine C analogue. As the 
supplemented Phe concentration was increased above 3.4 mM (8.7 mM Phe and 6.7 mM Trp 
total in medium) the production of the tryptocidine B analogue predominated. Concomitantly 
the proportion of the peptide production profile contributed by the tryptocidine C analogue 
decreased.  
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Figure 3.3 Peptide production profiles of extracts obtained from B. aneurinolyticus depicting 
the major peptide isoforms produced when the TGS base medium containing 5.3 
and 2.1 mM Phe or Trp respectively was supplemented with: (A) Phe, varying the 
total Phe concentration between 5.3 and 32.8 mM; (B) Trp, varying the total Trp 
concentration between 1.2 and 28.7 mM; or (C) at a fixed total Trp concentration 
of 6.7 mM and varying the total Phe concentration between 5.3 and 32.8 mM. The 
percentage contribution of each of the respective analogues to the total peptide 
profile of the tyrocidines and their analogues is presented. Rest represents the sum 
of those analogues not specifically indicated on the graph. Each data point is the 
mean obtained from four independent cultures. 
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When the supplemented concentration of Phe exceeded 21 mM (26.3 mM Phe and 6.7 mM Trp 
total in medium) the production of tryptocidine A exceeded that of tryptocidine C analogue 
(Fig. 3.2 C). Similarly, the peptide production profile was shifted between the different 
tryptocidine analogues when higher concentrations of Trp were supplemented, albeit at higher 
Phe concentrations (data not shown). As such, the peptide production profile was shifted from 
tyrocidine production (peptides containing Tyr7) in the non-supplemented state (5.3 mM Phe 
and 1.2 mM Trp in medium) to tryptocidine (peptides containing Trp7) production in the 
presence of supplemented Trp. 
3.4.4 Computational modelling of variability in residues in positions 3 and 4 
Assuming a simple competitive mechanism for the incorporation of Phe and Trp at position 3 
and 4, Eq. 7 was derived (refer to mathematical model analysis) for the relation between the 
fraction of an amino acid incorporated at the two respective positions and the concentration 
ratio in the medium of that amino acid and a competing amino acid. Thus, the percentage 
occupancy of Trp relative to Phe in the peptide was described using Eq. 7 and the fitted 
parameter values in Table 3.1 for position 3 (Fig. 3.4 A) and 4 (Fig. 3.4 B) respectively. 
Irrespective of the absolute concentrations of Trp and Phe in the medium, the occupancy of 
positions 3 and 4 by Trp in the peptide was described by a simple sigmoidal relationship for 
the Trp/Phe ratio at a fit of 96% and 37 degrees of freedom. At Trp/Phe ratios of 0.23 and 0.79 
Trp had a 50% occupancy of positions 3 and 4 respectively (Fig. 3.4 A and B). 
3.4.5 Computational modelling of variability in residues in position 7  
Again, by assuming a relatively simple competitive mechanism, a functional relationship 
between the percentage occupation of a specific amino acid and the ratio of that amino acid 
and the weighed sum of the three competing amino acids was used to derive Eq. 9 (refer to 
mathematical model analysis). To analyse the incorporation of the three amino acids at position 
7, Eq. 9 was used, and for each analysis a different amino acid is attributed to the variables x, 
y, and z in the equation.  
As there are three amino acids competing for occupancy at position 7, it was necessary to 
transpose the data to include the weighing factor C2 and the extent of cooperativity n. After this 
conversion, the data could be plotted as percentage occupancy of amino acid x, versus 
𝑥𝑛
𝑦𝑛+𝑐2𝑧𝑛
. 
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Using independently fitted values for Eq. 9 (Table 3.1), the occupancy of Tyr (Fig. 3.5 A) and 
Trp (Fig. 3.5B) at position 7 were well described by a simple hyperbolic relation. For the 
analysis of Phe incorporation at position 7, the C1 and C2 values obtained from the independent 
fits of Trp and Tyr incorporation were utilized. Using a value for n of 1.28 obtained from Tyr 
incorporation, the resulting fit of Phe incorporation emulated the trend followed by the 
experimental data (Fig. 3.5 C).  
From these data it is apparent that Trp is preferentially incorporated at position 7, followed by 
Tyr. Incorporation of Phe at position 7 only occurred at increased Phe concentrations, then only 
reaching a maximum just exceeding 20% of the total contribution at the highest Phe 
supplementation at a ratio of 0.04 Trp/Phe in the medium (32.8 mM Phe and 1.2 mM Trp in 
medium). 
Table 3.1 Fitted parameter values for Trp and Tyr incorporation in positions 3, 4 and 7 
Position Amino Acid C1 C2 n 
3 Trp 
𝑉𝑊3∙(𝐾𝐹3)n
𝑉𝐹3∙(𝐾𝑊3)n
= 49.75 
0 2.62 
4 Trp 
𝑉𝑊4∙(𝐾𝐹4)n
𝑉𝐹4∙(𝐾𝑊4)n
= 1.47 
0 1.47 
7 Trp 
𝑉𝑊7∙(𝐾𝐹7)n
𝑉𝐹7∙(𝐾𝑊7)n
= 62.70 
𝑉𝑌7∙(𝐾𝐹7)n
𝑉𝐹7∙(𝐾𝑌7)n
= 49.88. 
1.36 
7 Tyr 
𝑉𝑌7(𝐾𝑊7)n
𝑉𝑊7∙(𝐾𝑌7)n
= 0.80 
𝑉𝐹7∙(𝐾𝑊7)n
𝑉𝑊7∙(𝐾𝐹7)n
= 0.02 
1.28 
 
For each of the analyses the interpretation of C1 and C2 is different, they are not independent, 
see Table 3.1. For instance C1 in the Trp analysis is equal to 
1
𝑐2
 in the Tyr analysis at position 
7. The numerical values that were obtained via the independent fits to the data set are internally 
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consistent. It was apparent, however, that the occupancy at position 7 was considerably more 
sensitive to minor variations that occurred between one production culture and the next, 
particularly concerning the occupancy of Phe and Tyr.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Percentage contribution of the sum tyrocidine analogues containing Trp at the 
positions (A) 3 and (B) 4 respectively relative to the total peptide profile of the 
tyrocidines and their analogues. The occupancy of Trp at variable positons (A) 3 
and (B) 4, is described by a simple sigmoidal relationship (Fit of 96% and 37 
degrees of freedom) relative to the ratio of total Trp/Phe within the culture media. 
Using Eq. 7 the c values were gained from the resultant fit of the data of four 
independent cultures used to construct the computational model. The solid lines 
represent the sigmoidal curve fits and the dotted lines the 95% confidence interval 
of the resultant curve fit in which all the individual data points were considered.  
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Figure 3.5 Percentage contribution of the analogues at position 7 containing Tyr (A), Trp (B), 
or Phe (C). The occupancy of a given amino acid is expressed relative to the total 
peptide profile of the tyrocidines and their analogues. Using Eq. 9 the n and c values 
for Tyr (A) and Trp (B) were fitted independently and used to predict the 
occupancy of Phe (C). The solid line represents the hyperbolic curve fit and the 
dotted lines the 95% confidence interval of the resultant curve fit in which all the 
individual data points were considered. 
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3.4.6 Direct comparison of variability in residues in position 3, 4 and 7 
A comparison of Phe (Fig. 3.6 A) and Trp (Fig. 3.6 B) incorporation at the three variable 
positions revealed a variable rate of incorporation of Phe (Fig. 3.6 A) with position 4>3>>7 
being occupied by Phe, containing a smaller side chain relative to Trp. In contrast, position 3 
and 7 have a near equally strong preference for Trp relative to position 4. Position 3 and 7 are 
occupied by 50% Trp at Trp/Phe concentration ratio in the medium of 0.23 and 0.05 
respectively, while at a concentration ratio of 1 the Trp occupancy is > 95% at both positions, 
indicating the preference for a larger aromatic amino acid such as Trp. In contrast, position 4 
is occupied by 50% Trp at Trp/Phe concentration ratio in the medium of 0.79, indicating an 
increased preference for the smaller Phe residue at this position.  
3.5 Discussion 
The tyrothricin production profile has previously been found to be altered through 
supplementation of the growth medium with two amino acids namely Trp and Phe [8,15,16]. 
We have previously reported not only the effect of the mentioned amino acids on the growth 
of the producer strain, but also on total tyrothricin production. While this study also included 
variation in linear gramicidin production, it focused primarily on variation observed at the 
variable dipeptide unit (position 3 and 4) causing a shift in the production of the A, B and C 
cyclodecapeptide groups [8]. 
In this study the exact identities of the cyclodecapeptides produced with different Phe and Trp 
supplementation was elucidated and used, together with derived mathematical equations, to 
describe the variation at positons 3, 4 and 7. For the purposes of this study, a first approximation 
that the cytosolic ratio of concentrations of amino acids reflects the concentration ratio in the 
medium was made. As such, using the observed experimental data a competitive binding 
computational model was constructed which not only emulates these trends, but can also be 
used to determine the occupancy at the various sites and thereby the identity of the peptide/s 
formed at a given medium concentration of Phe and Trp. 
The differences observed for cyclodecapeptide analogues produced under the respective amino 
acid supplemented conditions, may largely be attributed to a few key factors. The 
bioavailability or concentration of the variable amino acids is closely associated with the 
affinity (KM) of the adenylation domains of the peptide synthetases for these residues. 
However, under saturated conditions the incorporation of these variable residues into the 
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B
,
A
growing polypeptide chain by the various peptide synthetases is influenced largely by 
production rate (𝑉𝑥𝑎) and extent of cooperativity (n), as is evident from Eq. 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Comparison of the contribution of Phe and Trp at variable positions 3 and 4 (A), 
and 7 (B). The occupancy of a given amino acid is expressed relative to the total 
peptide profile of the tyrocidines and their analogues. The red symbols in A is for 
peptide with Trp in position 3 and blue for Trp in position 4 with grey shaded area 
indicating the confidence interval. The red symbols in B indicate peptides with 
Tyr7, blue Phe7 and black Trp7. The shaded area in B indicates the boundary values 
of the model prediction under the experimental conditions used in its construction. 
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Once amino acids are in the cytosol of the cell they are available to the peptide synthetases to 
be bound and incorporated in the synthesis of the tyrocidines and their analogues. Consequently 
the affinity of the peptide synthetases for the variable amino acids influences the variation in 
the production of the different analogues. In the case of Phe and Trp supplementation; this is 
at the variable dipeptide unit, position 3 and 4, as well as the variable aromatic unit, position 
7. The affinity of the adenylation domains responsible for the incorporation of the variable 
amino acids at positions 4 and 7 has been reported by Mootz and Marahiel [5]. The affinity of 
these domains is much higher for Trp than any of the other aromatic amino acids that may be 
incorporated. As such, the adenylation domain at position 4 has a KM of 0.08 mM for L-Trp 
and 0.45 mM for L-Phe. The adenylation domain at position 7 has a KM of 0.1 mM for L-Trp 
and 0.3 mM for L-Tyr. No KM value is reported for Phe for the adenylation domain at position 
7, or for any amino acids at the adenylation domain at position 3; these are reported to 
principally activate and thereby incorporate Trp, despite their ability to also incorporate Phe 
[5]. 
With the knowledge in hand of the affinity of the peptide synthetases for the different 
supplemented amino acids as well as the production rates observed, some light maybe shed on 
the different analogues produced under the respective growth conditions. It is apparent that the 
high affinity of the peptide synthetases for Trp results in its incorporation, particularly at 
position 7, consequentially the tryptocidine analogues are produced under Trp supplemented 
conditions (Fig. 3.3 B and C). However, substitution of Trp by Phe at the variable dipeptide 
unit at positions 3 and 4 is observed under Phe supplemented conditions (Fig. 3.3 A), despite 
the reported KM values for positions 4 and 7 being similar, and positon 3 reported to principally 
active Trp [5]. 
When Phe was co-supplemented together with a fixed concentration of 5.5 mM Trp (6.7 mM 
Trp total in medium), the initial production of the tryptocidine C analogue is exceeded by 
tryptocidine B production once the concentration of Phe exceeded 3.4 mM (8.7 mM Phe total 
in medium) (Fig. 3.3 C). Similarly, tryptocidine B production increased at lower supplemented 
concentrations of up to 4.0 mM Trp (5.3 mM Phe and 5.2 mM Trp total in medium), where 
after production of tryptocidine C predominated when Trp alone was supplemented 
(Fig. 3.3 B). This attests to the ability of Phe to substitute Trp at position 4 at lower 
concentration ratios of Trp/Phe (Fig. 3.4 B), in relation to Trp substitution at position 3 
(Fig. 3.4 A). The substitution of Trp by Phe at position 3 and the consequent production of 
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tryptocidine A, however, only occurred at increasing concentrations of Phe (Fig. 3.4 C), in 
keeping with the reported affinity [5]. 
Therefore, while the affinity of the peptide synthetases for a specific variable residue plays a 
large role in determining the incorporation of a specific residue at the variable positions, it is 
only part of the picture. In our production model, incorporation of the variable amino acids at 
a specific site takes not only the affinity of the peptide synthetases into consideration, but also 
production rate (𝑉𝑥𝑎) and extent of cooperativity (n), as is evident from Eq. 9. These additional 
factors, acting together with the affinity (KM), lead us to conclude that a higher production rate 
and affinity for Trp at position 7 leads to its preferential incorporation (Fig. 3.4 B), as is evident 
from the higher fitted C1 value for Trp at position 7 (Table 3.1). 
This hypothesis is corroborated by the production of a range of tyrocidine A analogues (Phe3, 
Phe4) when only Phe was supplemented to the growth medium, indicating a high production 
rate at positions 3 and 4 for Phe despite the affinity of both adenylation domains of the variable 
dipeptide positions being lower for Phe. At position 7, however, the production of tyrocidine 
A (Tyr7) predominates (Fig. 3.5 A), indicating a high production rate for Tyr7, as supported by 
the large C2 value for Trp at position 7 (Table 3.1). Due to the lower affinity and production 
rate, incorporation of Phe7 only increased marginally (Fig. 3.5 C), where production of 
phenycidine A comprised just 25% of the total production profile at the highest total Phe 
concentration of 32.8 mM (Fig. 3.3 A). Using the independently fitted parameters for Trp7 and 
Tyr7, our production model emulated the observed experimental data for Phe7 (Fig. 3.4 C), 
thereby supporting the fitted parameter values used.  
The incorporation of Phe at the three variable positions (Fig. 3.5 A) indicated a varied affinity 
and production rate at all the variable positions with position 4> 3>>7. The incorporation of 
Trp at the three variable positions (Fig. 3.6 B) indicated the preferential Trp7 incorporation, 
which was marginally higher than Trp3, both of which showed a higher preference for Trp 
relative to Trp4. Ultimately, the specific ratio of competing amino acids, irrespective of their 
absolute concentrations, determined the incorporation of a residue at each of the variable 
positions relative to the unique kinetic properties of each of the peptide synthetases. 
As the incorporation of at a specific variable positon is dependent on the ratio of the competing 
amino acids, production of tryptocidine B predominated at the lowest concentration which Trp 
was fixed. Lowering of the concentration of the co-supplemented Trp would most likely result 
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in an earlier increase in tryptocidine A production, while marginally increasing tyrocidine A 
and B analogues in the current production medium. Particularly when considering the high 
affinity and production rate at position 7 for Trp. Therefore, the presence of Trp in the medium 
shifts the peptide production profile away from tyrocidine production toward the production of 
a new subset of peptides, the tryptocidines.  
3.6 Conclusions 
While our results concur with kinetic data of Mootz and Marahiel [5], it clearly indicated a 
preferential substitution of Trp by Phe first at position 4 and only at increased Phe 
concentrations was Trp substituted by Phe at position 3. Position 7, however, was 
predominantly occupied by Trp in all of the cases where Trp was supplemented to the medium. 
Therefore the adenylation domains at position 3 and position 7 in particular, are found to be 
preferentially Trp activating domains [5]. The higher rate of incorporation of Trp7 was likely 
to be due to the higher production rate at this position. Phe occupation of the variable aromatic 
positions only occurred at increased Phe concentrations and low basal Trp concentrations, and 
even more so at the variable aromatic position which only occurred at the highest Phe 
concentrations and in the absence of Trp supplementation.  
Using the constructed competitive binding model we are able to predict the cyclodecapeptides 
production profile of the producer organism under given aromatic amino acid concentrations 
within the growth media. This allows for the increased production of selected analogues.  
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Chapter 4  
Production and purification of the tyrocidines and analogues 
4.1 Introduction 
The tyrocidines have shown great promise targeting pathogens which cause substantial 
damage in both the agricultural and food industries. These include the food spoilage Gram 
positive bacteria Listeria monocytogenes [1,2], as well as a multitude of pre- and post-harvest 
fungi [3]. The damage caused by these pathogens through food spoilage and reduced 
agricultural production results in not only severe economic hardship, but they also directly or 
indirectly lead to extensive morbidity and mortality, particularly in developing countries.  
With existing chemical agents losing potency and increased resistance to their use; there is 
clearly a need for the development of novel, so called green-biocides [4]. These ideally need 
to have an alternate mode(s) of action to that of most conventional chemical control agents, 
as well as multiple cellular targets, thereby limiting the potential for resistance development. 
On the other hand these agents must be biodegradable, yet resistant enough to degradation 
that they may persist for long enough in the environment to offer protection against slow 
growing fungal pathogens or opportunistic bacteria, both in agricultural applications as well 
as in food packaging and storage.  
The tyrocidines, produced by the soil bacterium Bacillus aneurinolyticus, generally fit the 
criteria of a green-biocide. These cyclodecapeptides are produced together with the linear 15-
mer gramicidins after the logarithmic growth phase and are extracted as a complex known as 
tyrothricin (Table 4.1) [5,6]. They are safe for both topical applications [7-9] and oral 
consumption [10-14] and have been extensively utilised as the active ingredient in throat 
lozenges containing 1 mg tyrothricin under the trade name of Tyrozets® [15]. The cyclic 
structure of the tyrocidines increases their resistance to degradation by proteases, however, 
they remain biodegradable. They have multiple possible cellular targets ranging from the 
membrane and cell wall [16-18] to intracellular targets such as enzymes of the electron 
transport chain [19], while also including the ability to bind DNA and RNA [20-22].  
The ability to shift the tyrothricin peptide production profile of the producer organism to 
increase the production of selected analogues with enhanced activity toward specific 
pathogens has previously been demonstrated [24]. The tyrocidines maintain their 
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antimicrobial activity in a range of different environments; demonstrating resilience to a 
number of salts [1]. In light of their promising antimicrobial activity toward the mentioned 
food and agricultural pathogens, including their other defining characteristics, the tyrocidines 
show potential to serve as novel green-biocides. 
Table 4.1 Summary of the possible different peptides in the tyrothricin extract from 
Bacillus aneurinolyticus 
Peptide Abbr. Sequence a 
Mr 
Theoretical b 
m/z 
Singly 
charged 
m/z 
Doubly 
charged 
Tyrocidine A analogues (Ff) 
Phenycidine Ac PhcA Cyclo-(fPFfNQFVOL) 1253.6597 1254.6675 627.8377 
Phenycidine A1
c PhcA1 Cyclo-(fPFfNQFVKL) 1267.6753 1268.6832 634.8455 
Tyrocidine A TrcA Cyclo-(fPFfNQYVOL) 1269.6546 1270.6624 635.8351 
Tyrocidine Avc TrcAv Cyclo-(fPFfNQYVOV) 1255.6390 1256.6468 628.8273 
Tyrocidine A1 TrcA1 Cyclo-(fPFfNQYVKL) 1283.6703 1284.6781 642.8430 
Tryptocidine A TpcA Cyclo-(fPFfNQWVOL) 1292.6706 1293.6784 647.3431 
Tryptocidine A1 TpcA1 Cyclo-(fPFfNQWVKL) 1306.6862 1307.6941 654.3509 
Tyrocidine B analogues (Wf) 
Phenycidine B d /B’d PhcB Cyclo-(fPWf/Fw)NQFVOL) 1292.6706 1293.6784 647.3431 
Tyrocidine B/B’ TrcB Cyclo-(fP(Wf/Fw)NQYVOL) 1308.6655 1309.6733 655.3406 
Tyrocidine B1/B1’ TrcB1 Cyclo-(fP(Wf/Fw)NQYVKL) 1322.6812 1323.6890 662.3484 
Tryptocidine B/B’ d TpcB Cyclo-(fP(Wf/Fw)NQWVOL) 1331.6815 1332.6893 666.8486 
Tryptocidine B1
c/B1’d  TpcB1 Cyclo-(fP(Wf/Fw)NQWVKL) 1345.6971 1346.7050 673.8564 
Tyrocidine C analogues (Ww) 
Phenycidine Cd PhcC Cyclo-(fPWwNQFVOL) 1331.6815 1332.6893 666.8486 
Tyrocidine C TrcC Cyclo-(fPWwNQYVOL) 1347.6764 1348.6842 674.8460 
Tyrocidine C1 TrcC1 Cyclo-(fPWwNQYVKL) 1361.6921 1362.6999 681.8539 
Tryptocidine C TpcC Cyclo-(fPWwNQWVOL) 1370.6924 1371.7002 686.3540 
Tryptocidine C1
c Tpc C Cyclo-(fPWwNQWVKL) 1384.7080 1385.7159 693.3618 
Linear gramicidins 
Val-Gramicidin A VGA VGAlAvVvW-lWlWlW 1881.078 1882.0862 941.5470 
Val-Gramicidin B VGB VGAlAvVvW-lFlWlW 1842.067 1843.0753 922.0415 
Val-Gramicidin Cc VGC VGAlAvVvW-lYlWlW 1858.062 1859.0702 930.0390 
Ile-Gramicidin A IGA IGAlAvVvW-lWlWlW 1895.094 1896.1018 948.5548 
Ile-Gramicidin Bc IGB IGAlAvVvW-lFlWlW 1856.083 1857.0909 929.0494 
Ile-Gramicidin Cc IGC IGAlAvVvW-lYlWlW 1872.078 1873.0858 937.0468 
a Conventional one letter abbreviations used for amino acid sequences as obtained from Tang et al. [23] with O 
representing ornithine and lower case representing D-amino acids 
b Sum of the monoisotopic residual molecular masses of constituent amino acids within the peptide 
c Low to very low levels in tyrothricin  
d Has not been detected or identified up to date 
The use of the tyrocidines and their analogues as green-biocides, however, is dependent on 
their production and purification being both economically viable, as well as up-scalable to 
large scale production. Available literature on the production and purification of tyrothricin is 
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limited to the work of a few investigators world-wide. After the initial report on its discovery 
in 1939 [25], Dubos and a number of co-investigators described its production in stationary 
cultures in addition to subsequent purification and characterization [5,6,25,26]. Lewis et al. 
[27] reported in some depth the successful formation of tyrothricin in stationary cultures 
using both a tryptone based media as well as vegetable waste obtained from asparagus juice 
with yields in excess of 2000 mg/L.  
Tyrothricin production in submerged, aerated cultures using defined media and simple 
nitrogen sources was first reported by Stokes and Woodward [28]. Appleby et al. [29,30] 
continued with the topic and succeeded in producing yields as high as 890 mg/L. The 
production of tyrothricin in submerged (fermentor) cultures, however, remained well below 
that achieved in stationary cultures using complex nitrogen sources. Increased tyrothricin 
production by submerged culturing is limited to a single patent using the effluent from corn 
starch production reporting a yield of 1600 mg/L [31]. Production levels of 1400 mg/L in 
submerged cultures are briefly mentioned by Lewis et al. [27] with the same tryptone-based 
media used successfully in stationary cultures. 
Using the available literature as a basis, a study was performed where the yield of naturally 
produced tyrothricin by Bacillus aneurinolyticus was increased through the elucidation of the 
optimal production medium, as well as growth conditions. Furthermore, two purification 
methodologies were developed/optimised to purify the tyrocidines and their analogues from 
the culture broth of B. aneurinolyticus to an acceptable level of purity.  
4.2 Materials  
Bacillus aneurinolyticus ATCC 10068 was used as the tyrothricin producer strain while 
Aspergillus fumigatus ATCC 204305 served as the representative fungal target organism, 
both of which were from the American Type Culture Collection (Manassas, VA, USA). Gram 
positive bacteria target organisms Micrococcus luteus NCTC 8340 and Bacillus subtilis 168 
were obtained from the National Collection of Type Cultures (Porton Down, Salisbury, 
England) and Bacillus Genetic Stock Centre (Ohio State University, OH, USA) respectively. 
A selection of culture broths, yeast extract, glucose, agar, diethyl ether, acetone, ethanol 
(EtOH), sodium chloride (NaCl), and hydrochloric acid (HCl) were from Merck (Darmstadt, 
Germany). The L-amino acids: phenylalanine and tryptophan were from Sigma-Aldrich 
(Steinheim, Germany). Ultra-pure urea was from ICN Biomedicals Inc (Aurora, USA). 
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Tween 20 and potato dextrose broth (PDB) were from Fluka (Buchs, Switzerland). Skimmed 
milk powder was from Clover (Roodepoort, South Africa). Activated carbon was from Lurgi 
(Frankfurt, Germany). Trifluoroacetic acid (TFA; >98%), tertiary butanol (>99%), a 
commercially available tyrothricin extract, gramicidin S (GS), and XAD-16 resin were from 
Sigma-Aldrich (St. Louis, USA). Standard, sterile 96-well flat bottom microtiter plates and 
petri dishes were from Corning Incorporated (USA) and Lasec (Cape Town, South Africa) 
respectively. Acetonitrile (ACN; HPLC-grade, far UV cut-off) was from Romill Ltd 
(Cambridge, UK). Falcon® tubes were from Becton Dickson Labware (Lincoln Park, USA). 
An AKTA® chromatographic system was from Amersham Pharmacia Biotech (Uppsala, 
Sweden). Electrospray mass spectrometry (ESMS) was performed using a Waters Synapt G2 
mass spectrometer, NovaPak HR C18 HPLC semi-preparative column (6 m particle size, 300 
mm x 7.8 mm) and an Acquity UPLC® BEH C18 (1.7 µm particle size, 2.1 mm x 100 mm) 
ultra-performance liquid chromatography (UPLC) column were from Waters-Millipore 
(Milford, USA). Analytical grade water was prepared by filtering water from a reverse 
osmosis plant through a Millipore-Q® water purification system (Milford, USA). All media 
was sterilized by autoclaving for 15 minutes at 121 °C.  
4.3 Methods 
4.3.1 Culturing of organisms 
Pre-culturing of the producer strain: Single colonies of the Bacillus aneurinolyticus producer 
strain were obtained from freezer stocks. Using conventional sterile techniques, culturing was 
done for 48 hours on pre-culture agar plates, containing 0.5% (m/v) peptone, 0.25% (m/v) 
yeast extract, 0.1% (m/v) glucose and 0.1% (m/v) skimmed milk powder, 1.5% (m/v) agar in 
analytical grade water; pH 7.0. Single colonies were selected and incubated while shaking at 
220 rpm for 24 hours at 37 °C in Falcon® tubes containing 5 mL pre-culture medium (0.5% 
(m/v) peptone, 0.25% (m/v) yeast extract, 0.1% (m/v) glucose and 0.1% (m/v) skimmed milk 
powder; pH 7.0). 
Pre-culturing of the indicator organism: Gram-positive bacteria M. luteus NCTC 8340 was 
cultured on Luria Bertani agar plates (LBA; 1% (m/v) tryptone, 0.5% (m/v) yeast extract, 1% 
(m/v) NaCl, 1.5% (m/v) agar, in analytical grade water), while B. subtilis OKB 168 was 
cultured on tryptone soy agar plates (TSA; 3% (m/v) TSB, 1.5% (m/v) agar in analytical 
grade water) for 48 hours at 37 °C. Using normal sterile techniques selected colonies were 
incubated while shaking at 150 rpm for 16 hours at 37 °C in LB broth (1% (m/v) tryptone, 
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0.5% (m/v) yeast extract, 1% (m/v) NaCl in analytical grade water) medium to an optical 
density (OD) of approximately 0.8 at 595 nm. These cultures were subsequently sub-cultured 
in tryptone-soy broth (3% (m/v) TSB in analytical grade water) and grown to an OD of 0.6 at 
595 nm. 
Pre-culturing of fungi: Spores of the fungi A. fumigatus ATCC 204305 were obtained from 
freezer stocks and cultured using conventional sterile techniques on potato dextrose agar 
plates (PDA; 2.4% (m/v) PDB, 1.5% (m/v) agar, in analytical grade water) for three weeks. 
Subsequently 7 mL of Tween water (20 µL of Tween in 200 mL analytical grade water and 
autoclaved) was added to the plates, the spores lightly loosened using a hockey stick and 
hydrated over night at 4 °C. These were subsequently counted using a standard counting 
chamber and diluted with sterile water to a concentration of 50 spores/µL. 
4.3.2 Selection of high tyrothricin producers  
A radial diffusion assay was performed using methods adapted from those described by Du 
Toit and Rautenbach [32] and Lehrer et al. [33]. A gel solution (1% (m/v) powdered TSB 
medium, 1% (m/v) agar powder and 0.02% (v/v) Tween 20) was prepared with analytical 
grade water and autoclaved. One millilitre of M. luteus at an OD of 0.6 at 595 nm was added 
to 9 mL of the gel at 45°C and homogenized by inversion. The gel was then poured into 
sterilized culture dishes on a level surface and allowed to set for 30 minutes. Single colonies 
of B. aneurinolyticus were then spotted onto the gel 1.25 cm apart. The plates were incubated 
for 16 hours at 37 °C and the inhibition zones observed. From these, high tyrothricin 
producers were selected and cultured on pre-culture plates for 48 hours at 37 °C. These were 
suspended in 10% (m/v) skimmed milk powder and lyophilised. Subsequently, a spatula tip of 
these dried cultures was suspended in 0.5 mL of culture medium and allowed to hydrate for 4 
hours and streaked out on pre-culture plates prior to culturing in liquid pre-culture medium. 
4.3.3 Tyrothricin production and extraction 
For production the medium base (salts, sugars), N-source(s), metal ions, oxygenation and 
culture time was adapted to optimise production (medias A-D, refer to table 4.2). Due to 
future commercial applications of this part of the project very little detail of the production 
and purification methodologies can be revealed. The parameters and best media for the 
optimised productions in fermentation vessels have been determined by the BIOPEP® Peptide 
Group and are protected under non-disclosure agreements (NDAs) with all members working 
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on these fermentations to insure the future commercialisation potential of the peptide 
products. 
Flask/Stationary cultures: A 1% (v/v) of pre-cultured B. aneurinolyticus was added to the 
selected medium containing protein as N-source and a carbohydrate carbon source at culture 
volumes from 20 mL to up to 2.5 L. These cultures were incubated at 37 °C over a time 
period of 8 to 28 days. Growth was evaluated in terms of gram dry cell mass to determine 
biomass production. Tyrothricin production was equated to the crude extract mass obtained. 
Growth rate and tyrothricin production within the cultures was evaluated in 2 L Erlenmeyer 
flasks in quadruplicate (n=4). A 5 mL sample was taken every 24 hours until 240 hours, after 
which samples were taken every 48 hours until 384 hours. 
Fermenter/Submerged cultures: Further efforts to increase tyrothricin production and shorten 
the production time required were performed in 1L bioreactors using Media C (refer to table 
4.2). While the temperature was maintained constantly at 37 °C; the cultures were aerated 
with compressed air at one volume per volume per minute (VVM) and agitated at 60 rpm, 
unless otherwise stated. Samples of 5 mL were drawn off aseptically every two hours for the 
first 24 hours, and thereafter this was decreased to twice every 24 hours. The culturing period 
was extended up to a maximum of 240 hours. These cultures were run in parallel to 
stationary, shallow layer cultures to allow for direct comparison of the tyrothricin yields. 
The pH was measured and growth determined spectrophotometrically by measuring the 
optical dispersion at 595nm (OD595) from the samples taken of the respective cultures. A 
crude tyrothricin extract mass was obtained by extraction with 70% (v/v) ACN 
containing 0.3% (v/v) TFA in water. These samples were analysed by ESMS at a 
concentration of 1.0 mg/mL and the percentage of the detected tyrothricin peptide signal 
determined relative to the total signal. The mass of the extracts was subsequently adjusted 
relative to the earlier extracts where no peptide was detected. 
4.3.4 Amino acid manipulated productions 
The production of selected tyrocidine analogues was achieved through the supplementation 
of the growth medium with selected concentrations of phenylalanine (Phe) or tryptophan 
(Trp) established in Chapter 2 and 3. Production media was supplemented with either Phe or 
Trp alone or in combination at 5.5 and 16 mM. Pre-cultured B. aneurinolyticus were 
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inoculated at a volume of 1% (v/v) relative to the final volume production media and cultured 
in shallow stationary cultures as previously described. 
4.3.5 Tyrothricin purification  
The produced peptide was extracted according to an optimised method based on the original 
extraction methods [5,26]. The first optimised purification method (PM1) of crude peptide 
can only be briefly described since it is currently protected under a NDA as it has been 
classified as trade-secret (BIOPEP®, University of Stellenbosch). The biomass was extracted 
using an extreme pH step, organic solvent extractions, precipitation steps and/or activated 
carbon treatments, followed by chromatographic purification. This yielded crude extracts of 
about 40% peptide and purified peptide fractions with >75 tyrothricin. The purified fractions 
were chemically characterised using UPLC-MS as described below and by Vosloo et al. [24]. 
The second purification methodology (PM2) involved purification of the tyrothricin extract 
by means of adsorption chromatography. A XAD-16 resin was packed into a 0.8 cm radius 
glass column to a bed height of 12.75 cm and a column volume (CV) of 25.6 cm3. The crude 
tyrothricin extracts were suspended in 50% (v/v) EtOH in water, centrifuged for five minutes 
at 3000 × g to remove any particulate and injected onto the column connected to an AKTA 
chromatographic system. Using 0.1% (v/v) TFA in water (A) and EtOH (B) as solvents, the 
column was conditioned at a flow rate of 1.5 mL/minute for 1×CV at 20% B. At 20% B and 
flow rate of 0.2 mL/minute, 1.0 mL of sample was loaded onto the column followed by a 
further 0.2×CV at the same flow rate to allow for increased interaction time of the sample 
with the resin. The elution flow speed was subsequently increased to 1 mL/minute and the 
sample eluted using a step wise gradient. The fractions were eluted from the column with 
2×CV at 20% B, 3×CV at 50% B, 5×CV at 90% B, and 2×CV at 100% B. The column was 
then reconditioned using a linear gradient from 100% B to 20% B over 1×CV and then 20% 
B for 5×CV at a flow rate of 1.5 mL/minute. 
4.3.6 Antimicrobial activity assays 
Antibacterial activity assays: A variation of the microtiter broth dilution method described by 
Du Toit and Rautenbach [32] and Lehrer et al. [33] was used to test the antimicrobial activity 
of the peptides. A pre-culture of the B. subtilis was diluted with TSB to an OD of 0.2 at 
595 nm (±108 CFU/mL). A volume of 90 µL of diluted B. subtilis was added to all of the 
wells of the 96-well microtiter plate except for the top four wells in first column which 
Stellenbosch University  https://scholar.sun.ac.za
4.8 
 
received 90 µL of TSB. The wells of the first column received 10 µL of 15% (v/v) EtOH, 
thus served as sterility and growth controls respectively. Assays with the tyrocidine mixture 
obtained from commercial tyrothricin were repeated in triplicate (n=3) while those with GS 
were done in duplicate (n=2) in all the microtiter plates and served as positive controls. All 
the rest of the wells received 10 µL of one of the respective peptide extracts from the various 
purification steps repeated in triplicate (n=3). All peptides were suspended in 15% (v/v) 
EtOH, hence a final EtOH concentration of 1.5% (v/v) and peptide concentration ranging 
from 100 to 0.4 µg/mL. The microtiter plates were then covered and incubated for a period of 
16 hours at 37 °C, following which the light dispersion was measured spectrophotometrically 
at 595 nm using a Bio Rad™ microtiter plate reader. 
These data were analysed using GraphPad Prism® 4.03 (GraphPad Software, San Diego, 
USA) to plot the percentage growth inhibition of the respective peptide extract relative to the 
mean of the growth control, as previously described by Rautenbach et al. [34], using the 
following equation: 
Antifungal activity assays: A variation of the previously described microtiter broth dilution 
method optimised for antifungal assays was used to test the activity of the mentioned peptides 
toward A. fumigatus [35]. A volume of 50 µL of PDB was added to all the wells of a 
sterilized microtiter plate. The top four wells in the first column received 40 µL of sterilized 
water, while all the rest of the wells received 40 µL of the mentioned spore suspension. The 
rest of the assays setup was as described above for the bacterial assays. The microtiter plates 
were then covered and incubated for a period of 48 hours at 25 °C, following which the light 
dispersion was measured spectrophotometrically at 595 nm using a BioRad™ microtiter plate 
reader and the percentage growth inhibition determined as previously described. 
4.3.7 Semi-preparative HPLC of extracts to purify single peptides 
Selected extracts obtained were purified by reverse phase HPLC using methodology adapted 
from that previously described by Rautenbach et al. [1] and Eyéghé-Bickong [36]. Extracts 
were dissolved in 50% (v/v) ACN in water, centrifuged at 8600 × g for 10 minutes to remove 
any debris before being injected onto the column at a concentration of 10 mg/mL for crude 
samples and 4 mg/mL for partially purified samples. The chromatographic purification of the 
     % growth inhibition =    100  
100 × (A595 of well – Mean A595 of background) 
 
   (Mean A595 of growth control - Mean A595 of background) 
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tyrocidines and analogues was done according the method for the tyrocidines as described by 
Eyéghé-Bickong [36] and by Rautenbach et al. [1]. Briefly, a non-linear gradient (Waters 
gradient 6) at 3.0 mL/minute of 50% solvent A (0.1% (v/v) TFA in analytical grade water) to 
80% solvent B (10% (v/v) solvent A in 90% (v/v) ACN) over a period of 23 minutes (Method 
A) was used to purify the major tyrocidines on a semi-preparative C18 HPLC column. 
Alternatively, an adapted method, as described by Eyéghé-Bickong [36], for the purification 
of gramicidins was used to purify the more hydrophobic analogues of interest. This method 
(Method B) comprised of a 25.5 minute non-linear gradient (Waters gradient 6) at 
3.0 mL/minute of 60 to 100 % solvent B. Chromatography was monitored using a Waters 
Model 440 UV-detector at a wave length of 254 nm at a column temperature of 35 ºC, as 
described by Rautenbach et al. [1]. The respective fractions were then analysed by UPLC-MS 
to determine the purity of the isolated tyrocidines and analogues. 
4.3.8 ESMS and UPLC-MS analysis of tyrothricin extracts and purified 
peptides 
Samples were dissolved in 50% (v/v) ACN in analytical grade water to concentrations of 
10 mg/mL or 2.5 mg/mL regarding the culture extracts or peptides purified by HPLC 
respectively. These were then centrifuged at 8600 × g for 10 minutes to remove any debris 
prior to being diluted ten-fold using analytical grade water. Sample solutions (2 µL for direct 
analysis or 3 µL for separation by UPLC) were introduced by a Waters Acquity UPLCTM into 
a Waters Quadrupole Time-of-Flight Synapt G2 mass spectrometer with a Z-spray 
electrospray ionisation source in positive mode. Peptide extracts were subjected to a capillary 
voltage of 3.0 kV and cone voltages of 15 V or 25 V at a temperature of 120 ºC at the source, 
desolvation gas of 650 L/h and desolvation temperature of 275 ºC. Data acquisition was 
performed by scanning over a mass over charge ratio (m/z) range of 300 to 2000 in 
continuum mode at a rate of 0.2 scans per second.  
Separation of samples on an Acquity UPLC® BEH C18 column via the mentioned Waters 
Acquity UPLCTM chromatographic system was achieved at a column temperature of 60 ºC 
and flow rate of 0.300 mL/min; using a 1% (v/v) formic acid in analytical grade water (A) to 
ACN (B) gradient: 100% A from 0 to 0.5 minutes for loading, from 0 to 30% B over 0.5 to 1 
minute, then 30 to 60% B from 1 to 10 minutes, 60 to 80% B from 10 to 15 minutes. 
Reconditioning of the column was done from 80 to 0% B from 15 to 15.1 minutes and then 
100% A from 15.1 to 18 minutes.  
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4.4 Results and Discussion 
4.4.1 Optimisation of tyrothricin production in different media compositions  
In the present study a change in total tyrothricin production and colony morphology was 
observed with successive culturing on agar media. Variable tyrothricin production levels not 
only among different strains of the tyrothricin producers [26], but also between colonies of 
the same strain has been observed [27,29,30]. The maintenance of high producing colonies 
was instrumental for maximal tyrothricin production to occur. Selection of high producing 
colonies by spotting single colonies onto petri dishes seeded with M. luteus and production of 
freezer stocks prevented the systematic reduction of peptide production (data not shown). 
Variations in media composition as well as the culturing conditions were performed in an 
effort to elucidate the optimal environment in which B. aneurinolyticus maximally produced 
tyrothricin. Four different media compositions were used and the tyrothricin yield and 
peptide profile was assessed (Table 4.2). Initial tyrothricin production was achieved in a 
mixed animal and digested protein extract containing together with urea (media A). This 
production medium was of similar composition to that used by the pioneers of tyrothricin 
research [26], with the addition of urea as a simple nitrogen source, which is proposed to 
increase tyrothricin yields [37]. Our yields of crude extract were similar to those obtained by 
Dubos and Hotchkiss [26] for tyrocidine production in this medium, with TrcA (Mr = 1269.7) 
and TrcB (Mr = 1308.7) being the most abundant peptides. However, similar to these 
investigators [26], some variability was observed in the yields obtained between different 
cultures. However, the relative peak area obtained by UPLC-MS analysis determined these 
extracts were only composed of 19% (m/m) tyrothricin peptides and only 80 mg/L tyrothricin 
(Table 4.2). 
Increased tyrothricin production within stationary cultures is proposed to be dependent on the 
utilization of complex N sources [30]. Media B was as described by Appleby et al. [30] with 
a high percentage of complex nitrogen source instead of the additional simple nitrogen in the 
form of urea in Media A. Our yields were well below the 800 mg/L that they obtained, while 
UPLC-MS analysis determined the crude extract masses to contain only 15% (m/m) 
tyrothricin peptides with TrcA (Mr = 1269.7) being the most abundant peptide. In contrast, 
using Media C and D the crude extract masses obtained were greater than those of 
Lewis et al. [27] and contained 40% (m/m) tyrocidine peptides with TrcA (Mr = 1269.7) and 
TrcB (Mr = 1308.7) being the most abundant peptides in for Media C and TrcB (Mr = 1308.7) 
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and TrcC (Mr = 1347.7) for media D. The latter two media contained a high carbohydrate 
concentration, together with high concentrations of complex nitrogen. High tyrothricin 
production observed in Media C and D (Table 4.2) is supported by the Lewis et al. [27] who 
reported increased tyrothricin production in excess of 2000 mg/L to be dependent on the 
concentration of tryptone as a complex nitrogen source and glucose as carbohydrate source, 
which could be substituted with either glycerol or mannitol. The differences observed in the 
production levels found in this study relative to those of other investigators within the same 
or similar production media [26,28,30] could be because of differences in producer strains 
used by different investigators, as well as differences in culturing procedures. These results 
also corroborate our previous findings described in Chapter 2 and 3 on the sensitivity of the 
production profile towards the aromatic amino acid ratio, which probably differ substantially 
between the different media.  
Table 4.2 Summary of the mean tyrothricin yield extracted from cultures of 
B. aneurinolyticus grown in the respective media compositions 
Culture Medium 
(Fermentation 
Time) 
Media character 
Crude 
extract 
mass ± 
SEM (g/L) 
% 
Tyrocidine 
in extract* 
Calculated 
amount of 
tyrothricin 
(g/L)** 
Medium A 
(10 days) 
Mixed animal 
protein and digested 
protein + urea 
0.32±0.03 
(n=20) 
19 0.08 
Medium B 
(10 days) 
High digested animal  
protein content 
0.35±0.05  
(n=7) 
15 0.07 
Medium C 
(10 days) 
Glucose + digested 
milk protein 
2.80±0.17 
(n=45) 
40 1.49 
Medium D 
(10 days) 
Glucose + digested 
milk and plant  
protein 
2.40±0.20 
(n=7) 
40 1.28 
SEM, standard error of the mean; * determined via UPLC-MS, calculated relative to commercial tyrocidine 
mixture; ** Calculated from the expected 20:20:60 ratio of contaminants: gramicidins: tyrocidines in the crude 
[5,26]. 
Analysis of the peptide production profiles in the four different production media by ESMS 
revealed an increase in the contribution of the linear gramicidin component to the tyrothricin 
extract in Media C and more so in Media D (data not shown). The lack of detection of the 
linear gramicidins in Media A and B (data not shown) is most likely due to the low 
tyrothricin peptide content of these extracts combined with the reduced ionisation of the 
linear gramicidins hampering their detection. As production of the tyrocidines and analogues 
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was the main focus of this research, Media C was used in further efforts at evaluation of the 
optimal production conditions.  
4.4.2 Evaluation of the growth and tyrothricin production in Media C 
The yields of tyrothricin obtained were found to be dependent on the growth state of the 
producer strain, as well as the ratio of starter culture to production medium. Moreover, the 
selection of large, darker colonies grown for 48 hours on pre-culture plates was instrumental 
to high tyrothricin production. These were suspended into pre-culture media, having reached 
an OD595 of 06-1.0 in 24 hours. These cultures were inoculated into the production media at a 
ratio 1% of the final culture volume. If too high a ratio of starter culture was used high 
growth was observed, but tyrothricin production was suppressed (data not shown). The 
influence of culture depth on the growth and tyrothricin production has been extensively 
researched by Lewis et al.[27]. The growth and tyrothricin production within these flask 
cultures was investigated over a period of 384 hours (16 days) (Fig. 4.1). 
Production of the tyrocidines and related peptides in the tyrothricin complex is reported to 
commence toward the end of the logarithmic growth phase [25,25,26,38], as is evident in 
Fig. 4.1 after 48 hours. The end of the logarithmic growth phase was only reached after 72 
hours, however, the producer strain then entered a second growth phase where maximal 
tyrocidine production occurred, as apparent from the diauxic growth curve. Peptide 
production increased steadily throughout the second growth phase until reaching a maximum 
after 336 hours (14 days) when production suddenly declined, despite maintaining a high 
OD595. The pH of all the cultures increased systematically until 144 hours where after it 
started to decline steadily. Despite the variability of the pH it remained alkaline in all of the 
cultures, which is probably due to the high content of basic peptides that were produced.  
In an effort to increase tyrothricin production while also decreasing the time required for 
production, submerged cultures were performed in one litre bioreactors. The initiation of 
bacterial growth in these cultures was erratic; while in control cultures run in parallel growth 
was consistently observed within six hours, cultures in the bioreactors frequently failed to 
start growing. Efforts to initiate growth were performed by briefly increasing the aeration to 
2×VVM and/or agitation to 200 rpm. Once culture growth was initiated, the aeration and 
agitation were returned to their previous rates as maintenance at these increased rates resulted 
in high foam production which blocked the aeration source filters resulting in spillage and 
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subsequent termination of the cultures. After a lag of up to seven hours, the initiated cultures 
grew rapidly depleting the available dissolved oxygen concentration (dO2) and reached the 
end of the logarithmic growth phase near 24 hours (Fig. 4.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Growth and tyrothricin production of B. aneurinolyticus in flasks using Media C 
over a culturing period of 384 hours (16 days). A Growth of B. aneurinolyticus 
measured spectrophotometrically at OD595 and pH fluctuation over the growth 
period. B Extract mass obtained over the culturing period together with the 
percentage total tyrocidine peptide (Trc Peptides) relative to the total signal 
obtained in each ESMS analysis of the respective culture extracts. 
The pH from one culture to the next very rarely gave identical curves, however, they did 
follow specific trends either in the stationary (Fig. 4.1) or submerged cultures (Fig. 4.2), as 
has been reported in literature [27,29]. In the submerged cultures reported in literature [28,29] 
as well as those of our own (Fig. 4.2), the pH dropped after an initial small spike. This initial 
drop in pH has been associated with a phase of rapid anaerobic glucose utilisation [29], which 
coincided with a spike in dO2, after which the pH then rose again. Without doing any external 
pH adjustments in the fermenter, we observed after the logarithmic phase the pH oscillated 
between pH 5.9 and up to pH 7.4 throughout the rest of the culturing period. The fluctuation 
in pH varied greatly between one culture and the next going as low as 4.8 and as high as 10.3 
in other cultures (data not shown). Appleby et al. [29] has suggested that the increase in pH 
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after glucose depletion is due to initial anaerobic carbohydrate metabolism leading to acidic 
metabolites followed by protein breakdown and the release of ammonia. However, the 
production of tyrocidines with a pI>9 can also lead to increase in pH. Further investigation of 
this phenomenon was, however, beyond the scope of this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Growth and tyrothricin production of B. aneurinolyticus in Media C over a period 
of 175 hours cultured in a 1L bioreactor. A Growth of B. aneurinolyticus 
measured spectrophotometrically at OD595 and pH fluctuation over the growth 
period. B Variation of the dissolved oxygen concentration (dO2) over the 
culturing period together with the percentage total tyrothricin peptide relative to 
the total signal obtained in each ESMS analysis of the respective culture extracts 
taken at the respective time points. 
In contrast to what was observed in submerged cultures, glucose is reported to be utilised 
gradually throughout the culturing period in stationary cultures with tryptone as complex 
nitrogen sources and only depleted after 18 days of culturing [27]. The pH of these cultures 
also follows a different trend, where it steadily increases before beginning to decrease after 
an extended culturing period (Fig. 4.1). This would point toward altered metabolism of the 
cultures in the submerged relative to the stationary cultures and is supported by the 
observations described in literature [27-30]. 
The end of the logarithmic growth phase coincided with the first detection of the tyrothricin 
peptides in the culture extracts of the bioreactor cultures (Fig. 4.2) at 24 hours maintaining a 
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relative contribution of near 40% of the total ESMS signal. The flask cultures (Fig. 4.1) only 
reached the end of the logarithmic growth phase after 72 hours. The tyrothricin peptides were 
first detected in the culture extracts toward the latter end of the logarithmic growth phase at 
48 hours. In the shallow stationary cultures the percentage contribution of the tyrothricin 
peptides relative to the total ESMS signal increased from near 50% to 60% when the cultures 
had entered the second growth phase. At the end of the logarithmic growth phase at 24 hours 
the submerged cultures had reached an OD595 of 1.36 at a growth rate (D ln OD595/D time) of 
0.202, while the stationary cultures took 72 hours to reach higher an OD595 of 2.15 which 
equated to a slower growth rate of 0.039. After the initial rapid growth rate the stationary 
cultures continued to increase in biomass at a second slower growth rate of 0.001. 
Concomitantly the extract masses obtained from the stationary culture samples increased 
steadily throughout the culturing period.  
The ESMS spectra of the extracts obtained from the submerged cultures had a large amount 
of background noise due to much lower tyrocidine peptide peak intensity relative to those 
from the stationary cultures (data not shown). As a consequence of the low tyrothricin yield, 
co-extracted contaminants from the media and culture had a greater influence on the extract 
mass and ESMS spectrum. Therefore, the extracts obtained from the submerged cultures were 
highly variable with no discernible trend in tyrothricin production of the samples taken 
throughout the culturing period. Only the final extract mass of the total biomass extracted at 
the end of the culturing period was considered (Table 4.3). 
Maximal tyrothricin production occurred when the stationary cultures reached the secondary 
growth phase was of sufficient biomass, yet had not depleted all of the available nutrients. As 
glucose is proposed to still be available [27], oxygen limitation after the initial biomass 
production is the most probable trigger in the initiation of the transcription of the genes 
responsible for tyrothricin production to occur in these cultures (Fig. 4.1). This hypothesis is 
supported by the observed detection of the tyrocidines in the stationary cultures after 48 
hours. The cultures were then approaching the end of the logarithmic growth phase, however, 
there was still sufficient nutrients available for the cultures to continue increasing in biomass, 
albeit at a slower growth rate (Fig. 4.1). 
Detection of tyrocidine peptides in the submerged cultures here too occurred within 24 hours 
at the end of the logarithmic growth phase. Despite the fact dO2 already approached zero at 
10.5 hours, approximately three hours after the cultures started actively growing (Fig. 4.2). 
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The stress trigger that initiated tyrocidine production in the submerged cultures was most 
likely nutrient depletion. As such, these aerated cultures depleted the available nutrients 
producing initial biomass. When the tyrocidine production was initiated only the biomass 
present at that time produced any peptide, in contrast to the stationary cultures where a large 
increase in biomass was observed well after the end of the logarithmic growth phase and 
initiation of tyrocidine production, particularly after 192 hours (8 days) (Fig. 4.1, Table 4.3). 
Table 4.3  Summary of growth and tyrothricin production by B. aneurinolyticus in Media C 
under the respective culturing conditions and time periods. The final biomass 
obtained after 8 to 10 days culturing in four submerged cultures was used to 
represent the mean levels observed within the submerged cultures relative to 
those obtained from the stationary cultures over a period of between 8 and 18 
days. 
Culture pH ± SEM 
Dry cell mass ± 
SEM (g/L) 
Extract mass ± 
SEM (g/L) 
% 
Purity a 
Submerged culture 
(n=4) b 7.29±0.76 2.6±0.6 0.74±0.19 ND 
Stationary culture 
8 days (n=2) 7.68±0.09 3.5±0.1 1.77±0.07 39 
Stationary culture 
10 days (n=5) 7.31±0.28 4.5±0.4 2.78±0.23 41 
Stationary culture 
12 days (n=7) 7.31±0.04  5.4±0.2 2.42±0.49 42 
Stationary culture 
14 days (n=2) 7.23±0.14  3.3±0.6 2.49±0.42 41 
Stationary culture 
16 days (n=4) 7.50±0.31 6.0±0.5 3.32±0.50 40 
Stationary culture 
18 days (n=2) 7.89±0.43 5.0±0.2 2.54±0.09 39 
a The total peak area detected for the tyrocidine peptides in the UPLC-MS chromatogram is expressed as 
% relative to that of the commercial tyrocidine mixture at the same concentration of 1.00 mg/mL. 
b Mean values obtained from the final biomass after 8 to 10 days culturing 
Understanding the processes in control of the natural production of the tyrocidines is of 
particular relevance to the maintenance of high production. The initiation of tyrocidine 
production is under the control of the SpoA-AbrB regulatory pathway [39,40]; which is also 
associated with the activation of other genes responsible for the production of other 
secondary metabolites as well as sporulation [41]. The triggers for the initiation of these 
pathways are related to metabolic stress of the producer organism and include a range of 
factors ranging from oxygen limitation to nutrient starvation [42]. As the tyrocidines are 
extracted from the biomass, high tyrocidine production is dependent on increased biomass 
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production which has been sufficiently primed to produce peptide, yet not stressed to the 
extent that sporulation is initiated. 
Production of tyrothricin in the stationary cultures reached increased levels after 10 days of 
culturing, despite marginally lower yield of biomass. Increasing the culturing period beyond 
this did not significantly increase the total tyrothricin production. Increased production 
observed in the 16 day cultures may possibly be attributed to the daily disturbance of the 
cultures that occurred when samples were taken (Fig. 4.1) as these increases were not 
observed in succeeding cultures. 
Our results concur with those of Lewis et al. [27] who found that the tyrothricin yield within 
stationary cultures reached increased levels of production after 10 days of culturing. These 
investigators also report decreased growth and tyrothricin yields in cultures which had been 
disturbed and the pellicle layer of cells growing on top of the cultures disrupted. This was in 
contrast to what we observed after 16 days culturing. Extension of the culturing period for up 
to 28 days saw a considerable drop in the biomass and consequent peptide extracted relative 
to the initial culture volume (data not shown), attesting to the ability of the producer organism 
to sporulate once the nutrients had been depleted, similar as to what was observed in 
submerged cultures after nutrient depletion [28]. 
In an effort to emulate the production conditions observed in the stationary cultures, further 
submerged cultures were aerated through the head space of the bioreactor once the end of the 
logarithmic growth phase had been reached. This, however, did not increase the final biomass 
or tyrothricin production obtained from these cultures. The final biomass and tyrothricin 
production in the submerged cultures remained well below that of the stationary cultures 
(Table 4.3), despite the stationary cultures having a slower initial growth rate. 
The suppression of tyrothricin production in submerged cultures in media containing 
complex nitrogen sources, such as the tryptone or a complex mixture of amino acids, is 
corroborated in literature [28,29]. These investigators were, however, able to produce 
tyrothricin in submerged cultures using defined minimal media which utilized glutamic acid, 
asparagine [28], ammonium succinate or urea as the sole nitrogen source [29]. In all of the 
later cases total tyrothricin production varied between 100 to 500 mg/L. This value could be 
increased to 890 mg/L with the addition of biotin to the ammonium succinate media [29]. 
Growth of the producer strain in stationary cultures using these defined media containing 
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simple nitrogen sources was, however, sparse and subsequent tyrothricin production was 
limited [30]. 
All of the evidence indicates toward the previously mentioned control of the balance between 
growth of the producer strain, tyrothricin production and sporulation. Tyrothricin production 
in submerged cultures using defined media occurred at slower growth rates, similar to what 
was observed in the stationary cultures cultured using complex nitrogen sources (Fig. 4.2). 
Therefore the low nutrient content of these media is the trigger for tyrothricin production and 
not oxygen limitation in these submerged cultures, in contrast to stationary cultures with 
complex nitrogen sources. Moreover, sporulation of the producer organism was observed 
after culturing in the defined media for over 40 hours when nutrients were being depleted 
[28]. This would then account for the extreme pleomorphism reported between stationary 
relative to aerated submerged cultures [30]. 
Tyrothricin production in submerged cultures has not been reported to exceed 890 mg/L 
using a chemically defined media of ammonium succinate with the addition of biotin [29]. 
Successful submerged production with complex nitrogen sources is limited to a patent using 
“corn steep water” [31] where a yield of 1600 mg/L was obtained after 12 days of culturing. 
While Lewis et al [27] reported a yield of 1400 mg/L after 48 hours of submerged culturing 
in Media C, they reported discrepancies between submerged versus stationary cultures. One 
aspect, however, is unclear from these older studies, namely the purity of the tyrothricin 
produced, as no detailed analysis is given. Quantification of tyrothricin production by these 
investigators was achieved means of antimicrobial activity [28-30] or haemolysis [5,26,27] 
assays. Our experience of tyrothricin production by submerged culturing using Media C was 
less satisfactory, with erratic initiation of culture growth. Peptide as well as biomass 
production in the submerged cultures was consistently well below that observed in the 
stationary cultures that were performed in parallel (Table 4.3). Consequently, our efforts to 
produce increased tyrothricin yield focused on stationary cultures. 
4.4.3 Purification of the crude tyrothricin extract 
Having increased tyrothricin production, a need existed to purify the tyrothricin extracts 
obtained from the different cultures. Certain cultures were found to produce a dark pigment 
which was co-extracted together with tyrothricin. Manipulation of the organic extraction step 
by limiting any heating, as well as starter colony selection reduced this contamination. 
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However, co-extraction of other unwanted pigments and other compounds remained a 
problem. To this end two purification methodologies were developed and optimised to purify 
the mixtures of tyrocidines and analogues to an acceptable level of purity (>75% in terms of 
peptide mass) for use in agricultural field trials by our group and the bee toxicity study 
reported in Chapter 7. 
In the first purification methodology developed, PM1, the solubility of the solution was 
manipulated to remove contaminants, including precipitation steps [5,6]. The rate at which 
the precipitate is formed has been suggested to increase with heating at 50 °C [27], however, 
due to our experience of increased pigment contamination observed with heating, the 
opposite was performed and precipitation was achieved at 4 °C within four hours. This step 
served to remove co-extracted hydrophilic contaminants from the extracts. In this purification 
step the purity was increased from 40% to about 60%, however, this varied between culture 
extracts. Interaction with activated carbon was used to remove a large part of the co-extracted 
yellow/brown pigment leading to >75% pure tyrothricin extract (Te). The production of 
pigment(s) could also be reduced by addition of glucose as a 20× stock to the rest of the 
growth medium only after separate sterilization by autoclaving at 120 °C for 15 minutes and 
removal from the autoclave within 25 minutes once the pressure had reduced sufficiently.  
The removal of contaminating co-extracted culture pigments using activated carbon [43] was 
reportedly increased by heating at 60 °C, but we were unable to reproduce this result. Using 
the above purification methodology, PM1, the antimicrobial activity and detected peptide, 
according to UPLC-MS, increased relative to the crude extract systematically through the 
progression of the sequential purification steps attributing to contaminant removal. 
Ultimately, a final mass yield of approximately 33% of that of the initial crude extract mass 
was obtained with near double the antibacterial activity and purity of the crude extract (data 
not shown). 
Manipulation of the solubility of the initial crude extract (Fig. 4.3 A) resulted in the 
precipitation of the tyrothricin peptides from solution and the removal of hydrophilic 
contaminates (Fig. 4.3 B). Due to the lower solubility of the linear gramicidins, this may have 
resulted in a reduction in their concentration as deduced by their decreased signal intensity. 
This step, however, also removed some contaminants which aided the solubility of a group of 
hydrophobic contaminants which were insoluble in 90% ACN (Fig. 4.3 C). The presence of 
such hydrophobic contaminants has also been reported by others in literature [5,26]. After 
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treatment with activated carbon a large part of the co-extracted culture pigments could be 
removed. However, the presence of a contaminant observed at m/z value of 802.53 persisted 
throughout the various purification steps, indicating hydrophobicity similar to that of the 
tyrothricin peptides (Fig. 4.3). The Te obtained after the activated carbon step was composed 
primarily the tyrocidines with TrcA (Mr = 1269.7) and TrcB (Mr = 1308.7) being the most 
abundant peptides with a minor contribution of some of the linear gramicidins (Fig. 4.3 D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 ESMS spectra depicting the various tyrothricin peptide fractions containing the 
tyrocidines (Trcs) and linear gramicidins (Grms, VGB) together with 
contamination observed at m/z value of 802.53 obtained through the progressive 
steps of PM1 purification. A Crude culture extract: B Crude extract after 
precipitation: C Precipitate insoluble in 90% ACN after precipitation and D 
Crude extract to produce Te after treatment with activated carbon. The Y-axes of 
the spectra are linked in order to directly compare the intensity of the detected 
molecular ions of the different spectra.  
The gramicidin fraction could largely be removed by treatment of the activated carbon 
fraction three times with a 1:1 ratio of ether: acetone washes with the more hydrophobic 
gramicidins soluble in the solvent mixture. As the tyrothricin complex is composed of 
between 10% to 20% gramicidins and 40% to 60% contributed by the tyrocidines and their 
analogues [5], it was suspected both the gramicidins and some the more hydrophobic 
tyrocidines may have been removed during ether: acetone in the wash steps. Analysis of these 
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two fractions by UPLC-MS confirmed the ether: acetone fraction also contained tyrocidines 
and analogues together with the gramicidins (Fig. 4.4 A), leaving a relatively pure extract of 
the tyrocidines and analogues (Fig. 4.4 B).  
 
 
 
 
 
 
 
 
Figure 4.4 UPLC-MS chromatograms of tyrothricin extract after washing with 1:1 ratio of 
ether: acetone resulted in the fractionation of the tyrothricin peptides into two 
separate fractions: A Supernatant containing the linear gramicidins together with 
tyrocidines and B the final Te (acetone-ether precipitate) that remained containing 
relatively pure Trcs. The Y-axes of the chromatograms are linked in order to 
directly compare the resolved/detected peaks.  
The principals used in PM1 to purify the tyrothricin peptides are of such a nature that it may 
be adapted and up-scaled for purification of larger volumes. The tyrothricin peptides 
precipitated out of large volumes could be recovered using continuous flow centrifugation. 
Activated carbon would be utilised as a column chromatographic step. The large volumes of 
EtOH and ACN would be reduced by rotary evaporation or spray drying. However, one of 
the major limitations of PM1 is the number of handling steps required in drying the peptide 
and changing solvents. 
In the second purification methodology developed (PM2), the tyrocidines and their analogues 
were purified by exploiting their amphipathic nature using adsorption chromatography on an 
Amberlite XAD-16 resin. This resin is reported to have a high hydrophobic character and 
large surface area of >800m2/g, with resin beads composed of a skeleton of interlinked 
styrene-divinylbenzene copolymers [44]. After the initial organic extraction from the 
biomass, this purification entailed dissolving the dried crude extract in the minimal volume of 
50% EtOH, centrifugation to remove particulate and loading of the sample on to a column 
packed with XAD-16 adsorption resin and drying of selected, pooled fractions. Purification 
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was achieved using step-wise gradient of EtOH and 0.1% (v/v) TFA in analytical grade water 
(PM2; Fig. 4.5). Fractions were pooled from each of the respective step wise elution steps and 
their cyclodecapeptide composition and yield was determined using UPLC-MS, as well as the 
antimicrobial activity of fractions containing the most peptide. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Elution profile obtained when loading 30 mg of crude tyrothricin extract on a 
column packed with XAD-16 resin and elution using a step wise gradient of 0.1% 
(v/v) TFA in analytical grade water and eluent B composed of 100% ethanol. 
Fractions were obtained at elution volumes of: A 6-12.5 mL using 20% B; B 
12.5-50 mL using 20% B; C 64-120 mL using 50% B; D 142-152 mL using 90% 
B; E 152-210 mL using 90% B and F 250-285 mL using 100% B. 
A large fraction of hydrophilic contaminants were removed at the 20% B (Fig. 4.6 A and B) 
and 50% B (Fig. 4.6 C) elution steps of PM2. The first fraction collected at the 20% B elution 
step contained a minor amount of the tyrothricin peptides relative to the total amount of 
contaminants removed (Fig. 4.6 A). The vast majority of the tyrothricin peptides were eluted 
in the 90% B fraction (Fig. 4.6 D and E). The initial front part of the 90% B elution step 
(Fig. 4.6 D) contained predominantly tyrocidine peptides, while the tailing observed in the 
90% B elution step contained tyrocidine peptides together with an increased proportion of the 
linear gramicidins (Fig. 4.7 E). A small fraction of hydrophobic contaminants eluted in the 
100% B elution step (Fig. 4.7 F). The linear gramicidins, however, where observed to elute 
throughout the elution steps of PM2 (Fig. 4.7), in contrast to what was observed with the 
tyrocidine peptides being primarily concentrated in a single elution step. 
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Figure 4.6 UPLC-MS chromatograms depicting the elution of the tyrocidines and their 
analogues (Trcs) obtained when loading 30 mg of crude tyrothricin extract on a 
column packed with XAD-16 resin and elution using a step wise gradient of 0.1% 
(v/v) TFA in analytical grade water and eluent B composed of 100% ethanol. 
Fractions were obtained at elution volumes of: A 6-12.5 mL using 20% B; B 
12.5-50 mL using 20% B; C 64-120 mL using 50% B; D 142-152 mL using 90% 
B; E 152-210 mL using 90% B and F 250-285 mL using 100% B. 
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Figure 4.7 UPLC-MS chromatograms of the fractions obtained when loading 100 mg of 
crude tyrothricin extract on a column packed with XAD-16 resin and elution 
using a step wise gradient of eluent B composed of 100% ethanol illustrating the 
elution of the linear gramicidins. Fractions were obtained at elution volumes of: 
A 6-12.5 mL using 20% B; B 12.5-50 mL using 20% B; C 64-120 mL using 50% 
B; D 142-152 mL using 90% B; E 152-210 mL using 90% B and F 250-285 mL 
using 100% B. 
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Despite the minor losses of tyrothricin peptide observed, the 90% B elution step of PM2 
purification methodology yielded a peptide fraction of with approximately 1.5 times the 
peptide content in relation to the initial crude extract mass. After the initial four organic 
extraction steps, used in both purification methodologies, the number of handling steps were 
reduced from ten in PM1 down to four in the PM2 while still obtaining approximately the 
same purity (>75%) the remaining peptide yield was increased from in the vicinity of 33% to 
50% in terms of the initial crude extract mass. Future work required to optimise this 
purification methodology for utilisation in up-scaled purifications would entail including a 
methodology more amenable to reducing the large volumes of solvents that would be 
generated. The use of traditional rotary evaporation to reduce these volumes would be 
unfeasible. Thus the use of other techniques compatible with the drying of these large 
volumes of EtOH, typically used in the industrial recovery of pharmaceutical and 
biotechnology products would need to be optimised, one of which is spray drying [45]. 
4.4.5 Characterization of Te for use in plant and bee studies 
The antimicrobial activity of Te which had been purified by means of PM1 was determined 
toward the representative fungi A. fumigatus as well as the Gram-positive bacteria B. subtilis 
and compered to that of the highly purified commercial tyrocidine (Tc) (Table 4.4).  
Table 4.4 Activity of the tyrocidine extract (Te) relative to commercial tyrothricin (Tc) 
toward representative fungi A. fumigatus and Gram-positive bacteria B. subtilis.  
Target organism Peptide formulation 
IC50 (µg/mL) 
±SEM 
% relative activity 
±SEM a 
Aspergillus fumigatus Tc (n=7) 4.12±0.32 100±14.1 
 Te (n=37) 6.21±0.26 66.3±2.8 
Bacillus subtilis Tc (n=13) 7.51±0.87 100±11.6 
 Te (n=50) 8.58±0.141 87.5±1.4 
a Activity relative to that observed for Tc 
From these data it was apparent that the antimicrobial activity of Te was lower than that of Tc 
when the actual masses of the two peptide formulations were considered. Te was analysed 
further by means of fractionation into a hydrophilic, intermediate and hydrophobic fractions 
using semi-preparative HPLC (Fig. 4.8).  
After pooling the fractions collected from consecutive runs 70% of the total collected mass 
was obtained in fraction 2 which corresponded with the known elution times of the 
tyrocidines and their analogues, while 16% and 14% of the total mass was obtained in the 
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first and third fractions respectively (Fig. 4.8). UPLC-MS analysis of three Te factions 
(Fig. 4.9) was performed to determine their purity relative to Tc (Table 4.5). These analysis 
revealed Te to be composed of 75% (m/m) tyrocidine peptides, shedding further light on the 
reduced antimicrobial activity relative to Tc. 
 
 
 
 
 
Figure 4.8 Chromatogram of the fractionation of the tyrothricin extract (Te) by semi-
preparative HPLC on a reverse phase C18 column. Of the total 5.675mg 
collected, 16% (0.932 mg) was in fraction one at a retention time (Rt) 0-8.0 
minutes, 70% (3.942 mg) was within fraction two at Rt 8.0-19.3 minutes and 14% 
(0.801 mg) in fraction three at Rt 19.3-35 minutes.  
Table 4.5 Summary of the fractionation of Te by semi-preparative HPLC.  
Fraction Rt (min) a % Yield b % Purity c 
Fraction 1 0-8.0 16 0 
Fraction 2 8.0-19.3 70 99 
Fraction 3 19.3-35 14 21 
Total Te   100  75 
Rt, retention time 
a The retention time at which the fraction was collected by semi-preparative HPLC 
b The percentage of the total mass of the fractions collected by semi-preparative HPLC 
c The total peak area detected for the tyrocidine peptides in the UPLC-MS chromatogram is 
expressed as % relative to that of the commercial tyrocidine mixture at the same concentration of 
1.00 mg/mL. 
Considering the purity of Te, the antimicrobial activity is virtually identical to that of Tc, and 
even slightly higher towards B. subtilis (Table 4.4). Analysis of the three semi-preparative 
HPLC fractions of Te by UPLC-MS confirmed the majority of the tyrocidine peptides to be 
within fraction 2 together with a very small amount of VGA (Fig. 4.9 C) and had a purity of 
approximately 99% (Table 4.5).  
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Residual background contamination was observed in all of the different fractions as well as 
the blank and is most likely due to plasticiser contamination (Fig. 4.9). While no tyrocidines 
were detected in fraction 1, a small amount of the hydrophobic analogue TpcA was detected 
in fraction 3 together with IGB and VGA (Fig. 4.9 D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 UPLC-MS chromatograms of the fractions obtained of a tyrothricin extract 
fractionated into three fractions by semi-preparative HPLC. A Blank containing 
plasticiser contaminants which contaminated all the fractions; B Fraction 1; C 
Fraction 2 containing the majority of the tyrocidine analogues (Trcs) and linear 
gramicidin A (VGA); D Fraction 3 containing a single hydrophobic TpcA 
analogue of the Trcs together with linear gramicidins VGA and IGB. 
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The composition of Te was elucidated from the UPLC-MS analysis of the total Te as well as 
that of the semi-preparative HPLC fractions. The Te composition was divided into three 
primary fractions composed of: hydrophilic pigment/contaminants contributing 16% (m/m), 
the tyrocidines and analogues contributing 75% (m/m), with TrcA>TrcB/B’>TrcC being the 
most abundant peptides, while the rest of the mass contributed by a hydrophobic fraction of 
8% (m/m) composed of mainly VGA with the rest contributed by other linear gramicidins 
(Table 4.6). 
Table 4.6 Summary of the composition of Te.  
Component % a 
Pigment/hydrophilic contam.b 16.4 
Tyrocidines and analogues c 
Tyrocidine A 21.1 
Tyrocidine A1 4.4 
Tryptocidine A 6.3 
Tryptocidine A1 0.4 
Tyrocidine B 9.4 
Tyrocidine B' 8.5 
Tyrocidine B1 3.5 
Tryptocidine B 6.2 
Tryptocidine B1 0.5 
Tyrocidine C 10.7 
Tyrocidine C1 1.6 
Tryptocidine C 2.5 
Tryptocidine C1 0.3 
Linear gramicidins c 
Val-Gramicidin A 6.1 
Val-Gramicidin B 0.6 
Val-Gramicidin C 0.9 
Ile-Gramicidin A 0.6 
Contam, contamination 
a The percentage mass contribution of each of the respective components relative to the total 
b The percentage of the total mass of the fraction collected by semi-preparative HPLC 
c The percentage contribution of each of the different analogues is expressed in relation to the 
purity determined relative to the commercial tyrocidine mixture obtained from the respective 
UPLC-MS peak areas of the total Te and fraction collected by semi-preparative HPLC.  
4.4.6 Amino acid manipulated productions 
Two amino acids, namely phenylalanine (Phe) and tryptophan (Trp), were found to have the 
largest effect when shifting the tyrocidine production profile (refer to Chapter 2 and 3). The 
influence of these two amino acids on the growth rate and tyrothricin production by 
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B. aneurinolyticus was investigated in detail as reported in Chapter 2. Supplementation with 
Phe increased the growth of the producer strain as well as tyrothricin production 
(Fig. 4.10 A). In contrast, the growth of the Trp supplemented cultures was similar or less 
than that observed in the control, while tyrothricin production was similar or greater than that 
of the control (Fig. 4.10 A). When considering tyrothricin production relative to cell mass 
attained, Phe stimulated growth rather than tyrothricin production in the culture. In contrast, 
Trp stimulated increased production of tyrothricin, particularly at increased Trp 
concentrations (Fig. 4.10 B). 
 
 
 
 
 
 
 
 
Figure 4.10 Effect of supplementation of the growth medium of B. aneurinolyticus with 
either phenylalanine (Phe) or tryptophan (Trp) compared to the non-
supplemented growth control. A Dry cell mass as well as tyrothricin yield of the 
supplemented cultures relative to non-supplemented control. B The relative 
tyrothricin yield per mg of cells obtained under the different supplemented 
conditions. 
The growth media of cultures were supplemented with specific ratios of Trp/Phe to increase 
the production of selected analogues relative to the non-supplemented control. These culture 
extracts were purified using PM1 and PM2 and their purity determined relative to Tc by 
means of UPLC-MS, as has been previously described (Fig. 4.11). Supplementation of the 
growth medium with Phe shifted the tyrocidine production profile toward the increased 
production of the more hydrophobic A analogues (Phe3, Phe4) (refer to table 4.1) which were 
the purified to ±70% purity in terms of tyrocidines and their analogues (Fig. 4.11 B). 
Trp supplementation shifted the peptide production profile toward the production of another 
subset of cyclodecapeptides, the tryptocidines (Trp7), predominantly tryptocidine C 
analogues (Trp3, Trp4), which were in turn purified to ±75% purity in terms of tyrocidines 
and their analogues (Fig. 4.11 C).  
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Figure 4.11 UPLC-MS chromatograms of culture extracts of B. aneurinolyticus which have 
been purified by PM1 or PM2. A Non-supplemented medium producing a wide 
range of tyrocidine analogues; relative to cultures supplemented with: B 27.5 mM 
Phe to produce predominantly the more hydrophobic A analogues (Phe3, Phe4), C 
16.5 mM Trp resulting in increased tryptocidine C/C1 (Trp
3, Trp4) production and 
D a combination of 5.5 mM Trp and 16.5 mM Phe to yield increased tryptocidine 
(peptides with Trp7) production. 
Using defined ratios of these two amino acids the peptide production profile could be nudged 
to increase the production of selected intermediate analogues (refer to Chapter 2 and 3 for 
more detailed analysis). Supplementation with 5.5 mM Trp together with 16.5 mM Phe 
increased the proportional contribution of the tryptocidine A (Phe3, Phe4) and B (Trp3, Phe4) 
analogues in addition to the C analogue, after purification yielded a ±78% pure extract 
(Fig. 4.11 D). 
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4.4.7 Purification and analyses of single peptides 
The different tyrocidine analogues may vary by as little as a single CH2 group, this poses a 
significant challenge to the purification of selected analogues from the broad range of 
different analogues that are produced. Production and purification of the tyrocidines and their 
analogues was optimised according to the analogues of interest which were being purified.  
The increased production of selected tyrocidine or analogues was increased by supplementing 
the growth medium of the producer organism with defined ratios of Trp/Phe (Fig. 4.11). Once 
the culture extracts were purified to an acceptable level of purity using PM1 or PM2 and the 
linear gramicidins had been removed by ether/acetone precipitation, the tyrocidines and 
analogues were purified from the culture extracts by semi-preparative HPLC. When the more 
hydrophilic tyrocidines and their analogues were purified, purification Method A was utilised 
for optimal purification. While when the purification was focused on the more hydrophobic 
phenylalanine rich tyrocidine analogues, Method B was utilised for purification. Using these 
adaptations to the production and purification methodologies greatly increased the ease of the 
purification of the different tyrocidine analogues.  
The identity of the different tyrocidine analogues was confirmed by UPLC-ESMS/MS 
analysis (refer to Chapter 2, supplementary data). After a single round of semi-preparative 
HPLC purification the majority of the peptides were found to be of high purity as determined 
by UPLC-MS. In relation to a previous study using only the commercial tyrocidine extract as 
the source of peptide [46], considerably higher yields of purified peptides where attained, 
while also increasing the efficiency of purifying rare analogues which were absent or only 
present in very low quantities in the commercial tyrocidine extract (Table 4.7). 
The selection of the peptide productions which had a compliment of peptides which were 
amenable to easy purification was found to be instrumental to the purification of selected 
analogues of >90% purity. Cultures extracts found to contain large amounts of co-produce 
TrcB and TpcC or, TrcA and TpcB posed a significant challenge for purification. These 
peptides were found to elute at similar times off the column and hence created a challenge to 
obtaining peptides of high purity. This was particularly evident in the purification of TpcB 
which could be produced at higher quantities in cultures co-supplemented with increased Phe 
and lower Trp concentrations (Fig. 4.11 D). Increased production of TpcA in the former co-
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supplemented cultures allowed for its purification. This peptide has not been purified 
previous studies [1,18,46,47] due to a combination of its low yield and co-elution with TrcA.  
In the present study the ease of the purification of selected analogues was greatly increased. 
In previous studies the purification of TrcA from TrcA1 posed a significant challenge that 
required the use of their purification at very low concentrations using analytical HPLC 
methodology [1,18,46,47]. Through the high production protocol and supplementation of the 
growth medium with high concentrations of Phe the production of TrcA was increased, while 
its purification by semi-preparative HPLC was considerably improved using Method B 
(Table 4.7). Using the same purification method, TpcA and PhcA were purified. However, 
due to a combination of the similarity in their structures and a tendency of the tyrocidines and 
their analogues to aggregate some analogues required additional purification by semi-
preparative HPLC.  
Table 4.7 Summary of antimicrobial peptides purified from amino acid supplemented 
culture extracts. 
Peptide 
mg yield 
from 10 L 
culture 
extract 
mg yield 
200 mg from 
commercial 
extract a 
Tyrocidine A 288.1 5.8 
Tyrocidine B 51.5 b 9.4 
Tyrocidine C 31 13.6 
Tryptocidine A 67.6 b - 
Tryptocidine B 74.3 b - 
Tryptocidine C 47.3 - 
Phenycidine A/A1 28.5
  - 
a Purification yields obtained from Spathelf [46] and Eyéghé-Bickong [36] 
b Purity <90% calculated from UPLC-MS and required additional purification by semi-preparative 
HPLC 
As the aim in this study was the upscaling of the production and purification of the 
tyrocidines and their analogues for application in food and agricultural environments, it was 
decided to focus purification on the major tyrocidine analogues which were produced under 
the different culturing conditions. A substantial amount of purified peptides were needed to 
elucidate the aggregation phenomena of the different peptides under different solvent 
conditions (Chapter 5). Moreover, substantial quantities of purified peptide were required to 
investigate the synergistic interaction of different tyrocidine analogues (Chapter 6). These 
investigations were performed in order to facilitate the optimal formulation of peptides, 
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allowing for the selection of which culture extracts or combination of extracts should be 
tailored for different applications.  
Several selected culture extracts were purified further in order to obtain the major tyrocidines 
and analogues for utilisation in for more detailed bio-activity and biophysical studies. More 
than 330 mg of peptide with purity >90% was obtained (refer to Table 4.7), while 220 mg 
peptide that was >80% enriched in one peptide was utilised in further purifications 
(Table 4.8).  
These high mass yields compared to those of previous studies [36,46] illustrated the success 
of the purification approach. Supplementation with tyrosine marginally increased TrcB 
production (data not shown), the intermediate hydrophobicity of TrcB (Trp3, Phe4) posed a 
challenge to its purification where co-production of TrcB1 and background levels of TpcC 
contaminated the elution peak captured via the initial semi-preparative HPLC run and 
required additional purification or purification from the commercial tyrocidine extract. 
Similarly, TpcA was contaminated by aggregation with TrcA, however, >90% purity, as 
determined with high sensitivity and resolution UPLC-MS, could be attained with additional 
purification.  
In contrast, only 80% purity was obtained for PhcA with 12% of the contamination 
contributed by PhcA1. TpcB could not be fully purified to more than 53% purity from culture 
extracts that had been co-supplemented with 5.5 mM Trp and 16.5 mM Phe, despite being 
produced in larger quantities in these cultures as these cultures also produced TrcA, which 
co-eluted together with TpcB (Fig. 4.11 D). Despite much lower levels of production, 
subsequent purifications performed by members of our group have demonstrated TpcB could 
be purified from cultures only supplemented with Trp where the production of TpcC 
predominated together with lower levels of TpcB (Fig. 4.11 C) (personal communication 
W. Laubscher). This illustrated the importance of culture selection in the purification of 
different analogues. A summary of the purity of the tyrocidine and analogues that was 
obtained through the combine approach of manipulated culturing and the utilisation of 
different HPLC methods is presented (Table 4.8). 
High resolution ESMS confirmed the chemical integrity and purity and none of the purified 
cyclodecapeptide preparations contained any traces of gramicidins and contamination was 
primarily with traces of the co-produced tyrocidines and analogues (Fig.4.12). 
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Figure 4.12 ESMS mass spectra generated with the MaxEnt algorithm of the purified 
peptides with experimental Mr (theoretical Mr). A tyrocidine A 1269.6500 
(1269.6546), B tyrocidine B 1308.6643 (1308.6655), C tyrocidine C 1347.6740 
(1347.6764). 
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Figure 4.12 (continued) ESMS mass spectra generated with the MaxEnt algorithm of the 
purified peptides with experimental Mr (theoretical Mr). D phenycidine A/A1 
1253.6604 (1253.6597)/ 1267.6736 (1267.6753), E tryptocidine A 1292.6702 
(1292.6706), F tryptocidine C 1370.6896 (1370.6924). 
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Table 4.8 Summary of ESMS and LC-MS analysis data of the peptides purified in this 
study and used in subsequent studies reported in Chapter 5 and 6. 
Identity 
Culture 
source 
Exp Mr 
(Theor Mr) 
UPLC-MS chromatogram 
UPLC 
Rt 
% 
Purity 
Tyrocidine A 16.5 mM Phe 1269.6500 
(1269.6546) 
 
 
9.68 94 
Tyrocidine B 
Non-
supplemented/
commercial 
extract 
1308.6643 
 (1308.6655) 
 
8.38 90 
Tyrocidine C 
Non-
supplemented/ 
16.5 mM Phe 
+ 5.5mM Trp 
1347.6740 
 (1347.6764) 
 
8.08 91 
Phenycidine 
A/A1 
16.5 mM Phe 
1253.6604/ 
1267.6736 
(1253.6597)/
(1267.6753) 
 
9.49 
92 
(80/12) 
Tryptocidine A 
16.5 mM Phe 
+ 5.5mM 
Trp 
1292.6702 
 (1292.6706) 
 
9.50 94 
Tryptocidine B 
+  
Tyrocidine A 
16.5 mM Phe 
+ 5.5mM 
Trp 
1331.6815/ 
1269.6534? 
(1331.6710)/
(1269.6546) 
 
 
 
 
 
 
8.89 
87 
(53/34) 
Tryptocidine C 16.5 mM Trp 1370.6877 
(1370.6924) 
 
 
 
 
 
 
 
8.13 91 
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4.5 Conclusions 
To allow for the successful utilisation of the tyrocidines as green-biocides; high production 
yields need to be maintained and activity of the final product needs to remain consistent. The 
naturally obtained tyrothricin yields have been greatly increased. In this study it has been 
shown that consistent tyrothricin production can be obtained by careful selection of bacterial 
cultures in a medium with both protein nitrogen and carbohydrate as nutrients (Table 4.2). 
The production of the tyrothricin peptides occurs after the logarithmic growth phase 
[25,25,26,38] upon initiation by metabolic stress signals [42]. Oxygen limitation within the 
early culturing stages around 48 hours was the most likely trigger of tyrothricin production 
within the flask cultures, sufficient nutrients were still available to support biomass 
production and resultant increased tyrothricin production while not stressed to the extent of 
sporulation [41] (Fig. 4.1).  
In contrast, in aerated submerged cultures performed in bioreactors the producer organism 
had an alternate metabolism [30] as apparent in the difference in pH profile between the two 
culturing environments (Fig. 4.1 and 4.2). The trigger for tyrothricin production within the 
submerged cultures is most likely nutrient depletion. Tyrothricin production was thus 
suppressed in these submerged cultures having depleted the available nutrients before peptide 
production commenced. Successful tyrothricin production within submerged cultures using 
defined minimal media containing simple nitrogen sources [28-30] is well below that 
observed in stationary cultures. It is thus questionable whether tyrothricin production by 
submerged culturing would yield sufficient product at a cost which would make it feasible for 
agricultural or industrial applications. 
Having increased total tyrothricin production to well above initial yields (Table 4.2), two 
purification methodologies were developed and/or optimised that are of such a nature as to 
allow for future cost effective, high volume through-put purification of the tyrocidines and 
their analogues. The first methodology used to purify the tyrothricin peptides (PM1) involved 
manipulation of the solubility of the tyrothricin peptides to purify them from a large 
contingent of the contaminants increasing the tyrocidines and analogues to approximately 
75% (m/m) the extract content. The main limitation was the number of handling steps. 
Utilising a chromatographic separation (PM2) the crude extract could be purified from the co-
extracted contaminants with four handling steps after the initial extraction. Approximately 
50% of the initial mass was recovered with peptide purity similar to PM1 which entailed ten 
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handling steps after the initial extraction and recovery of 33% of the initial mass. 
Antimicrobial activity of these purified fractions was increased to an acceptable level for 
agricultural and industrial applications (Table 4.4). 
Using the knowledge garnered to shift the antimicrobial peptide production profile, together 
with judiciously considered semi-preparative HPLC methodology greatly eased the 
purification of selected tyrocidine analogues. Large quantities of single peptides were 
obtained using a minimal number of semi-preparative HPLC purifications.  
Progress has been made toward making it feasible to use the tyrocidines in agricultural and 
industrial applications. We have demonstrated the ability to produce high, economically 
viable yields of tyrothricin that were used in an in vivo trail to assess bee toxicity (Chapter 7). 
The characterisation and interaction of the major cyclodecapeptide analogues produced in 
these cultures were investigated and reported in Chapter 5 and 6. More knowledge regarding 
the behaviour of the peptides in the tyrothricin mixture would allow for informed decisions to 
be made on which cultures extracts or blends thereof, as well as formulations, should be used 
in different applications to target fungi and/or bacteria. 
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Chapter 5 
Structure and oligomerisation relationships of the six 
major cyclodecapeptides purified from  
Bacillus aneurinolyticus cultures 
5.1 Introduction 
The antimicrobial activity of the tyrocidines and their analogues (Trcs) is proposed to primarily 
be as a result of their interaction with the cell membrane [1], causing its permeabilization [2] 
and ultimately cell lysis [3]. Interaction with the cell membrane and permeabilization, however, 
is proposed to be dependent on the oligomerisation of the peptides into dimers which are 
proposed to be the active structures required for antibacterial activity [4,5]. Excessive 
aggregation, forming oligomers greater than dimeric structures, however, causes deceased 
antimicrobial activity [6-10]. To assess the influence of solvent environment in Trc 
formulations, used for in vivo studies, and carbohydrates, used in activity assays it was 
necessary to gain an understanding of the structure, self-assembly/aggregation and activity 
relationships of these peptides.  
The aggregation of cyclic peptides in general is determined by the influence of both their own 
characteristics, derived from their primary structure, as well as that of the environment; both 
of which act in union to determine the forces which act on the molecule [6,7,11-14]. The 
primary structure will largely dictate the conformation of the Trcs in relation to the distribution 
of different amino acid side chains (containing groups of different charge, size and polarity) 
determines the amphipathicity and charge distribution of the monomeric peptide will in turn 
dictate the propensity to aggregate into higher order structures [6,7,9,15,16]. 
The Trcs contain a fairly conserved cyclic decapeptide structure (Fig. 5.1). Tang et al. [17] 
have identified 28 different analogues with minor variations of the primary peptide sequence 
composed of both D and L amino acid residues. The Trcs in this study contain a primary 
structure composed of cyclo(D-Phe1-L-Pro2-L-X3-D-X4-L-Asn5-L-Gln6-L-X7-L-Val8-L-Orn9-L-
Leu10) [17], with three letter amino acid abbreviations indicating the respective residues and 
ornithine (Orn), while the three variable positions are depicted by X. Analogues of the Trcs 
containing L-Phe3, D-Phe4 or L-Trp3, D-Phe4 or L-Trp3, D-Trp4 at the variable dipeptide unit L-
X3-D-X4 are referred to as the A, B or C analogues respectively. While analogues in which the 
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variable aromatic amino acid position L-X7 is occupied by L-Tyr7, L-Trp7 or L-Phe7 are referred 
to as the tyrocidines, tryptocidines or phenycidines respectively [18] (Fig 5.1). These peptides 
share 50% sequence homology with the cyclic peptide gramicidin S (GS) composed of two 
repeating subunits of the conserved region of the Trcs (L-Val8-L-Orn9-L-Leu10-D-Phe1-L-Pro2). 
Consequently, many studies regarding the conformation of the Trcs have been done using GS 
as a reference point [11,12,14,19]. 
Supplementation of the growth medium of the producer organism, Bacillus aneurinolyticus 
with various ratios of Trp and Phe caused the increased production of selected Trcs [18]. Seven 
different cyclodecapeptides were produced in larger quantities under the latter conditions; of 
which three contained the L-Phe3-D-Phe4 dipeptide moiety: tyrocidine A (TrcA), 
phenycidine A (PhcA) and tryptocidine A (TpcA) (Fig. 5.1 A, C and E), one peptide with L-
Trp3-D-Phe4 tyrocidine B (TrcB) and two peptides with L-Trp3-D-Trp4 namely tyrocidine C 
(TrcC), and tryptocidine C (TpcC) (Fig. 5.1 B, D and F) were purified from the culture extracts 
of the producer organism (refer to Chapter 4).  
Previous investigators have noted a structure-activity relationship of the various Trc analogues 
toward a range of target organisms including: the Gram-positive bacteria 
Listeria monocytogenes [20,21], the fungi Fusarium solani and Botrytis cinerea [22], as well 
as the malaria parasite Plasmodium falciparum [23,24]. Among the range of different 
analogues produced, maximal activity toward a specific target organism has been observed to 
be determined by characteristics of both the target organism, as well as those of the different 
Trcs that result due to variation in their primary structure [20-23]. 
The cyclic conformation of the TrcA and TrcC monomers have an amphipathic type I β-turn 
and type II β-turn in antiparallel β-pleated sheet conformation stabilised by four intramolecular 
hydrogen-bonds, as determined from X-ray crystallography and nuclear magnetic resonance 
studies [4,5,25-28]. Oligomerisation in an aqueous environment by TrcA [4,5] and TrcC [4] 
into amphipathic dimers are proposed to be the active units of the peptides which interact with 
the cell membrane [4,5].  
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Figure 5.1 Primary structures of the six cyclodecapeptides used in this study. Structures of the 
three cyclodecapeptides containing L-Phe3-D-Phe4 dipeptide moiety: A 
tyrocidine A (TrcA), C phenycidine A (PhcA) and E tryptocidine A (TpcA); and 
L-Trp3-D-Phe4 containing dipeptide moiety B tyrocidine B (TrcB) and two peptides 
with L-Trp3-D-Trp4, namely D tyrocidine C (TrcC) and F tryptocidine C (TpcC). 
Residues are referred to using standard three or one letter amino acid abbreviations 
with Orn/O representing ornithine. Residues are numbered according to their order 
of incorporation during biological synthesis, with variable amino acids represented 
in italics. 
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Upon membrane interaction β-sheet peptides, such as the Trcs, have been observed to form ion 
conducting pore/channel like structures in model membranes [unpublished results, personal 
communication E Zaitseva, University of Freiburg] which are possibly related to their lytic 
activity [29]. Oligomerisation of these small peptides would be necessary to form 
transmembrane pores. Oligomerisation into large aggregate structures in aqueous 
environments, however, has been attributed to a reduction of the antimicrobial activity of these 
peptides [6-10]. Therefore, a fine balance is proposed to exist between the extent of 
oligomerisation aggregation by these peptides and antimicrobial activity. The aggregation of 
cyclic peptides in general is determined by the influence of both their own characteristics 
derived from their primary structure, as well as that of the environment; both of which act in 
union to determine the forces which act on the molecule [6,7,11-14].  
The structural predictors of the Trcs to oligomerize into higher ordered structures was 
investigated further by means of electrospray mass spectrometry (ESMS), circular dichroism 
(CD) and fluorescence spectroscopy (FS), which are techniques which are well established in 
the field of studying the interactions of biomolecules [30-37]. Each of the three techniques 
could make a valuable contribution to understanding some of the characteristics associated with 
the oligomerisation of the Trcs. ESMS has proven to be a valuable methodology to study the 
non-covalent interactions of different biomolecules [34,35,38-41]. As such, ESMS has been 
used as a means to illustrate the oligomerisation of the Trcs [4]. However, interaction of 
biomolecules detected by ESMS are devoid of hydrophobic non-covalent interactions 
[38,39,41]. ESMS is complemented by optical spectrometry such as CD and FS which study 
the structures of biomolecules in both aqueous and membrane mimicking environments.  
Using the sensitivity of the chiral properties related to the peptide bond to changes in solvent 
environment, CD is a well-established technique used to study the structural features of 
proteins and peptides [31,32], including the Trcs [4,14,16]. FS utilises the fluorescent 
properties associated with the four aromatic amino acids in the Trcs and their sensitivity to 
local environment changes. Differences in their fluorescent yields can be used to indicate 
structural changes due to differences in the local environment of these residues, especially Trp. 
The three aromatic amino acids Phe, Tyr and Trp show maximal absorbance at wavelengths of 
256 nm, 276 nm and 282 nm and emission maximum at wavelengths of 282 nm, 303 nm and 
357 nm respectively [30,42-46]. As Trp has the largest extension coefficient and absorbs at the 
highest wavelength, this causes its emission spectra to overshadow that of the other two 
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aromatic amino acids. Moreover, in many instances the energy absorbed by Tyr and Phe is 
often transferred to the Trp residue by resonance energy transfer [47]. Only in the absence of 
Trp does the fluorescence of Tyr make a significant contribution to the fluorescent signal 
observed [30,37]. The fluorescence due to Phe is not observed due to a combination of its lower 
quantum yield and excitation at 280 nm or 295 nm, above its maximum absorption wavelength.  
5.2 Materials and Methods 
5.2.1 Materials and Reagents 
The peptides: TrcA, TrcB, TrcC, TpcA, TpcC and PhcA where purified from culture extracts 
of Bacillus aneurinolyticus ATCC 10068 using modified organic extraction methodology [48] 
as well as from commercial tyrocidine mixture obtained from Sigma-Aldrich (Steinheim, 
Germany). Peptides were purified using semi-preparative reverse phase high performance 
liquid chromatography (RP-HPLC). Purity of TrcA, TpcA, TrcC and TpcC was confirmed 
>90% by ultra-performance liquid chromatography linked to mass spectrometry (UPLC-MS) 
as described in Chapter 4. The enriched PhcA preparation contained 12 % PhcA1 (92% 
combined purity) and was referred to as PhcA in this study. Acetonitrile (HPLC-grade, far UV 
cut-off) was from Romil Ltd (Cambridge, UK) and 2,2,2-trifluoreoethanol (TFE) was from 
Sigma (St. Louis, USA). Glucose (Glc), ethanol (EtOH), and N,N-Dimethylformamide (DMF) 
were obtained from Merck (Darmstadt, Germany). Analytical grade water was prepared by 
filtering water from a reverse osmosis plant through a Millipore-Q® water purification system 
(Milford, USA).  
5.2.2 Detection of oligomerisation with ESMS 
Dried analytical aliquots of the purified tyrocidine peptides were dissolved in 50% (v/v) of 
DMF and diluted to a concentration of 0.200 mM at a solvent concentration of 5% (v/v) in 
water. These samples were allowed to stand at room temperature overnight prior to being 
diluted to a final concentration of 0.100 mM and final solvent concentration of 2.5% (v/v). 
The type of predominant aggregates/oligomers formed within the above formulations was 
determined by means of high resolution ESMS using a Waters Q-TOF Synapt G2 mass 
spectrometer with a Z-spray electrospray ionisation source. Injections of 2 µL of sample were 
introduced directly into the mass analyser in positive mode at a flow rate of 0.3 mL/minute and 
a carrier solvent concentration of 60% (v/v) acetonitrile (ACN) containing 1% (v/v) formic acid 
in water. Peptides were subjected to a capillary voltage of 2.5 kV and cone voltages of 15 V at 
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a source temperature of 120 ºC, desolvation gas of 650 L/h and desolvation temperature of 
275 ºC. Data acquisition was performed by scanning over a mass over charge ratio (m/z) range 
of 300 to 2000 in continuum mode at a rate of 0.2 scans per second. Data analysis was 
performed using MassLynx V4.1 (Waters, Miliford, USA).  
The ESMS spectral data was analysed using MassLynx V4.1 (Waters, Miliford, USA) to 
determine the proportion of the different types of oligomers formed. Set to auto-peak width 
determination the MaxEnt 3 algorithm was used to determine the oligomeric species between 
a range of 300 to 10 000 amu with a maximum of 10 charges and 50 iterations. From these data 
the percentage of the different oligomers formed by each of the respective peptides was 
determined using the ion signal of each oligomer in relation to the total ion signal intensity of 
all the different oligomers detected in each of the respective spectra. 
5.2.3 Optical spectrometric analysis of the influence of different solvent 
environments on peptide structure 
Due to the high background absorbance of DMF, dried aliquots of the purified peptides were 
dissolved in 50% (v/v) ACN in water and diluted to a concentration of 200 µM at a solvent 
concentration of 5% (v/v). These samples were incubated overnight prior to dilution to a 
concentration of 100 µM in water with or without the addition of 5% (m/v) of either Glc or 
50% (v/v) TFE. Samples were analysed at 37 ºC on a Chirascan Plus circular dichroism (CD) 
spectrometer (Applied Photophysics, UK). CD scans were performed between 185 to 295 nm 
at a band width of 0.5 nm using a quartz cuvette with a path length of 0.05 cm simultaneously 
collecting CD as well as the ultra violet (UV) absorption spectra.  
FS was performed on the same instrument using a quartz cuvette with a path length of 1 cm 
using samples at a concentration of 33 µM. Scans were performed detecting emission spectra 
at a band width of 1 nm between 300 to 400 nm at 90 ºangle to the excitation source at 280 or 
295 nm. Each of the CD and FS spectra is the representation of three scans from which the 
blank had been subtracted and normalised. 
5.2.4 Curve fitting and data analysis  
All curve fits and statistical analysis were done using GraphPad Prism® 4.03 (GraphPad 
Software, San Diego, USA). Curves were fitted to the data using first or second order 
polynomial correlations (linear or quadratic equations) which best described the trend of 
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structure-oligomerisation relationships observed. Single data points that did not allow a fit with 
R2>0.7 where excluded as indicated on the respective graphs.  
5.3 Results and Discussion 
As the interaction of the Trcs with one another [4,5] and their membrane targets [1] relies 
heavily on the contribution of hydrophobic interactions [5], it is vitally important that the 
contribution of the higher order structures formed by the respective peptides be considered to 
obtain a more in depth understanding of the true nature of the active structures.   
The Trcs in this study differ at the variable dipeptide positions 3 and 4, occupied by either Trp 
or Phe; or at position 7 which may be occupied by any one of the three aromatic amino acids 
Phe, Trp or Tyr [17]. The three amino acid residues variable hydropathy of 2.8, -0.9 and -1.3 
for Phe, Trp and Tyr respectively [49] alters the hydrophobicity, amphipathicity, ionizability, 
side chain surface area and ability of the different analogues to form hydrogen bonds. As a 
result of the variation in peptide sequence, the latter may influence the 
aggregation/oligomerisation of the different analogues into higher order structures [4-7,11] as 
well as the strength of their interactions with the target cell membrane [12,19,23] which are 
proposed to influence the antimicrobial activity of the Trcs. 
5.3.1 Analysis of the cyclodecapeptides oligomerisation in aqueous and 
hydrophobic environments 
5.3.1.1 ESMS detection of different homo-oligomers  
The use of ESMS to detect the extent of the oligomerisation of the Trcs has previously been 
reported [4]. Analysis of the type of oligomeric structures formed by the different analogues of 
the Trcs in DMF by ESMS revealed a general trend of an increased proportion of dimeric 
oligomers relative to monomeric peptides, particularly by the more hydrophobic analogues 
(Figs. 5.2 and 5.3). For example, under the set ESMS conditions we observed oligomers up to 
pentamers for TrcA and only trimers for TrcC (Fig. 5.2).  
Using the UPLC retention times (Rt; refer to Chapter 4) as an indication of hydrophobicity of 
the different Trcs, it was evident that increased dimerization was more prevalent in the more 
hydrophobic A analogues (Phe3, Phe4), than in the more polar C analogues (Trp3, Trp4) 
(Fig. 5.4). This phenomenon may possibly be related to an altered conformation adopted by the 
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different analogues that arises due to variation of the aromatic amino acid identity in their 
primary structures, leading to different propensities to form dimers and larger oligomers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 ESMS mass spectra generated with the maxEnt algorithm depicting the difference 
in oligomerisation between A the more hydrophobic A analogue (Phe3, Phe4) TrcA 
where oligomers as large as pentamers detected and B the more polar C analogue 
TrcC, where the monomeric peptide species was the predominant isoform that was 
detected. 
 
 
 
 
 
 
 
Figure 5.3 Comparison of the proportion of different oligomeric structures formed by the 
respective Trc analogues, as determined with ESMS. Peptides where dissolved in 
a final solvent concentration of 2.5% (v/v) DMF. The proportion contribution of 
the detected monomer, dimer or oligomers (n>2) is expressed as a percentage 
relative to the total ion signal for all the detected peptide species. 
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A decrease in the proportion of oligomers larger than dimers was noted for the two most 
hydrophobic peptides, according retention on the C18 matrix during UPLC, namely TpcA and 
PhcA (Fig 5.3 and 5.4). This, however, may be as a result of the precipitation of larger 
aggregates out of solution prior to analysis by ESMS or that formation of these aggregates 
relied primarily on hydrophobic forces, which are removed during ESMS desolvation 
[38,39,41]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Comparison of the proportion of different oligomeric peptide species formed by 
the respective Trcs determined by ESMS analysis relative to their respective UPLC 
retention times (Rt) in minutes, Trc analogues numbered accordingly: 1 TrcC, Rt 
7.46; 2 TpcC, Rt 7.87; 3 TrcB, Rt 8.25; 4 TrcA, Rt 9.26; 5 PhcA, Rt 9.55; 6 TpcA, 
Rt 9.61. The proportion contribution of the detected monomer, dimer or oligomers 
(n>2) is expressed as a percentage relative to the total ion signal detected for all the 
oligomeric species. Curves indicate trends for monomers and dimers fitted with a 
second order polynomial (quadratic equation). The circled Trc analogues did not 
fit the linear regression line fitted for the oligomers (n>2). 
Apart from the higher order oligomers, a good relationship between retention on C18 and 
dimerization was found with a concomitant increase in dimer detection with the increase in 
retention (Fig. 5.4). The process of ionisation of a molecule ESMS removes water from the 
molecular or aggregate ion, thereby negating the hydrophobic non-covalent interactions 
[38,39,41]. Therefore, the oligomers and in particular the dimers detected by ESMS can be 
regarded as the result of mostly electrostatic interactions such as ionic interactions and 
hydrogen bonding between the peptide molecules. This finding correlates with the dimers 
modelled from X-ray crystallography and nuclear magnetic resonance studies performed in 
methanol or in a 50% ACN solution, respectively [4,5].  
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5.3.3.2 Analysis of the cyclodecapeptide structures by circular dichroism  
Circular dichroism of the cyclodecapeptides in water and TFE can serve as a valuable means 
of elucidating the contribution of hydrophobic forces to the aggregation and self-assembly of 
peptides. This technique is well established in the study of structural changes of proteins and 
peptides by utilizing the sensitivity of the chiral properties related to peptide bond to different 
solvent environments [31,32].  
The structure of the Trcs has previously been investigated by means of CD [14]. Due to the 
presence of D-amino acids the CD spectra of the Trcs is distorted to resemble that of an α–
helix. However, in conformation with the determined X-ray crystal structure of the Trcs [5,25-
28], their structure together with that of the analogous GS has been confirmed by CD to be 
composed of β-turns and β-sheets which correspond to two negative minima at 205-207 nm 
and 215-217 nm [14,50-53]. An increase in the intensity of these minima is associated with an 
increase in the proportion of ordered β-turn and β-sheet structures [4,11,12,54-56]. A change 
in the ratio of the two negative ellipticity minima (θ206±2 nm/θ215±2 nm) is associated with a change 
is the backbone conformation [11,50]. An increase in the hydrophobicity of the solution by 
suspending the peptides in TFE increases the stability of the higher ordered β-turn and β-sheet 
structures by placing the peptides in a model membrane environment [55,57-59]. Therefore, 
the latter can be used as a reference point to indicate increased ordered structures that are due 
to the backbone structure as would be delineated by increased negative minima. 
These data could compliment the observations made by ESMS to shed some light on the 
relationship between the primary sequences of the peptides and oligomerisation. However, the 
shape and intensity of the CD spectra could be influenced by the aromatic amino acids (which 
contribute 40% of the amino acid content to the structure of the Trcs [17]), as well as the 
aggregation state [14,52]. Specifically the second minimum at 215 nm could be influenced by 
the contribution of aromatic amino acids, particularly Trp that influences the UV spectrum 
around 220 to 230 nm [16,42,43]. In future, more detailed studies must be performed, using for 
example fluorescence detected CD, to elucidate the influence of the aromatic residues on the 
CD spectra of these cyclodecapeptides. The varied aromatic amino acid identity between the 
different Trc analogues therefore poses a challenge to the direct comparison of the ellipticity 
of the different Trcs [52,60]. Consequently, as an indication of change in ordered structures of 
a particular analogue, the ellipticity changes were considered at the lower wavelength of 
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206 nm, which is due to the n to π* transition of 2p unpaired electrons of the carbonyl oxygen 
[54].  
The cyclodecapeptide CD spectra in water and TFE correlated well with previous studies 
[4,14,16], showing minima at 206±2 nm and 215±2 nm (Fig. 5.5). TFE, a so-called membrane 
mimicking solvent [58], lead to a substantial increase in the negative ellipticity at 206±2 nm 
for all the peptides, indicating increased β-turn structures [4,11,12,54-56] (Fig 5.5; Table 5.1). 
Although similar minima were observed, the L-Trp3 containing peptides (TrcB, TrcC and 
TpcC) presented visibly different spectra to the L-Phe3 (TrcA, TpcA and PhcA) containing 
peptides (compare Fig. 5.5 A, C, E with B, D, F; Table 5.1).  
Increased negative ellipticity of both the minima was observed for the L-Phe3 containing 
peptides in TFE, while for the L-Trp3 containing peptides the 215 nm minimum either remained 
the same (TrcC and TrcB) or decreased (TpcC) (Fig. 5.5). Consideration of the ellipticity ratio 
(206±2nm/ 215±2nm) [11,12,16] of the two peptide groups indicates a separation in the type of 
backbone structure adopted in TFE. The ellipticity ratio of the L-Phe3 containing peptides was 
lower than that of the L-Trp3 containing peptides, possibly indicating an increased proportion 
of -sheet structures by L-Phe3 containing peptides (Table 5.1).  
These results could indicate that residue 3 influences the oligomeric structures and/or the 
backbone structure in TFE. These L-Trp3 containing peptides also showed a similar increase in 
positive ellipticity up to the measured 185 nm in both water and TFE, with TpcC showing a 
maximum at 188 nm in water and the rest of the peptides at <185 nm (Fig. 5.5 B, D and F). 
This could be a blue shifted maximum of the →* transition of p-electrons from carbonyl 
groups (C=O) [54,61].  
A red shifted maximum at 194±1 nm was observed for all the L-Phe3 containing peptides in 
water and TFE, indicating participation of the carbonyl groups in hydrogen bonding [54,61] 
(Fig. 5.5 A, C and E). TFE increased the ellipticity for this maximum as well as both negative 
minima, which could also indicate the formation of more -sheet type structures [14,54,61], 
possibly in oligomers (Fig. 5.5 A, C and E). The intensity of the maxima at 194±1 nm was 
greatest for TrcA>PhcA>>TpcA which may also be an indication of the degree of higher order 
structure formation through the oligomerisation. This indicates that residue 7 has an influence 
on the structure and possibly oligomerisation of these hydrophobic analogues.  
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Figure 5.5 CD spectra of the different tyrocidine analogues at a concentration of 100 µM in 
an aqueous (water) and membrane mimicking environment (50% TFE). A PhcA, 
C TrcA, E TpcA, analogues with Phe3, Phe4 and Phe7, Tyr7 or Trp7 respectively. B 
TrcB with Trp3, Phe4 and Tyr7 and D TrcC, F TpcC, with Trp3, Trp4 and Tyr7 or 
Trp7 respectively. 
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Table 5.1 Variability in the CD spectra of the different tyrocidine analogues in an aqueous or 
membrane mimicking environment.  
Peptide 
(n=3) 
In water In 50% TFE 
θ206±2 nm θ215±2 nm θ206±2 nm/θ215±2 nm θ206±2 nm θ215±2 nm θ206±2 nm/θ215±2 nm 
TrcA -15.8±0.12 -18.8±0.12 0.841±0.0011 -25.0±0.042 -22.8±0.043 1.10±0.0022 
TrcB -19.9±0.064 -18.4±0.085 1.08±0.0055 -23.5±0.011 -17.9±0.033 1.31±0.0029 
TrcC -12.4±0.11 -14.5±0.18 0.854±0.0033 -19.6±0.0073 -14.9±0.021 1.31±0.0023 
TpcA -10.2±0.089 -12.9±0.085 0.789±0.0024 -16.3±0.021 -15.7±0.041 1.04±0.0029 
TpcC -16.9±0.11 -22.1±0.11 0.765±0.0036 -27.6±0.24 -19.3±0.14 1.43±0.0023 
PhcA -16.0±0.074 -19.6±0.071 0.818±0.0025 -22.0±0.097 -21.6±0.074 1.02±0.0057 
Molar ellipticities (θ) in 107 × deg.dmol-1.cm-1. Each minima or ratio thereof is expressed as the mean value obtained from 
three spectra ± SEM. 
The D-Trp4 containing peptides, TrcC and TpcC, also presented an additional shoulder at 
230 nm, which presents as a negative minimum in TFE (Fig. 5.5 D and F). This could indicate 
a difference in the backbone structure or the influence of this aromatic amino acid on the CD 
spectrum [11,12,50,52,60].  
Comparison of the ellipticity minima at 206 nm in water indicated a decreased proportion of 
ordered structures by the Trcs with the lowest and highest UPLC Rt, TrcC and TpcA 
respectively (Table 5.1; Fig. 5.6). The rest of the Trcs displayed an increased degree of ordered 
structure indicating oligomerisation, with ordered structure sequence as follows: 
TrcB>TpcC≥PhcA~TrcA>TrcC>TpcA.  
The above relationship is put into perspective when comparing the ellipticity observed at 
206 nm in an aqueous (water) and membrane mimicking (TFE) environments relative to: 
hydrophobicity (Rt) (Fig. 5.6 A and C), or proportion of dimers formed by the respective Trcs 
(Fig. 5.6 B and D). Good quadratic trends, separating the peptide in two distinct groupings, of 
increased intensity of the negative minima at 206 nm was observed with both Rt and 
dimerization. This indicated the formation of a higher proportion of ordered structures by the 
peptides of intermediate hydrophobicity (Rt~8.5) and of ~60% dimer population. As 
dimerization had already been established to be directly correlated with hydrophobicity a 
similar trend was to be expected. TrcB (Trp3, Phe4) as the intermediate between the A and C 
analogues it contains properties of both groups, thus it is observed to associate with both the A 
analogues (Ff) and C analogues (Ww) or not fit into the observed trend (Fig. 5.6).  
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Figure 5.6 Comparison of the ellipticity minima of the different Trcs observed at 206±2 nm 
in an aqueous (water) or membrane mimicking (TFE) environment respectively 
relative to: the UPLC Rt as in indication of hydrophobicity (A and C) and the 
proportion of dimers detected by ESMS for the respective Trc (B and D),. Curves 
indicate trends fitted with a second order polynomial. The encircled data point in 
each graph indicate the peptide that was excluded to obtain a fit with R2>0.5 Trc 
analogues numbered: 1 TrcC, Rt 7.46; 2 TpcC, Rt 7.87; 3 TrcB, Rt 8.25; 4 TrcA, Rt 
9.26; 5 PhcA, Rt 9.55; 6 TpcA, Rt 9.61. 
The difference in hydrophobicity of the Trcs is determined by the variation of aromatic amino 
acids in their primary structures which in turn governs the higher order conformation(s) of the 
different analogues. The potential steric hindering of the larger Trp residue could in turn 
determine how different monomers associate with one another to oligomerize into higher order 
structures. It is interesting to note that the most hydrophobic peptide PhcA did not fit well into 
the trends, which could indicate that either some peptide was lost due to precipitation during 
the analyses or that a residue with hydrogen bonding character in position 7 is important for 
increased intensity of the negative ellipticity. The fact that this preparation contains 12% of the 
Lys analogue PhcA1 could also lead to skewing of the results. 
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Modelling of the monomeric structure of TrcA using information regarding conformation 
obtained from X-ray crystal structure resulted in an amphipathic two-stranded, antiparallel β-
sheet monomeric structure with a defined curved structure with most of the amino acid side 
chains forming the hydrophobic convex side and only the side chain of positively charged 
ornithine on the polar concave side [5]. 
Dimerization of these monomers forms an amphipathic four-stranded sheet structure which is 
stabilised by both backbone-backbone hydrogen bonds and hydrophobic interactions. Further 
stabilisation of the dimer occurs through “edge to face” interaction of the ring structures of 
Phe1 and Tyr7 [5]. These active structures then interact with membrane targets, the hydrophobic 
Phe4 inserting deep into the membrane while the more hydrophilic Tyr7 is nearer to the surface 
[5]. 
Munyuki et al. [4] proposed a model for the dimerization of both TrcA and the TrcC analogue 
in an aqueous environment. Disagreement regarding the location of the Phe4 side chain resulted 
in these investigators proposing the monomeric peptide has low amphipathicity in contrast to 
the structure proposed by Loll et al. [5]. However, in agreement with Loll et al. [5], these 
investigators proposed dimerization by means of sideways association and stabilisation by 
predominantly backbone-backbone hydrogen bonding results in an amphipathic structure. 
Munyuki et al. [4] proposed dimerization may also occur by π-stacking interactions between 
the aromatic ring structures of the aromatic amino acids, resulting in stacking of residues on 
top of one another through association by hydrophobic interactions. 
The oligomerisation of the Trcs may thus occur through both the interaction of different 
residues by means of hydrophobic interactions and hydrogen bonding. Comparison of the 
ellipticity of the different A analogues (Phe3, Phe4) provides evidence of the influence of the 
variability of the aromatic amino acid at position 7 on oligomerisation of the Trcs in relation 
to Phe occupying both positions of the variable dipeptide unit.  
As has been previously proposed [5], the Tyr7 found in TrcA may optimally stabilise the active 
dimer structure formed by backbone-backbone hydrogen bonding, and result in increased 
membranolytic antimicrobial activity. Substitution of Tyr7 with Trp7 to form TpcA may disrupt 
the optimal interaction of Phe1 and residue 7 (Trp7), the indole group of which now forms a 
bulkier protruding side chain in the dimerised structure creating a protruding surface where 
previously the smaller phenol group of Tyr7 was found. This conjugated ring structure can still 
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serve as an anchoring point for further hydrophobic interactions with other dimers or 
monomers, but is sub-optimal thereby disrupting the formation of ordered structures 
(Fig. 5.5 and 5.6). This may elude to why increased proportion of dimeric structures of TpcA 
where observed by ESMS (Fig. 5.3 and 5.4), but did not increase proportions of ordered 
structures detected by CD (Fig. 5.5 and 5.6) where the combined influence of hydrophobic 
interactions resulted in association of residues unable to assemble into higher order structures.  
In contrast, a different scenario may be at play where Tyr7 is substituted with Phe7 in the PhcA 
analogue. The smaller size of Phe would allow it to act as an anchoring point for hydrophobic 
interactions. Therefore, the observed dimer population (Fig. 5.3 and 5.4), as well as ordered 
structures detected by CD (Fig. 5.5 and 5.6), are similar to that observed for TrcA. If the three 
peptides with an L-Trp3 are compared we find that the ellipticity at 206 nm decrease as follows, 
TrcB>TpcC>>TrcC, which could indicate a more complicated role of Trp and other aromatic 
residues in oligomerisation (Table 5.1; Fig. 5.6).  
In order to assess the overall influence of structure on the backbone structure of the peptides 
the ellipticity ratio between the two major minima (206±2nm/ 215±2nm) was considered 
[11,12,16,56,56]. Good quadratic trends of the ellipticity ratio with UPLC Rt and % dimers 
detected by ESMS were only found for the peptides in TFE, indicating that this parameter is 
not only dependent on dimerization, but also the hydrophobicity of the peptides (Fig. 5.7).  
The ratio of the two minima was >1.0 for the TrcB analogue in an aqueous environment, in 
contrast to the rest of the Trcs (Fig. 5.7), suggesting TrcB has a backbone conformation 
containing a greater proportion of β-turn structures [11,12,50,54,56,61] in an aqueous 
environment which differed from that of the rest of the peptides in the study (Table 5.1; 
Fig. 5.7 A and B). TrcB (Wf) acts as an intermediate having characteristics of both the A and 
C analogues. Oligomerisation of TrcB followed a similar trend to that observed for TrcA to 
form an increased proportion of dimeric oligomers as determined by ESMS (Fig. 5.2 and 5.3). 
TrcB would seem to form an increased proportion of ordered structures when the added 
influence of hydrophobic effect was included, as deduced by the increased intensity of the 
minima observed at 206 nm by CD analysis (Table 5.1; Fig. 5.3 and 5.4). This is most likely 
due to the influence of Phe3 to Trp3 substitution between TrcA and TrcB resulting in an altered 
conformation which was influenced to a greater degree by hydrophobic effect in an aqueous 
environment. The negative minima of the TrcB analogue at 206 nm increased the least of all 
the peptides in the study between the aqueous and membrane mimicking environments 
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(Table 5.1). It is postulated that TrcB adopts a similar structure as proposed for TrcA by 
Loll et al. [5], but the steric bulk of Trp3 indole group may force the hydrophobic Phe4 benzyl 
side chain into a more solvent exposed environment, thereby allow it to act as anchoring point 
for further hydrophobic interactions and higher order structure formation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 The ratio of the ellipticity minima 206 nm/215 nm in the two respective solvent 
environments versus A UPLC Rt and B versus % dimers detected via ESMS. Trc 
analogues numbered: 1 TrcC, Rt 7.46; 2 TpcC, Rt 7.87; 3 TrcB, Rt 8.25; 4 TrcA, 
Rt 9.26; 5 PhcA, Rt 9.55; 6 TpcA, Rt 9.61. Curves indicate trends fitted with a 
second order polynomial (quadratic function). 
The ratio of the two minima were observed to be >1.0 only in the membrane mimicking 
environment for the rest Trcs indicating an altered backbone conformation between the two 
environments (Table 5.1). While the ellipticity ratio of TrcB still increased upon exposure to 
the membrane mimicking environment, this was to a lesser degree than was observed by TpcC 
and TrcC, where a sharp increase in the intensity of the minima was observed between water 
and TFE. This indicated TrcB was in a more ordered structure before exposure to the membrane 
mimicking environment (Fig. 5.7, refer to data points numbered 1, 2 and 3). Again a distinct 
separation is observed between the backbone conformation adopted by the C analogues (Ww) 
relative to the A analogues (Ff), with TrcB (Wf) as an intermediate has characteristics of both 
(Fig. 5.7). This indicated a difference in backbone structures as determined by the identity of 
the variable dipeptide position. Moreover, a much smaller increase in the ratio was found for 
the A analogues, indicating that these peptides already have a highly ordered backbone 
structure in water. 
Substitution of Phe3, D-Phe4 with Trp3, D-Trp4 at the variable dipeptide unit which occurs 
between the A and C analogues could alter the backbone conformation adopted by the C 
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analogues. The greater steric bulk of Trp at the variable dipeptide unit may influence the 
structure of the dimers as well as their propensity to form; that is if TrcC and TpcC follow a 
similar structural conformation to the TrcA proposed by Loll et al. [5]. This hypothesis is 
supported by the decreased proportion of dimeric oligomers observed for the TrcC analogue 
(Fig. 5.2 and 5.3). This also concurred with the decreased proportion of ordered structures and 
lower ellipticity ratio in water, as detected for this analogue by CD (Table 5.1; 
Fig. 5.5, 5.6 and 5.7).  
In contrast to TrcC, the TpcC analogue was observed to form just in excess of 52% dimeric 
oligomers (Fig. 5.2) as well as exhibit an increased negative ellipticity (Table 5.1; Fig. 5.5). 
The presence of Trp at all three of the variable aromatic amino acid positions may alter the 
conformation of the TpcC monomer which is possibly quite different to that proposed for TrcA 
by Loll et al. [5]. Dimerization may also occur by π-stacking interactions between the aromatic 
ring structures as proposed by Munyuki et al. [4]. The high prevalence of Trp increases the 
steric bulk attributed to the indole side chains. This results in an altered capacity to form 
hydrogen bonds, ring stacking and hydrophobic interactions with other monomers, thereby 
influencing the propensity to dimerize, as well as form higher order structures. The TpcC 
analogue displayed an increase in the intensity of the minima observed at 215 nm in water 
which results in lower ellipticity ratio, eluding to an altered back bone conformation.  
An altered conformation adopted by the C analogues (Fig 5.3 D and F) is supported by an 
altered CD spectrum displaying a shoulder attributed to Trp4 [4,14,16], observed at 230 nm in 
this study. An altered peptide backbone conformation may also be the cause of a red-shift in 
the ellipticity of the β-sheets resulting from altered hydrogen bonding [16].  
Variability of the aromatic amino acid composition of the different Trcs influences the 
conformation which they adopt. This in turn has a downstream knock on effect regarding their 
propensity to oligomerize into higher order structures. 
5.3.3.3 Assessment of the influence of aromatic amino acids by fluorescence spectroscopy 
Further information regarding changes in the location/exposure of the aromatic side chain, 
particularly those of Trp, may be made using FS. The indole group of the Trp residue is highly 
sensitive to its local environment and polarity [33,37,43,62]. Exposure of Trp to a hydrophobic 
environment results in a blue shift in the emission maxima from the usual 348 nm observed in 
an aqueous environment [30,33,42,62]. Moreover, Trp fluorescence is a good indicator of 
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aggregation/oligomerisation state of the Trcs due to its high sensitivity to hydrophobic 
environments and solvent/polar environment quenching [30,33,42,62]. The latter occurs via 
numerous avenues including: complex formation in the ground state, collisional quenching by 
exposure of Trp to an aqueous environment, as well as excited-state reaction with surrounding 
polar groups [30,33,42,62]. These groups include amide groups located in the peptide 
backbone, as well as side chains of Asn and Gln, amino group of Orn and hydroxyl group of 
Tyr [30,62]. 
The fluorescence emission spectra of the four Trp containing Trc analogues were examined to 
elucidate the orientation and effect of aggregation on the Trp residues. In all of the Trcs a shift 
in the emission maxima was observed from the expected 357 nm [46] to 347 nm, indicating 
the Trp residues are located in a hydrophobic environment within an oligomeric structure 
(Fig. 5.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Fluorescence emission spectra of the Trp containing Trc analogues in an aqueous 
(water) or membrane mimicking (TFE) environment. Excitation at 295 nm to 
comparing the Trp emission of: A TrcB with Trp4, B TrcC Trp3, Trp4, C TpcA with 
Trp7 and D TpcC with Trp3, Trp4 and Trp7. Fluorescence quantum yield indicated 
in arbitrary units (a.u). 
For all the analogues containing L-Trp3, namely TrcB, TrcC and TpcC, increased fluorescence 
intensity was observed in an aqueous environment relative to the TFE membrane mimicking 
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environment, while the fluorescence maximum was blue shifted to 342 nm (Fig. 5.8). The blue 
shifted max implies that the indole group(s) is transferred into an even more hydrophobic 
environment [46]. 
If the fluorescence or quantum yields are compared between the four Trp containing peptides, 
we find no direct relationship in either of the two solvents (Fig. 5.9). This is particularly 
apparent when comparing the fluorescent yields obtained for TrcB with Trp3 and TpcA with 
Trp7 in the two solvent environments (Fig. 5.9). Both of these peptides contain a single Trp 
residue but are located at different positions in the backbone structure. This result indicates that 
the Trp residue(s) in the different peptides are possibly in different environments leading to 
differences in fluorescence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 Comparison of the fluorescence quantum yield obtained from emission spectra of 
the Trp containing Trc analogues in an aqueous (water) or membrane mimicking 
(TFE) environment. Excitation at 295 nm to comparing the Trp emission of: TpcC 
with Trp3, Trp4 and Trp7, TrcC with Trp3, Trp4, TrcB with Trp3 and TpcA with 
Trp7. 
When TrcB, TrcC and TpcC are in a membrane mimicking environment an altered backbone 
conformation is adopted (as indicated by our CD results, Table 5.1) and quenching of their 
fluorescence yields was observed (Fig 5.8 A, B and D). The altered backbone conformation 
could lead to the formation of higher order structures that expose Trp3 to the solvent 
environment resulting in collisional quenching, as would occur when forming β-sheet 
structures. Alternatively, substantial quenching could occur as a result of a resonance energy 
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transfer interaction between Trp3 in the variable dipeptide unit and other chromophores, such 
as Phe and Tyr [47]. Higher order structure formation could also lead to quenching by excited-
state reactions which resulted due to conformations bringing the Trp residues into close 
proximity of polar chains or amide and amine groups [33,37,46,62]. This hypothesis is 
supported by the large change in the ellipticity ratio observed for the C analogues within the 
two solvent environments by CD (Fig. 5.7 A and B), implying a large change in backbone 
structure and oligomerisation by these analogues between the two environments. Moreover, a 
similar blue shifted max and quenching of TrcB fluorescence were observed by Leussa [24] in 
the presence of liposomes mimicking the membranes of Gram-positive bacteria. 
In contrast to what was observed for the peptides with Trp3, the opposite was observed with 
TpcA containing Trp7. In an aqueous environment this residue displayed a decreased 
fluorescent intensity relative to that observed in a membrane mimicking environment. 
Indicating that the position of this residue allowed for its fluorescence to be quenched 
(Fig. 5.5 C). This supports our earlier hypothesis proposing that the steric properties of the 
indole group within this position may cause this residue to be more solvent exposed. This could 
result in collisional quenching due exposure to the hydrophilic environment. Alternately 
quenching of this residue may be due to ground-state interaction of the Trp7 residue. The latter 
would also result in increased proximity of excited-state quenchers; such as those of the peptide 
backbone, other amides or amines, such as the Asn, Gln or Orn residues or resonance energy 
transfer to the Phe residues in the peptide. The increased fluorescent yields observed in a 
membrane mimicking environment implied location within a more hydrophobic environment, 
where hydrophobic exclusion which caused interaction with quenchers was removed.  
5.3.2 Influence of glucose on the cyclodecapeptides 
The importance of environmental factors such as the presence of calcium are shown to alter the 
antifungal [22] and antibacterial activity [16,24] of the Trcs changing the mode of action from 
primarily a lytic to a non-lytic which causes the disruption of intracellular processes. 
Differences in target cell properties, together with the environment, have been observed to 
influence a broad range of antimicrobial peptides [63-67], including the Trcs [20-24].  
Glucose (Glc) is ubiquitously present, not only in the environments of the agricultural and food 
industries where the microbial pathogens which the Trcs target exist in, it also forms part of 
the target cell structures. The cell wall of fungi is compromised predominantly of glycoproteins 
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and polysaccharides of mainly glucan and chitin whose monomeric subunits are derived from 
Glc [68]. The importance of the fungal cell wall on the antifungal activity of the Trcs has 
previously been shown by Troskie [69]. Moreover, Glc is present at 0.25% (m/v) and 1.0% 
(m/v) in TSB or half strength PDB respectively; the growth media used to culture the two model 
target organisms in this study B. subtilis and A. fumigatus. Glc may thus have a profound 
influence on the activity of the Trcs. It was therefore decided to elucidate the influence of Glc 
on the oligomerisation of the Trcs into higher order structures 
Analysis of the influence of Glc on the oligomerisation of the different tyrocidine analogues in 
this study revealed it to have the largest influence on TrcB>PhcA>>TrcA decreasing the 
intensity of the minima at 206 nm and 215 nm, but without causing a substantial change in the 
ellipticity ratio of the two minima (Table 5.2, Fig. 5.10). This would indicate that Glc possibly 
acts as chaotropic agent on these Trc analogues, decreasing the proportion of higher order 
structures formed in an aqueous environment as it has a minimal influence on the backbone 
conformation. The change in ellipticity observed in the vicinity of 195 nm in all the analogues 
is attributed to light scattering due to the presence of Glc [70]. 
The ellipticity minimum at 206 nm was again used to compare the influence of Glc on 
oligomerisation of the different Trcs (Fig. 5.11). We again found good quadratic trends similar 
to those in water, except that TrcB did not fall into the trend observed with UPLC Rt 
(Fig 5.11 A). Glc had a major influence on the ellipticity of TrcB (Fig. 5.11 B, data point 3) 
and Phc A (Fig. 5.11, data point 5), containing Phe4 and Tyr7 or Phe7 residues respectively. The 
decreased intensity of the ellipticity minima in the presence of Glc indicated its interference 
with the higher order structures. The influence of Glc on the other four peptides was minimal. 
Glc but did not have a noteworthy effect on the backbone structure as indicated by the similar 
trends and intensities observed for the ratio of the two ellipticity minima (Fig. 5.11 C).  
The interaction of Glc with the Trcs was investigated further by means of fluorescence to 
deduce if it causes a change in conformation which would influence the orientation and 
exposure of Trp residues (Fig. 5.12). Concurring with the observations made in CD, Glc did 
not change the conformation of the TpcC analogue hence the fluorescence yield remained fairly 
constant between the two environments (Fig. 5.12 D).  
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Figure 5.10 CD spectra of the different tyrocidine analogues at a concentration of 100 µM in 
an aqueous (water) or in water together with 5% (m/v) glucose (Glc). A PhcA, C 
TrcA, E TpcA, analogues with Phe3, Phe4 and Phe7, Tyr7 or Trp7 respectively. B 
TrcB with Trp3, Phe4 and Tyr7 and D TrcC, F TpcC, with Trp3, Trp4 and Tyr7 or 
Trp7 respectively. 
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Table 5.2 Variability in the CD spectra of the different tyrocidine analogues in an aqueous 
environment or together with 5% (m/v) glucose 
Peptide 
(n=3) 
In water In 5% Glucose 
θ206±2 nm θ215±2 nm θ206±2 nm/θ215±2 nm θ206±2 nm θ215±2 nm θ206±2 nm/θ215±2 nm 
TrcA -15.8±0.12 -18.8±0.12 0.841±0.0011 -15.8±0.073 -17.3±0.165 0.912±0.0045 
TrcB -19.9±0.064 -18.4±0.085 1.08±0.0055 -14.7±0.11 -13.6±0.12 1.08±0.0029 
TrcC -12.4±0.11 -14.5±0.18 0.854±0.0033 -12.5±0.089 -13.9±0.157 0.897±0.0040 
TpcA -10.2±0.089 -12.9±0.085 0.789±0.0024 -11.0±0.157 -13.6±0.21 0.814±0.0017 
TpcC -16.9±0.11 -22.1±0.11 0.765±0.0036 -18.2±0.31 -22.1±0.46 0.821±0.0031 
PhcA -16.0±0.074 -19.6±0.071 0.818±0.0025 -13.2±0.067 -16.0±0.053 0.823±0.0019 
Molar ellipticities (θ) in 107 × deg.dmol-1.cm-1. Each minima or ratio thereof is expressed as the mean value obtained from 
three spectra ± SEM. 
In support of the minimal change in ordered structure formation, observed in CD of TrcC in 
the presence of Glc, only a marginal decrease in fluorescence yield was observed, indicating a 
slightly different conformation adopted by TrcC relative to that of TpcC. The substitution of 
Trp7 with Tyr7 may thus alter the conformation adopted by TrcC to cause Trp3, Trp4 to be 
exposed to a greater degree on the surface of the higher order structure thereby allow for 
interaction with water and Glc causing marginal quenching of the fluorescence yield to occur 
but without disrupting the higher order structures (Fig. 5.12 B). 
The structure adopted by TpcA has been shown via ESMS to allow dimerization (Fig. 5.3), but 
not form increased proportions of higher order structures. The addition of Glc in an aqueous 
environment did not disrupt the aqueous structures that were observed via CD (Fig. 5.10 E), 
however, it did increase the fluorescence yield (Fig. 5.12 C), indicating that the Trp7 residue 
moved into a more hydrophobic environment. Alternatively, this could indicate that Glc acted 
as a chaotropic agent disrupting the association of quenchers with Trp7 allowing this residue to 
associate with hydrophobic groups, thereby be protected from collisional or dynamic 
quenching. The removal of water may also slightly ease the conformation adopted by the 
dimerised structure to allow Trp to move away from active groups which quenched the excited-
state Trp7. 
The substitution of Trp4 with Phe4 between TrcC and TrcB caused an entirely different scenario 
to occur. The increased hydrophobicity of Phe is observed to increase the dimerization 
(Fig. 5.3). A conformation adopted when the peptide structure contained Phe4 together with 
Tyr7 or Phe7 allowed interaction with Glc that resulted in decreased ordered structure 
formation, with the most pronounced effect observed in TrcB (Fig. 5.12 A). 
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Figure 5.11 Comparison of the change in ellipticity minima of the different Trcs in an aqueous 
(water) environment only or together with glucose (Glc). Change in ellipticity 
minima observed at 206 nm relative to A the UPLC Rt as in indication of 
hydrophobicity and B the % dimers detected by ESMS. C The ellipticity ratio 
206 nm/215 nm of the two minima for the different peptides. The respective Trc 
analogues are numbered as before. Circled analogues were not included in the 
second or third order polynomial trends fitted for the rest of the Trcs. 
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Figure 5.12 Fluorescence emission spectra of the Trp containing Trc analogues membrane 
mimicking (TFE) or in an aqueous (water) environment alone or together with 
glucose. Excitation at 295 nm to comparing the Trp emission of: A TrcB with 
Trp4, B TrcC Trp3, Trp4, C TpcA with Trp7 and D TpcC with Trp3, Trp4 and Trp7. 
The difference in fluorescence emission spectra observed between TrcB and TrcC may elude 
to a difference in the conformation adopted by the residues of the variable dipeptide unit 
(Fig. 5.12 A and B). The Trp3, Phe4 intermediate nature of the variable dipeptide unit causes a 
possible change in conformation, which suggests to greater exposure of the hydrophobic Phe4 
residue which resulted in increased higher order structure formation. This change allowed for 
increased interaction between dimerised peptides to form higher ordered structures (Fig. 5.4). 
The disruption of higher order structures by Glc is proposed to be related to the nature of the 
interaction caused by the hydrophobic Phe4 residue in higher order structure formation. 
Disruption of higher order aggregates by Glc may alter the conformation of the peptides, in the 
case of TrcB result in the Trp3 residue being placed in a more hydrophobic environment away 
from quenching groups, hence the increased fluorescence yield observed in the presence of Glc 
(Fig. 5.12 A). 
It is thus proposed that the chaotropic effect observed by Glc on TrcA, TrcB and PhcA may 
form part of their mode of antimicrobial activity through a balance between the disruption of 
higher order structures formed in an aqueous environment by these more hydrophobic Trc 
analogues and interaction with the target cell. Glc may most likely influence hydrophobic 
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packing interactions between the aromatic ring structures in the side chain of Phe and Tyr. 
Furthermore, it also has the potential to disrupt hydrogen-bonding networks and other 
electrostatic interactions which stabilise the higher order structures. Glc, however, was found 
to have lesser of an influence on Trp7. Eluding to a possible alternate conformation adopted by 
the active structures of these peptides which was less accessible to Glc. 
5.3 Conclusions 
Changes in the aromatic amino acid content of the Trcs and analogues results in variation in 
the conformation and character affecting their oligomerisation and higher order structure 
formation. Increased dimerization is observed by the more hydrophobic analogues 
(Fig. 5.3 and 5.4), although increased ordered structure formation, as observed via CD, was 
dependent on an intermediate hydrophobicity and dimerization (Fig. 5.6). A distinct separation 
was observed between the characteristics of the A and C analogues containing Phe3, Phe4 or 
Trp3, Trp4, respectively in the variable dipeptide unit. While TrcB with Trp3, Phe4, as an 
intermediary peptide, tended to have characteristics of both, or at times didn’t associate with 
either of the two peptide trends (Fig. 5.7). Changes of the variable aromatic amino acid between 
Tyr7, Phe7 or Trp7 altered the character of the different analogues as exemplified by the 
differences in the three different A analogues (TrcA, PhcA and TpcA). The C analogues (TrcC 
and TpcC) and TrcB containing Trp3 showed variable higher ordered structure formation, 
demonstrating the influence of the three variable aromatic amino acids acting to alter the 
conformation and character. 
The model structure and membrane interaction proposed by Loll et al. [5] for dimers of TrcA 
will need some amendments for the other cyclodecapeptides, as one model might not fit all. 
The model by Loll et al. [5] still only eludes to the initial membrane interaction by these 
peptides. Due to the curvature of the dimeric structure proposed by Loll et al. [5] they 
questioned the feasibility of linking the dimeric structures into extended sheets. The high 
stability oligomers observed for the cyclodecapeptides in this study and also reported in 
literature [6-8,10] point to a high tendency to form structures larger than dimers. Furthermore 
our group in collaboration with Dr E. Zaitseva (University of Freiburg) observed ion 
conducting pore/channels for all the peptides in this study in a variety of model membranes 
[unpublished results]. To form such pores, higher order structure formation is most likely due 
to a combination of hydrogen bonding and stacking interactions in addition to other non-
Stellenbosch University  https://scholar.sun.ac.za
5.28 
 
covalent interactions, which would correlate better with the models for TrcC and TrcA 
proposed by Munyuki et al. [4]. 
The variability of the structures of the different Trcs and analogues leads one to question 
whether the different conformations may dictate the specificity toward different pathogens. 
Moreover, as these cyclodecapeptides are co-produced, the question is whether combinations 
of different analogues with different conformations could complement each other’s 
antimicrobial activity. This aspect of the activity and oligomerisation of selected peptide 
combinations will be addressed in Chapter 6. 
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Chapter 6 
Oligomerisation-activity relationships of the single and 
combinations of the six major cyclodecapeptides 
purified from Bacillus aneurinolyticus cultures 
6.1 Introduction 
Supplementation of the Bacillus aneurinolyticus producer organism’s growth media with 
defined ratios of two aromatic amino acids, Trp and Phe, resulted in the increased production 
of defined subsets of different tyrocidines and their analogues (Trcs) as determined by 
variation of their aromatic amino acid content [1]. Changes in the aromatic amino acid 
content of the Trcs results in the variable character and activity profiles of the different 
analogues [2-6]. The antimicrobial activity of the Trcs is proposed to be primarily the result 
of their interaction with the cell membrane [7] causing its permeabilization [8] and ultimately 
cell lysis [9]. This mode of action is probably associated with higher order structure formation 
in the membrane to form pores.  
The Trcs have been shown to readily associate by non-covalent interaction to form larger 
aggregates which are attributed to a reduction in their antimicrobial activity [10-15], while 
association into amphipathic homo-dimeric structures is proposed to be the active units 
responsible for membrane interaction [16,17]. Therefore an interplay may exist between the 
non-covalent self-association of the cyclodecapeptides and their antimicrobial activity against 
certain targets. Considering the variable degree of higher order structure formation observed 
by the different Trcs (Chapter 5), the influence of non-covalent association by different 
analogues and combinations of peptides on their antimicrobial activity was questioned.  
In this chapter the ability of the different Trcs and analogues to oligomerize into dimers, as 
well as higher order structures (Chapter 5), is related to their antimicrobial activity. The six 
different cyclodecapeptides and five peptide combinations were tested against two 
representative target organisms namely, the Gram-positive bacteria Bacillus subtilis 168 (non-
peptide producer) and the ubiquitous fungal pathogen Aspergillus fumigatus and related to the 
oligomerisation parameters of the single peptides and peptide pairs.  
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6.2 Materials and Methods 
6.2.1 Materials and Reagents 
Peptides and solvents were as describe in Chapter 5, ethanol (EtOH), tryptone soy broth 
(TSB), agar, and N,N-dimethylformamide (DMF) were obtained from Merck (Darmstadt, 
Germany). Gramicidin S (GS) was obtained from Sigma-Aldrich (Steinheim, Germany) and 
served as the positive control in all antimicrobial activity assays. Tween 20, potato dextrose 
agar (PDA) and potato dextrose broth (PDB) were from Fluka (Buchs, Switzerland). Sterile 
polystyrene 96-well flat bottom microtiter plates were from either Greiner bio-one 
(Frickenhausen, Germany) or Corning (Corning, NY, USA). Petri dishes were from Lasec 
(Cape Town, South Africa). Falcon® tubes were from Becton Dickson and Company 
(Franklin Lakes, NJ, USA). Analytical grade water was prepared by filtering water from a 
reverse osmosis plant through a Millipore-Q® water purification system (Milford, USA).  
Aspergillus fumigatus ATCC 204305 was from the American Type Culture Collection 
(Manassas, VA, USA). Bacillus subtilis 168 obtained from the Bacillus Genetic Stock Centre 
(Ohio State University, OH, USA).  
6.2.2 Detection of oligomerisation with ESMS 
Dried analytical aliquots of purified tyrocidine peptides were dissolved in 50% (v/v) DMF in 
water to a concentration of 2.00 mM. Single peptides as well as five selected co-produced 
peptide pairs were prepared to a final concentration of 0.200 mM and final solvent 
concentration of 2.5% (v/v) high purity DMF. Peptide pairs consisted of 1:1 ratio of: 
TrcA and TrcB; TrcB and TrcC; TrcC and TpcC; TpcC and TpcA, as well as TrcA and PhcA. 
These samples were allowed to stand at room temperature overnight prior to the type of 
predominant hetero-oligomers formed within the above formulations being determined by 
means of high resolution electrospray mass spectrometry (ESMS) using a Waters Q-TOF 
Synapt G2 mass spectrometer with a Z-spray electrospray ionisation source as described in 
Chapter 5.  
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6.2.3 Preparation of peptides for antimicrobial activity assays 
Analytically weighed aliquots of the dried peptides were dissolved in 50% (v/v) DMF in 
water. These were subsequently diluted to a concentration of 1.00 mM at a solvent 
concentration of 10% (v/v) DMF in sterilised water. While maintaining the solvent 
concentration, the respective peptides were prepared in a doubling dilution series over eight 
dilution steps. The concentration of the single Trc peptides was varied between 500 to 40 µM, 
while preparations of the five previously mentioned peptide pairs were prepared at 3:1 and 
1:1 ratios of the former dilution series for both peptides. Preparation of the GS control 
peptide was done in 15% (v/v) EtOH in a doubling dilution series with concertation varied 
between 440 to 30 µM. These were subsequently diluted 10x to a final solvent concentration 
of 1% (v/v) DMF in the growth media used in the respective antimicrobial activity assays. 
6.2.4 Antifungal activity assays  
Using standard sterile practices, spores of the fungi A. fumigatus ATCC 204305 were 
obtained from freezer stocks and cultured using normal sterile techniques on PDA plates for 
three weeks. Subsequently 7 mL of 0.01% Tween (20 µL of Tween in 200 mL analytical 
grade water and autoclaved) was added to the plates, the spores lightly loosened using a glass 
rod and hydrated overnight at 4 °C. The spores were subsequently counted using a 
haemocytometer and diluted with sterile water to a concentration of 50 spores/µL. 
A variation of a microtiter broth dilution method, as described by Troskie et al. [18], was 
used to test the antimicrobial activity of the respective peptides toward A. fumigatus. A 
volume of 50 µL of PDB was added to all the wells of a sterile microtiter plate. The top four 
wells of the first column received 40 µL of sterilized water, while all the rest of the wells 
received 40 µL of the mentioned spore suspension. The wells of the first column received 
10 µL of 10% (v/v) DMF, thus the first column served as sterility and growth controls 
respectively. All the rest of the wells received 10 µL of one of the respective peptides 
prepared as previously described. The single Trc peptides and combinations of two peptides 
were applied in duplicate (n=2) in each dose response assay, while a single column was 
reserved for application of the GS control peptide.  
The microtiter plates were then covered and incubated for a period of 48 hours at 25 °C, 
following which the light dispersion was measured spectrophotometrically at 595 nm using a 
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BioRad™ microtiter plate reader. Using these data the percentage growth inhibition was 
plotted and used to derive the related activity parameters. 
6.2.5 Antibacterial activity assays  
Single colonies of the Gram-positive bacteria B. subtilis 168 were obtained from freezer 
stocks by culturing using normal sterile techniques on tryptone soy agar (TSA) plates (3.0% 
(w/v) TSB and 1.5% (w/v) agar in analytical grade water). Single colonies were selected and 
incubated while shaking at 220 RPM for 16 hours at 37 °C in Falcon® tubes containing 
20 mL TSB (3.0% (w/v) TSB in analytical grade water; pH 7.0) medium to an optical density 
(OD) of approximately 0.8 at 595 nm. These cells were subsequently sub-cultured in TSB and 
grown to an OD of 0.6 at 595 nm. 
A variation of the previously described microtiter broth dilution method [19,20] as used to 
determine the activity of the mentioned peptides toward the Gram-positive bacteria. A pre-
culture was diluted with TSB to an OD of 0.2 at 595 nm (±108 CFU/mL). A volume of 90 µL 
of the diluted culture was added to all of the wells of the microtiter plate except for the top 
four wells first column which received 90 µL of TSB. The peptide and solvent controls were 
as previously described. These microtiter plates were then covered and incubated for a period 
of 16 hours at 37 °C, following which the light dispersion was measured 
spectrophotometrically at 595 nm using a Bio Rad™ microtiter plate reader. The percentage 
growth inhibition and related activity parameters were determined from these data. 
6.2.6 Data analysis  
The percentage growth inhibition of the respective peptides in all antimicrobial activity assays 
was determined relative to the mean of the growth control, as previously described by 
Rautenbach et al. [21], using the following equation: 
GraphPad Prism® 4.03 (GraphPad Software, San Diego, USA) was used to plot all graphs as 
well as perform all statistical analysis, except for those obtained by ESMS analysis. The dose 
response curves generated where fitted by non-linear regression to sigmoidal curves with a 
     % growth inhibition =    100     
100 × (A595 of well – Mean A595 of background) 
 
   (Mean A595 of growth control - Mean A595 of background) 
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slope set at <7 [21]. Antimicrobial activity parameters determined from these plots included: 
IC50 (concentration causing 50% growth inhibition) and ICmax (calculated concentration 
causing 100% growth inhibition). ICmax is directly related to the minimum inhibitory 
concentration (MIC, lowest concentration used where no growth is visually observed), but 
was calculated from the dose response curve as described by Du Toit and Rautenbach [20]. 
Using the determined IC50 activity parameters possible interaction by antagonism, synergism 
or sum of activities within the five peptide pairs was evaluated by calculation of fractional 
inhibition (FIC) and FIC index (FICI) in each assay performed using the following equations 
[22]. 
FIC (A) = ICmax (peptide [A] in A+B mixture)/ ICmax (peptide A alone) 
FIC (B) = ICmax (peptide [B] in A+B mixture)/ ICmax (peptide B alone) 
with FIC index = FIC (A) + FIC (B) 
The FIC index a value of one indicated a sum of activities and no interaction between the 
peptide pair. FIC index >1 indicating antagonistic activity while FIC index <1 delineated 
synergistic interaction between peptides A and B [22].  
The data obtained by means of ESMS was analysed using MassLynx V4.1 (Waters, Miliford, 
USA) to determine the proportion of the different types of oligomers formed. Set to auto-peak 
width determination the MaxEnt 3 algorithm was used to determine the oligomers between a 
range of 300 to 10 000 amu containing a maximum of 10 charges and 50 iterations. From 
these data the percentage of the different oligomers formed by each of the respective peptides 
was determined using the ion signal of each oligomer in relation to the total ion signal 
intensity of all the different oligomers detected in each of the respective spectra. 
6.3 Results  
6.3.1 Formation of homo- and hetero-oligomers by the cyclodecapeptides 
The Trcs have been shown to readily oligomerize in dimeric structures [16,17] as well as 
larger oligomers [10-15]. Analysis of the types of oligomeric species formed by ESMS 
showed that the Trcs tended to dimerize. The more hydrophobic Trcs showed a tendency to 
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form larger oligomers, where up to pentamers where detected for TrcA (refer to Chapter 5). In 
the more polar analogues such as TrcC, decreased oligomerisation was observed together 
with an increase in the monomeric peptide species.  
Analysis of the oligomerization of peptide mixtures, however, revealed a change in 
oligomerisation trend. Irrespective of the hydrophobicity of the two peptides in the mixture, 
dimeric oligomers were predominantly formed. The latter is exemplified by comparison of 
the oligomers formed by TrcA and PhcA relative to those of TpcC and TrcC; the most and 
least hydrophobic peptide pairs analysed respectively (Fig. 6.1 A, B). Comparison of the 
composition of oligomeric structures revealed an increased contribution of dimers while 
trimers where generally the largest oligomers detected in any appreciable amount. Moreover, 
comparison of the signal intensities reveals a lower amount of the monomers of the more 
hydrophilic analogue in the peptide pair. Concomitantly, a reduction in homodimers of the 
more hydrophilic peptide was observed, while the highest signal intensity was detected for the 
heterodimer (Fig. 6.1, 6.2 B, C).  
 
 
 
 
 
Figure 6.1 ESMS mass spectra generated with the maxEnt algorithm depicting the difference 
in oligomerisation between A the more hydrophobic peptide pair TrcA (A) and 
PhcA (fA) relative to B the more polar peptide pair TpcC (wC) and TrcC (C). 
Irrespective of the peptide combination, the dimers were the predominant peptide 
species detected while trimers where the largest oligomeric species detected in 
any appreciable amounts. 
Comparison of the oligomeric structures formed by single peptides (Fig. 6.2 A) relative to 
those formed by the peptide pairs (Fig. 6.2 B) revealed the largest shift in the oligomerisation 
pattern by the hydrophilic C analogues (TrcC and TpcC) toward mixed heterodimer formation 
(Fig. 6.2 C). Similar dimerization of TrcA and PhcA was observed for the single peptides 
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(Fig. 6.2 A) as well as in their mixtures (Fig. 6.2 B), where heterodimers were the 
predominant isoform (Fig. 6.2 C). Peptide mixtures containing TrcB still predominantly 
formed dimeric oligomers, but the predominant isoform were homodimers of the more 
hydrophobic peptide in the peptide pair (Fig. 6.2 C). This may elude to a conformation 
adopted by TrcB which makes it less amenable to heterodimer formation.  
6.3.2 Variability in antimicrobial activity of different cyclodecapeptides 
The antimicrobial activity of these selected analogues was then determined toward two 
representative target organisms namely, the Gram-positive bacteria B. subtilis and the 
ubiquitous fungal pathogen A. fumigatus (Table 6.1). Although the activity parameters were 
within a narrow concentration range, the nature of our assays and number of repeats allowed 
statistical comparisons. Statistical analysis of the determined activity parameters showed that 
the activity of most of the peptides were indeed significantly different from each other to 
allow activity-structure correlations (Table 6.2). The activity parameters were therefore 
correlated with their observed oligomerisation (ESMS study), structure (circular dichroism 
study) and hydrophobicity (retention time during C18 UPLC analysis). 
Toward the fungus A. fumigatus nearly equivalent antifungal activity was observed for TrcA 
and TrcB analogues followed by TpcC and PhcA, while the TrcC and TpcA analogues had 
the lowest activity (Table 6.1). When considering the antibacterial activity of the different 
cyclodecapeptide analogues, the TrcA analogue was again observed to display the most 
potent activity. In contrast to what was observed toward the representative fungal pathogen 
A. fumigatus, TpcC was now the second most active analogue, the TrcB analogue now had 
reduced activity and TpcA the lowest antibacterial activity (Table 6.1). 
Variability was thus observed in antimicrobial activity of not only the different 
cyclodecapeptides, but also toward the different representative target organisms. These 
differences were put into context by relating the differences in antimicrobial activity to the 
various properties of the different peptides (Fig. 6.3). In Chapter 5 it was shown that the more 
hydrophobic A analogues containing Phe3, Phe4 exhibited increased dimerization and higher 
order oligomers, while the more hydrophilic C analogues were less inclined to dimerization 
and formation of higher order oligomers.  
Stellenbosch University  https://scholar.sun.ac.za
6.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Comparison of the proportion of oligomeric structures formed by the respective 
cyclodecapeptides determined with ESMS of: A single peptides, B 1:1 peptide 
mixtures, and C composition of the dimeric species detected in the peptide 
mixtures in B depicting the proportions of homo- and heterodimers. The 
proportion contribution of the detected monomer (X), dimer (XX) or oligomers 
(X)n is expressed as a percentage relative to the total ion signal for all the detected 
peptide species. Abbreviations used: TrcA, A; TrcB, B; TrcC, C; TpcA, wA and 
TpcC, wC. 
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Table 6.1 Activity parameters of the purified peptides toward the representative fungi 
A. fumigatus and Gram-positive bacteria B. subtilis. 
Peptide 
IC50 ± SEM 
(µM) 
ICmax ± SEM 
(µM) 
Aspergillus fumigatus   
TrcA (n=16) 2.58±0.23 3.56±0.29 
TrcB (n=16) 2.54±0.20 3.84±0.26 
TrcC (n=16) 4.21±0.08 5.87±0.13 
TpcA (n=8) 3.48±0.21 5.68±0.18 
TpcC (n=16) 3.23±0.22  5.09±0.31 
PhcA (n=8) 3.89±0.29 5.33±0.37 
Bacillus subtilis   
TrcA (n=16) 4.47±0.28 8.13±0.75 
TrcB (n=16) 9.54±0.46 13.84±0.69 
TrcC (n=16) 8.04±0.46 12.13±0.72 
TpcA (n=8) 10.26±0.64 28.06±1.58 
TpcC (n=16) 5.67±0.31 10.85±0.64 
PhcA (n=8) 8.50±1.2 13.79±0.76 
SEM, standard error of the mean. 
 
Table 6.2  Summary of the P-values from statistical analysis of the activity parameters in 
Table 6.1, using the Newman-Keuls multiple comparison test (One way Anova). 
In the table “ns” denotes a P-value > 0.05 and the top and bottom values to the 
maximum P-value for A. fumigatus and for B. subtilis as target organisms, 
respectively. 
 
 
 
 
Tpc A Trc A Trc B Trc C TpcC 
Phc A 
ICmax 
ns 
0.001 
0.001 
0.001 
0.01 
ns 
ns 
ns 
ns 
ns 
IC50 
ns 
ns 
0.001 
0.001 
0.001 
ns 
ns 
ns 
ns 
0.01 
Tpc A 
ICmax  
0.05 
0.001 
0.001 
0.001 
ns 
0.001 
ns 
0.001 
IC50  
0.001 
0.001 
0.05 
ns 
ns 
0.05 
ns 
0.001 
Trc A 
ICmax   
ns 
0.001 
0.001 
0.001 
0.001 
0.05 
IC50   
ns 
0.001 
0.001 
0.001 
0.05 
ns 
Trc B 
ICmax    
0.001 
ns 
0.001 
0.05 
IC50    
0.001 
ns 
0.05 
0.001 
TrcC 
ICmax     
ns 
ns 
IC50     
0.01 
0.001 
A general trend of increased antifungal activity was observed with increased oligomerisation 
of the analogues containing Trp3, Trp4/Phe4 (Wx) (Fig. 6.3 A).  
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Figure 6.3 Relation of the antimicrobial activity of the different Trc analogues to variation in 
their character derived from changes in their aromatic amino acid content. 
Antimicrobial activity relative to: A the proportion of different oligomeric species 
formed in an aqueous environment, B UPLC retention time as an indication of 
hydrophobicity, C ellipticity at 206 nm in TFE emulating higher order structure 
formation in a membrane mimicking environment. Trc analogues numbered as 
follows on the here graphs: 1 TrcC, 2 TpcC; 3 TrcB; 4 TrcA; 5 PhcA; 6 TpcA. 
(Biophysical data were as reported in Chapter 5). 
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High antifungal activity was only observed for one of the A analogues (Ff), namely TrcA. 
Despite increased proportions of dimerized species, antifungal activity of the other two Ff 
analogues decreased to that observed for the more hydrophilic Wx analogues which contained 
decreased proportions of the dimeric species. This would indicate that dimerization alone is 
not the only determining factor for increased antifungal activity. The relation of the antifungal 
activity to hydrophobicity indicates increased activity by analogues of intermediate 
hydrophobicity, namely TrcA and TrcB (Fig. 6.3 B). Moreover, from the circular dichroism 
studies reported in Chapter 5 the increased ellipticity intensity at 206 nm of these two 
analogues in trifluoroethanol (TFE) indicate the probable formation of ordered structures 
within membrane-like environments (Fig. 6.3 C). However, these consistent trends must be 
tested with a larger library to clarify if the antifungal activity towards A. fumigatus is 
determined by both oligomerisation into higher ordered structures, as well as an intermediate 
hydrophobicity to allow for optimal membrane or target interaction.  
No overt trend of antibacterial activity with increased oligomerisation was observed for the C 
group (including TrcB) (Fig. 6.3 C). Furthermore, the A analogues showed a high tendency to 
form dimers while their activity was significantly different, in particular TpcA’s activity was 
the lowest while TrcA the highest (Fig. 6.3 A), hence again no clear conclusion could be 
drawn on the role of dimerization. Correlating the antibacterial activity with hydrophobicity 
and ordered structure formation (Fig. 6.3 B and C) it is observed that despite minor variation 
of increased TrcA and reduced TrcB activity, no overt trend was observed for the Trcs, with 
only the least active peptide TpcA indicating a loss of activity with increase in 
hydrophobicity. Near equivalent antimicrobial activity was found by the C analogues and 
TrcB containing Trp3, Trp4/Phe4 (Wx), as well as the A analogues containing Phe3, Phe4 (Ff) 
which produced variable amounts of oligomeric species. However, extensive aggregation and 
lack of ordered structure formation may be attributed the lack of antimicrobial activity of the 
TpcA analogue. This correlated with previous studies by Leussa and Rautenbach [2]. 
6.3.3 Activity of peptide mixtures 
The antimicrobial activity of the single peptides was now established toward the two 
representative target organisms; five pairs of cyclodecapeptides which were co-produced 
under the same culturing conditions (Fig. 6.4; refer to Chapter 2 and 3 for more detail) were 
selected to determine if these peptides displayed any interaction with one another which may 
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influence their antimicrobial activity. TrcA and TrcB are the predominant co-produced 
analogues under non-supplemented growth conditions. The latter two peptides showed an 
increased tendency to form higher order structures, particularly dimers (Chapter 5). TrcC and 
TrcB are co-produced at intermediate concentration of Trp and Phe in the growth media, 
while also being the predominant Trcs found in the commercial Trc extract (Fig. 6.4, refer to 
Chapter 2 and 3). The latter two peptides have been reported to display increased antibacterial 
activity [4]. The peptide pairs: TpcC:TrcC and TrcA:PhcA, are produced at high Trp and high 
Phe concentrations, with the TpcC and TrcA the major species, respectively (Fig. 6.4). TpcC 
and TpcA represent the odd combination that are co-produced under a low Trp/Phe ratio. 
While five peptide pairs were selected for analysis in this study; it should be noted that there 
are numerous further possible co-produced peptide pairs such as tryptocidine B (TpcB):TpcC, 
TrcA:TrcC and TpcA:TrcA (refer to Chapter 2 and 3). In this current exploratory study, we 
did not consider mixtures with more than two peptides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Depiction of the shift in the cyclodecapeptide production profile of 
B. aneurinolyticus at different concentration ratios of Phe and Trp. The 
contribution of each subset: Ff, Wf or Ww was calculated as a percentage of the 
sum of the total UPLC peak areas of the different peptides as determined by the 
identity of the variable aromatic amino acids dipeptide unit. The selected co-
produced peptide pairs are indicated. (Cyclodecapeptide production data were as 
reported in Chapter 2, figure adapted from [1]). 
Using the ICmax values obtained for the single peptides, as well as the respective peptide 
mixtures toward the two representative target organisms possible synergistic/antagonistic 
relationships were established between the peptide pairs using FIC-derived isobolograms. The 
0.01 0.1 1 10
-20
0
20
40
60
80
100
Ff (TrcA; PhcA, TpcA)
Wf (TrcB, TpcB)
Ww (TrcC, TpcC)
TrcA; TrcB
TrcA; PhcA
TrcB; TrcC
TpcC; TrcC
Trp/Phe in culture medium
%
 U
P
L
C
 p
e
a
k
 a
re
a
Stellenbosch University  https://scholar.sun.ac.za
6.13 
 
antimicrobial activity of the peptide pairs containing an A analogue (Phe3, Phe4) (Fig. 6.5) or 
C analogues (Trp3, Trp4) (Fig. 6.6) indicated difference in the sensitivity of two target 
organisms toward the different peptide pairs. 
Peptide pairs containing TrcA displayed appreciable synergism toward A. fumigatus. The 
trend of synergistic activity in a peptide combination containing TrcA:TrcB was slightly 
weaker toward A. fumigatus, particularly at increased TrcB concentrations where an additive 
relationship was observed (Fig. 6.5 A). The synergistic response towards A. fumigatus, of 
PhcA and TrcA was improved, particularly at increased concentrations of PhcA, where an 
FIC index of 0.6 is observed (Fig. 6.5 C). The combination of TpcC with TpcA proved to 
weaken the activity towards this fungal target (Fig. 6.5 E). Toward B. subtilis as target an 
overt synergistic relationship of the TrcA:TrcB combination was observed with FIC index of 
0.9 to 0.7 (Fig. 6.5 B), while a general additive relationship is observed by the other two A 
analogue peptide combinations toward B. subtilis (Fig. 6.5 D, F). 
For the combinations with C analogues only a combination of TrcC and TrcB showed 
synergism toward B. subtilis with the FIC index of between 0.75 and 0.8 (Fig. 6.6 B), while 
this combination showed additive activity against A. fumigates (Fig. 6.6 A). Slight 
antagonistic activity is observed in peptide combinations containing TpcC toward both 
A. fumigatus and B. subtilis (Fig. 6.6 C, D, E).  
Comparison of the FIC index calculated for the different peptide pair at 1:1 equimolar ratio 
showed that only the TrcC:TpcC pair to be slightly antagonistic towards both organisms 
while all the other pairs benefitted antibacterial activity (Fig. 6.7 A). Furthermore all the pairs 
containing a peptide with Trp4 (C analogues) led to lower activity against the fungal target, 
while those with a Phe4 (A analogues) in the peptide pair showed improved antibacterial and 
antifungal activity (Fig. 6.7 A). Correlation of the FIC index with the proportion of dimers 
formed by the different peptide pairs again displays a relationship of optimal antifungal 
activity by peptide pairs forming an intermediate proportion of ~65 to 75% dimers which 
corresponds with the peptide pairs of TrcA:TrcB and TrcA:PhcA (Fig. 6.7 B refer to data 
points 2 and 3). This result correlates with the proportion of dimers formed by the two single 
peptides TrcA and TrcB, which were most active against A. fumigates, as well as the 
proportion of dimeric species detected in the peptide combinations with these two analogues 
(refer to Fig. 6.3). The dimer populations of the TrcA:TrcB combination where 
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predominantly composed of homodimer species of TrcA and to a slightly lesser degree 
heterodimers of both the latter analogues. However, this trend will have to be tested with a 
larger library of mixed peptide pairs in future studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Isobolograms constructed using the FIC values of peptide pairs containing A 
analogues: TrcA and TrcB (A and B); TrcA and PhcA (C and D); TpcA and TpcC 
(E and F) toward A. fumigatus or B. subtilis respectively. Each data point depicts 
the mean of 8 replicates ± SEM. Note that the data points and solid line below the 
dotted line suggests synergism, on the dotted line additive activity and above the 
dotted line antagonistic activity. 
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Figure 6.6 Isobolograms constructed using the FIC values of peptide pairs containing C 
analogues: TrcC and TrcB (A and B); TrcC and TpcC (C and D); TpcA and TpcC 
(E and F) toward A. fumigatus or B. subtilis respectively. Each data point depicts 
the mean of 8 replicates ± SEM. Note that the data points and solid line below the 
dotted line suggests synergism, on the dotted line additive activity and above the 
dotted line antagonistic activity. 
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Figure 6.7 A. Comparison of the FIC index of the five peptide pairs at a 1:1 ratio toward the 
two representative target organisms. B. Correlation of the % dimer population 
formed by the respective peptide combinations with their observed antimicrobial 
activity toward A. fumigatus or B. subtilis. FIC index values of peptide pairs are 
indicated by increasing proportions of dimeric species: TrcC and TrcB (1); TrcA 
and TrcB (2); TrcA and PhcA (3); TpcA and TpcC (4); TrcC and TpcC (5).  
It is possible that the antifungal activity was influenced to a larger degree by TrcA activity 
and would account for synergistic effect observed for this peptide combination. The 
proportion of heterodimer formed by PhcA together with TrcA was reduced relative the 
homodimers formed by PhcA, as a single peptide (refer to Fig. 6.2), possibly eluding to a 
slightly altered conformation adopted by PhcA together with TrcA in heterodimers which 
may have caused an increase in activity.  
In contrast, all the peptide pairs and dimer populations displayed similar activity toward 
B. subtilis, barring the highest dimer population of the TrcC:TpcC pair (Fig. 6.7 B). The 
slightly antagonistic activity correlated with the formation of heterodimeric structures with 
TpcC, containing Trp7, whose steric bulk could hinder optimal interaction and higher order 
structure formation. 
A possible structure-activity relationship arising due to changes in the dipeptide unit may 
account for the differences observed in antimicrobial activity (Fig. 6.8). Synergistic activity 
toward A. fumigatus would seem to be dependent on peptide pairs containing Phe3 in one or 
both of the peptides (Fig. 6.8 A). This would include TrcA:PhcA and TrcA:TrcB 
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combination, while TpcA:TpcC is hindered by the reduction in activity of this odd 
combination containing Phe3, Trp4, and Trp7. 
 
 
 
 
 
Figure 6.8 Correlation of the peptide structure at variable dipeptide unit and interaction. 
Occupancy of the variable dipeptide unit with FIC value obtained by the 
respective peptides at a 1:1 ratio toward A A. fumigatus or B B. subtilis 
respectively.  
No statistical correlation of the FIC indexes was observed for activity toward B. subtilis 
indicating activity is independent of the aromatic residues in the dipeptide unit. (Fig. 6.8 B). 
Reduction of antibacterial activity probably occurs due to excessive aggregation, as observed 
for TpcA, which may be due to an altered conformation which enables greater 
oligomerisation into unordered structures (aggregates) (refer to Chapter 5). However, it has to 
be taken into account that the combined activity of peptide pairs was mostly additive. The 
data presented in Fig. 6.8A was therefore influenced by the overt synergism observed in 
combinations of TrcA:PhcA and TrcA:TrcB toward A. fumigatus.   
6.4 Discussion 
All the peptides in this study had a high tendency to dimerize, which was also found for 
peptide mixtures where high proportions of heterodimers were observed (Fig. 6.1, 6.2). 
However, the propensity to form heterodimers were highly dependent on the character of the 
aromatic dipeptide moiety (Fig. 6.2 C), indicating a role of this moiety in dimerization. The 
antibacterial activity of the Trcs is proposed to be reliant on their oligomerisation into active 
dimeric structures which allow for optimal interaction with membrane targets [16,17]. 
Variability in the antimicrobial activity of the Trcs has been reported by previous 
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investigators who found the more polar of the major tyrocidine analogues (Tyr7) namely TrcB 
and TrcC to be most active toward the Gram-positive bacteria L. monocytogenes [4]. 
However, subsequent investigators have also reported increased activity of TrcA [2], as was 
observed in the present study. Variation in the antimicrobial activity of the Trcs has been 
reported by Leussa and Rautenbach [2] toward different bacterial strains and organisms. We 
observed that the antibacterial activity of the Trcs toward B. subtilis was largely independent 
of the variable characteristics of the different analogues (Table 6.1). Our results indicate that 
the variable aromatic dipeptide moiety and in general dimerization (Fig. 6.2) does not 
influence the activity against B. subtilis (Fig. 6.3). This implies that the antibacterial activity 
could be more dependent on the conserved gramicidin S pentapeptide (VOLfP) in these 
peptides. 
Variation in antifungal activity has also been reported toward different fungal organisms [6]. 
Antifungal activity toward A. fumigatus depended on a fine interplay between the variable 
characteristics of the cyclodecapeptides where those of intermediate character, such as TrcA 
and TrcB, displayed the highest activity, while TrcC and TpcA showed the lowest activity 
(Table 6.1, Fig. 6.2, 6.3, refer to Chapter 5). Troskie et al. [6] reported near equivalent 
antifungal activity towards Fusarium solani and Botrytis cinerea in PDB growth medium for 
the analogues containing Tyr7 which include TrcA, TrcB and TrcC, with the lowest antifungal 
activity for the TpcC analogue containing Trp7. When the fungi were cultured in yeast 
supplemented tryptone soy broth (YTSB), Troskie et al. [6] reported a significant decrease in 
the antifungal activity of PhcA, while that of TpcC increased to within the range observed for 
the rest of the analogues with Tyr7. As YTSB contains a higher salt content than PDB, this 
result indicates that aggregation could play a role in antifungal activity.  
The higher antifungal activity of TrcA and TrcB may be also attributed to their optimal 
balance between hydrophobicity and target cell interaction which allowed for the increased 
formation of higher order pore like structures in the cell membrane after initial contact with 
the carbohydrate moieties in cell wall. Glucose caused little or no disruption of the ordered 
structures formed by TpcA the least active peptide, indicating that this interaction may be 
important for activity. The lower antimicrobial activity of TpcA may also be attributed to its 
hydrophobicity. Adopting a conformation similar to that proposed for TrcA by 
Loll et al. [17], the steric bulk of Trp7 may hinder optimal higher order structure formation 
and would account for decreased higher oligomers despite increased dimerization being 
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observed. Alternatively, decreased antimicrobial activity may be attributed to tighter 
membrane binding of the indole group through hydrogen bonding to lipid carbonyl groups 
[27]. The peptide complex may be trapped in a conformation unable to optimally interact with 
other peptides to possibly form a pore/channel like structure and cause permeabilization of 
the cell membrane.  
The different target cell properties influence the selectivity and mode of action of the Trcs, as 
has been observed for a broad range of antimicrobial peptides [28-32]. The Trcs are proposed 
to primarily execute their antimicrobial activity through their interaction with the cell 
membrane [7] and its subsequent permeabilization [8] and/or cell lysis [9]. However, Troskie 
[33] also illustrated the importance of the cell wall in the antifungal activity of the Trcs in 
addition to the cell membrane. The potent activity of the cyclodecapeptides activity toward A. 
fumigatus would indicate a strong relation to the target cell properties. It is highly likely that 
one of these properties is the hexose content of the fungal cell wall. The role of hexoses, such 
as glucose and it’s analogues, in antimicrobial activity of the Trcs may involve balancing the 
disruption of higher order oligomers formed in aqueous environment and association with 
polysaccharides such as the -glucan, chitin and peptidoglycans in the target cell wall 
structure [34]. These interactions may then serve as the seeding intermediates for further 
membrane penetration and disruption. The slight variations in conformation of the different 
Trcs could be the reason for variable interaction with different target cells which influences 
their antimicrobial activity and possibly eluding to an evolutionarily role of producing such a 
wide spectrum of peptides by the producer organism. Previous investigators have reported 
high antibacterial [2,4] and antifungal [6] for TrcB and TrcC analogues. The variability in 
antimicrobial activity observed in the current study may be attributed to differences in peptide 
character and different target cell properties. This is exemplified by the aberration in TrcB 
activity toward the two different target organisms. TrcB maintained high antifungal activity, 
its relative antibacterial activity was reduced, indicating an influence of the properties of the 
different targets.  
With peptides that are co-produced in culture were combined, we observed that the activity of 
most of the peptide pairs were additive, while those containing tryptocidines were slightly 
antagonistic, which offers no benefit to the producer organism. Combinations of the peptides 
with Tyr7 proved to be superior to those with Trp7 and overt synergism was observed in 
combinations of TrcA:PhcA and TrcA:TrcB toward the fungal target, and TrcA:TrcB and 
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TrcB:TrcC toward the bacterial target. The observed synergism is possibly related to an 
intermediate hydrophobicity and dimerization allowing for active structures which optimally 
interact with the fungal target cell structure. These peptide combinations formed similar 
proportions of dimers to those seen for the most active analogues TrcA and TrcB (Fig. 6.2). 
Synergism observed in combinations of TrcA:PhcA toward A. fumigatus is possibly due to 
PhcA forming reduced dimers caused by an altered heterodimer structure relative to that 
formed by homodimers (Fig. 6.2, 6.5 and 6.7). The antagonism of pairs containing TpcC 
toward both the bacterial and fungal targets correlates with the increased formation of 
heterodimers, which indicates that TpcC related activity may be less dependent on 
dimerization (Fig. 6.2, 6.6 and 6.7).  
6.5 Conclusion 
The differences in antimicrobial activity observed in this study are most likely due to 
differences in target cell properties, as well as the character of the cyclodecapeptides, as has 
been noted by other investigators [2-4,6], However, when peptides are combined a more 
complicated scenario that is closer to the natural process is simulated. We found that 
combinations of peptides with TpcC may not be beneficial to the producer organism, which is 
probably why TpcC is almost exclusively produced in Trp-rich media. The fact that TrcA, 
TrcB and TrcC are naturally produced in the highest concentrations (>40%) and that their 
combinations are synergistic, does benefit the producer organism by providing and improved 
overall antimicrobial defence. This study therefore reveals the first evidence for the natural 
production of such a complex peptide cyclodecapeptide library. The identification of 
synergistic pairs also aids the formulation of peptide mixtures for specific applications. We 
therefore decided to use the natural tyrothricin extract with high TrcA and TrcB in an in vivo 
study using honey bees and their larvae as our model insect (Chapter 7). 
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Chapter 7  
Formulation of tyrothricin extracts and in vivo toxicity 
testing toward honey bees 
7.1 Introduction 
The tyrocidines and analogues have been shown to display potent activity toward 
agronomically relevant fungal pathogens [1], including the ability to target these pathogens as 
well as Gram-positive bacteria in plants [2]. However, to allow for the use of these peptides 
in an agricultural environment their influence on non-target, beneficial organisms such as 
honey bees needs to be determined. Honey bees are central to the survival and maintenance of 
a healthy ecosystem through their role in the pollination of flowers [3]. Their role as 
pollinators is of the utmost importance to humans not only from the perspective of 
maintaining balanced ecosystems [4], they are pivotal to global food security [5] which goes 
hand-in-hand with their economic value [6]. The commercial use of honey bees as crop 
pollinators has exemplified the dangers of their exposure to chemical fungicides increasing 
susceptibility toward pathogens [7]. 
The combination of increased antimicrobial resistance toward many chemical antimicrobial 
agents, together with increased awareness of the negative impact of chemical control agents 
has driven the impetus for alternate so called green-biocides [8]. The tyrocidines (Trcs) are 
cyclic antimicrobial peptides produced by the soil bacterium Bacillus aneurinolyticus together 
with the linear gramicidins and are extracted together in what is known as the tyrothricin 
complex [9-12]. These antimicrobial peptides fit the criteria as green-biocides (refer to 
Chapter 4), however, for them to truly be considered green-biocides, they should not 
negatively affect non-target species. 
Antimicrobial peptides are ubiquitously present throughout prokaryotic and eukaryotic 
kingdoms [13-15] as such are often considered the natural way of maintaining a balanced 
ecology [16]. Many antimicrobial peptides are produced naturally in healthy soil and water 
bodies by bacteria and are natural products that are biodegraded to nutrients, as are the 
peptides of focus in this research, the peptides in the tyrothricin complex. Plants have been 
shown to be protected from numerous fungal pathogens by soil bacteria which produce a 
variety of cyclic antimicrobial peptides including: iturin [17,18], iturin A and surfactin [19], 
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as well as gramicidin S [20-22], a peptide with 50% analogy to the tyrocidines and analogues. 
The peptides surfactin and fengycin are also shown to protect plant by inducing systemic 
resistance [23]. Additionally, antimicrobial peptide producing bacteria have been shown to 
promote plant growth [24]. Consequently, many of these antimicrobial peptide producing 
microorganisms have been used as bio-control agents in agricultural applications [17,19-
21,25]. Their natural role in maintaining healthy, balanced ecosystems and use as bio-control 
agents has been recognised as early as the middle of the last century [16]. With the movement 
away from chemical control agents, there has been a resurgence of interest in these natural 
bio-control agents to control plant diseases [26-28]. 
In this study the focus was on the economical, natural production of the Trcs extracted from 
their producers and applications in agriculture and industry (refer to Chapter 4). As these 
antimicrobial peptides can be economically produced in large quantities, it enables the use of 
the extracts and purified peptides in a broader range of applications and control, 
circumventing the inherent unpredictability and limitations of utilising only the producer 
microorganism in agricultural conditions. As such, Rautenbach et al. [2] were the first to 
utilize the tyrothricin peptides within an agricultural environment to treat plants. 
The tyrothricin peptides, as well as other amphipathic antimicrobial peptides, have been 
proposed to work via a rapid membranolytic mode of action [29], in addition to a number of 
other less overt antimicrobial targets [30]. In the case of the tyrothricin peptides, potential 
targets vary widely from the ubiquitous membrane [29,31], to also include the cell wall [32], 
enzymes of the electron transport chain [33] and also possibly including DNA and RNA [34-
36]. With these multiple cellular targets there is thus a reduced likelihood of resistance 
development [37]. Part and parcel with the membranolytic activity, some toxicity of the 
tyrothricin peptides has been reported when applied intravenously [38,39]. There disruption 
of cell membranes is particularly evident in their haemolytic [10,39-43] as well as their 
leukocytic toxicity [38]. However, these peptides have been safely utilised when applied 
topically [44-47] or when taken orally in mammals [39,48-51]. 
To our knowledge, however, only a single report exists reporting the maximum tolerable 
dosage of a highly purified tyrocidine analogue to treat the nematode Caenorhabditis elegans 
in a medical infection model of the yeast Candida albicans [52]. This is the first extensive 
evaluation of the toxicity of the tyrothricin peptides toward insects, and more specifically 
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honey bees. Before the bee study could be executed the feeding formulation of the tyrothricin 
peptides in the solvent, as well as the influence of the main sugars in their feeding solutions 
was evaluated. After determining the oral toxicity of the tyrothricin peptides toward adult 
bees and their larvae; the potential of these peptides to protect honey bees from pathogens 
affecting them within their larval developmental stage was evaluated. Thereby establishing 
the relative safety of the tyrothricin containing culture extracts in environments where they 
would be utilised to target agronomically relevant pathogens. 
7.2 Materials and Methods 
7.2.1 Materials and Reagents 
Sucrose (Suc), glucose (Glc), fructose, ethanol (EtOH), tryptone soy broth (TSB), agar, 
sodium bicarbonate and N,N-Dimethylformamide (DMF) were obtained from Merck 
(Darmstadt, Germany). Tyrothricin, and gramicidin S (GS), lactalbumin hydrolysate, 
gentamycin, penicillin, streptomycin, amphotericin B and dimethoate (DiM) were obtained 
from Sigma-Aldrich (Steinheim, Germany). Tween 20, potato dextrose agar (PDA) and 
potato dextrose broth (PDB) were from Fluka (Buchs, Switzerland). Sterile polystyrene 96-
well flat bottom microtiter plates were from either Greiner bio-one (Frickenhausen, Germany) 
or Sarstedt (Nümbrecht, Germany). Petri dishes were from Lasec (Cape Town, South Africa). 
Grace’s insect cell culture medium and pluronic F-68 were from Gibco Life Technologies 
(Waltham, MA, USA). Falcon® tubes, Columbia sheep blood agar plates, yeast extract and 
yeastolate were from Becton Dickson and Company (Franklin Lakes, NJ, USA). Promega 
(Madison, USA) supplied the Cell Titer-BlueTM Cell Viability Assay kit. Polycarbonate 
Erlenmeyer flasks were from Corning Incorporated (Corning, NY, USA). Foetal bovine 
serum was from Biochrom GmbH (Berlin, Germany). Brain, heart infusion (BHI), glycerol, 
glucose, fructose, potassium sulfate (K2SO4) used in assays toward bee larvae were from Roth 
(Karlsruhe, Germany). Royal jelly was from Imkereitechnik Möller (Borsum, Germany). 
Grafting cells where supplied by Nicotplast (Maisod, France). Dental roll and 48-well culture 
dishes were from Celluron (Wiener Neudorf, Austria) and Greiner bio-one (Frickenhausen, 
Germany) respectively. Analytical grade water was prepared by filtering water from a reverse 
osmosis plant through a Millipore-Q® water purification system (Milford, USA). Tyrothricin 
(Te) was obtained from culture extracts of Bacillus aneurinolyticus ATCC 10068 using an 
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organic extraction methodology [12] modified as previously described (Chapter 4). 
Temperature and humidity were recorded using Thermochron DS1922L i-Buttons from 
Maxim Integrated Products (San Jose, USA). 
Aspergillus fumigatus ATCC 204305 was from the American Type Culture Collection 
(Manassas, VA, USA). Bacillus subtilis 168 was obtained from the Bacillus Genetic Stock 
Centre (Ohio State University, OH, USA). Spodoptera frugiperda (Sf9) cells were obtained 
from Allele Biotechnology and Pharmaceuticals/Orbigen (San Diego, CA, USA). 
Paenibacillus larvae reference strains DSM 7030 (ERIC I), DSM 25430 (ERIC II) and LMG 
16252 (ERIC III), LMG 16247 (ERIC IV) were obtained from the German Collection of 
Microorganisms and Cell Cultures, Leibniz Institute DSMZ (Braunschweig, Germany) and 
Belgian Co-ordinated Collection of Microorganisms, Ghent University (Ghent, Belgium) 
respectively. Isolates of P. larvae were obtained from American Foulbrood positive 
honey/food or scale/glue-like liquid collected at the Lower Saxony State Office for Consumer 
Protection and Food Safety, Institute for Apiculture (Celle, Germany). The strain identity of 
the isolates was confirmed by 16S rRNA-PCR [53], and the genotype (ERIC) was confirmed 
by rep-PCR (Genersch et al. 2006) using ERIC-primers obtained from Eurofins Genomics 
(Ebersberg, Germany). Melissococcus plutonius LMG 20360, Comamonas denitrificans 
LMG 21602, Bacillus pumilus LMG 3455, Delftia acidovorans LMG 1226, 
Ralstonia Picketti LMG 5342, Saccharibacter floricola LMG 23170, 
Janthinobacterium lividum LMG 2892, Pedobacter africanus LMG 10345, 
Bacillus megaterium LMG 7127 and Bacillus subtilis LMG 2099 were obtained from the 
Belgian Co-ordinated Collection of Microorganisms, Ghent University (Ghent, Belgium). 
Paenibacillus alvei DSM 29, Enterococcus faecalis DSM 20376, Pseudomonas fluorescens 
DSM 6147, Brevibacillus borstelensis DSM 6347, Planococcus maritimus DSM 17275, 
Salmonella enterica subsp. enterica DSM 11320, Staphylococcus pasteuri DSM 30868, 
Gluconobacter oxydans DSM 2003, Streptomyces griseus DSM 1471 and 
Planomicrobium okeanokoites DSM 15489 were from the German Collection of 
Microorganisms and Cell Cultures, Leibniz Institute DSMZ (Braunschweig, Germany). 
Oral toxicity studies were performed using adult African honey bees, Apis mellifera 
scutellata, at the Agricultural Research Council Plant Protection Research Institute, 
Vredenburg Research Centre (Stellenbosch, South Africa). Carniolan honey bee, 
Apis mellifera carnica, larvae were obtained from hives at the Technische Universität 
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Braunschweig (Braunschweig, Germany) using queen bees that were bred at the Lower 
Saxony State Office for Consumer Protection and Food Safety, Institute for Apiculture (Celle, 
Germany). 
7.2.2 Preparation of peptide formulations for antimicrobial activity assays 
Analytically weighed aliquots of the dried peptide formulations, tyrocidine extract from 
commercial tyrothricin complex (Tc) and tyrothricin extract (Te) from B. aneurinolyticus 
(refer to Chapter 4) were dissolved in either 50% (v/v) DMF in water or 75% EtOH (v/v) in 
water. These were subsequently diluted using either sterilised water or one of the respective 
sugars to a concentration of 1.00 mg/mL at a solvent concentration of either 10% (v/v) DMF 
or 15% EtOH (v/v) in either water or 50% (m/v) of one of the respective sugars. While 
maintaining the solvent and sugar concentration, the respective peptide formulations were 
prepared in a doubling dilution series. These were subsequently diluted 10-fold in the 
antimicrobial assays to a final solvent concentration of either 1% (v/v) DMF or 1.5% (v/v) 
EtOH in either water and/or 5% (m/v) of one of the respective sugars. 
7.2.3 Antifungal activity assays toward Aspergillus fumigatus 
Spores of the fungi A. fumigatus ATCC 204305 were obtained from freezer stocks and 
cultured using normal sterile techniques on PDA plates for three weeks. Subsequently 7 mL 
of Tween water (20 µL of Tween in 200 mL analytical grade water and autoclaved) was 
added to the plates, the spores lightly loosened using a hockey stick and hydrated over night 
at 4 °C. These were subsequently counted using a haemocytometer and diluted with sterile 
water to a concentration of 50 spores/µL. 
A variation of a microtiter broth dilution method, as described by Troskie et al. [54], was 
used to test the antimicrobial activity of the tyrothricin extracts toward A. fumigatus. A 
volume of 50 µL of PDB was added to all the wells of a sterile microtiter plate. The top four 
wells of the first column received 40 µL of sterilized water, while all the rest of the wells 
received 40 µL of the mentioned spore suspension. The wells of the first column received 
10 µL of solvent or sugar formulation at a concentration equivalent to that the peptide 
formulations were dissolved in, thus the first column served as sterility and growth controls 
respectively. All the rest of the wells received 10 µL of one of the respective peptides 
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dissolved in the respective solvents or sugar formulations. Application of Tc and Te were 
repeated in triplicate (n=3) at a final concentration ranging from 100.0 to 0.80 µg/mL; while 
those of GS were in duplicate (n=2) at a final concentration ranging from 50.0 to 0.40 µg/mL.  
The microtiter plates were then covered and incubated for a period of 48 hours at 25 °C, 
following which the light dispersion was measured spectrophotometrically at 595 nm using a 
BioRad™ microtiter plate reader. From which the percentage growth inhibition was 
determined. 
7.2.4 Antibacterial activity assays toward Bacillus subtilis 
Single colonies of the Gram-positive bacteria B. subtilis 168 were obtained from freezer 
stocks by culturing using normal sterile techniques on tryptone soy agar (TSA) plates (3.0% 
(w/v) TSB and 1.5% (w/v) agar in water). Single colonies were selected and incubated while 
shaking at 220 rpm for 16 hours at 37 ºC in Falcon® tubes containing 20 mL TSB (3.0% (w/v) 
TSB in water; pH 7.0) medium to an optical density (OD) of approximately 0.8 at 595 nm. 
These cells were subsequently sub-cultured in TSB and grown to an OD of 0.6 at 595 nm. 
A variation of the microtiter broth dilution method as described by Du Toit and Rautenbach 
[55] and Lehrer et al. [56] was used to determine the activity of the mentioned peptide 
formulations toward the Gram-positive bacteria B. subtilis 168. A pre-culture was diluted 
with TSB to an OD of 0.2 at 595 nm (±108 CFU/mL). A volume of 90 µL of the diluted 
culture was added to all of the wells of the microtiter plate except for the top four wells first 
column which received 90 µL of TSB. The peptide and solvent controls were as previously 
described. These microtiter plates were then covered and incubated for a period of 16 hours at 
37 ºC, following which the light dispersion was measured spectrophotometrically at 595 nm 
using a Bio Rad™ microtiter plate reader. The percentage growth inhibition was then 
determined [55,57]. 
7.2.5 Influence of different solvents and sugars on aggregation 
Dried peptide aliquots of the Tc and Te were dissolved in 50% (v/v) of either DMF or EtOH 
and diluted to a concentration of 260.0 µg/mL with 5% (v/v) solvent in analytical grade water. 
These samples were allowed to stand at room temperature overnight prior to being diluted to 
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a final concentration of 130.0 µg/mL with 2.5% (v/v) solvent in analytical grade water with or 
without the addition of 5% (m/v) of either Suc or Glc. 
The type of predominant aggregates/oligomers formed within the above formulations was 
determined by means of high resolution electrospray mass spectrometry (ESMS) using a 
Waters Q-TOF Synapt G2 mass spectrometer with a Z-spray electrospray ionisation source. 
Injections of 2 µL of sample were introduced directly into the mass analyser in positive mode 
at a flow rate of 0.3 mL/minute using 60% (v/v) acetonitrile. Peptide extracts were subjected 
to a capillary voltage of 2.5 kV and cone voltages of 15 V at a temperature of 120 ºC at the 
source, desolvation gas of 650 L/h and desolvation temperature of 275 ºC. Data acquisition 
was performed by scanning mass over charge ratio (m/z) range of 300 to 2000 in continuum 
mode at a rate of 0.2 scans per second. 
Particle size of the aggregates formed within these formulations was then determined by 
means of dynamic light scattering (DLS) using a Malvern ZetaSizer 1000HSa instrument 
equipped with a He-Ne laser. Samples were placed in a 1.0 cm diameter quartz cuvette and 
allowed to equilibrate at 37 ºC within the instrument. Operating at 633 nm wavelength, 
scattered light was detected at a 90º angle. The mean of three measurements, each composed 
of 10 sub-runs, was used to determine the particle size and distribution from particle size was 
calculated using CONTIN analysis and expressed as the diameter of the particles in 
nanometres (nm). 
7.2.7 Toxicity toward insect cell lines 
Insect cells toxicity assays were done at Stellenbosch University (Stellenbosch, South Africa) 
in collaboration with Timo Tait. Spodoptera frugiperda (Sf9) cells were initially grown as 
monolayers in a non-humidified, ambient air-regulated incubator set to 27 ºC in complete 
TNM-FH medium (Grace’s insect cell culture medium supplemented with: 3.33 g/L 
yeastolate, 3.33 g/L lactalbumin hydrolysate, 0.35 g/L sodium bicarbonate, 10% (v/v) foetal 
bovine serum, 100 U penicillin, 100 mg/L streptomycin, 10 mg/L gentamycin and 2.5 g/L 
amphotericin B in analytical grade water). Cells were habitually counted by means of a 
haemocytometer to assess cell density while cell viability was assessed by the resorufin-
resazurin (also known CellTiter-BlueTM or Trypan Blue) assay. Passages of monolayers were 
performed at 90–95% confluence; cells were subsequently plated at seeding densities of 
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5 x 104 viable cells/cm2. Sf9 cells were transferred to suspension culture once regular 
exponential growth was obtained at a sustained cell viability of greater than 90%. Cells were 
suspended in 100 ml complete TNM-FH in sterile 250 mL polycarbonate Erlenmeyer flasks at 
constant agitation of 100 rpm at 27 °C. Pluronic F-68 was added at a final concentration of 
0.1 % (v/v) to reduce cell shearing. Cells were routinely passaged to a cell density of 2 x 105 
viable cells per millilitre when the culture reached a density of > 2 x 106 viable cells/mL. 
Prior to the assays being performed cells were collected by centrifugation at 500 ×g for 5 
minutes. The pelleted cells were then washed with 10 mL sterile phosphate buffered saline 
and suspended at a concentration of 2 x 105 viable cells/mL in complete TNM-FH barring the 
addition of antibiotics (penicillin, streptomycin, gentamycin and amphotericin B). The 
toxicity of Te was performed through a variation of the previously described microtiter broth 
dilution method [55,57]. Briefly, the adjusted TNM-FH media alone or including Sf9 cells at 
a cell density of 2 x 105 viable cells/mL served as the sterility and growth controls 
respectively, as such they were only treated with solvent at an equivalent concentration used 
to apply the peptides. The peptides exposure ranged in concentration between 100.0 to 
0.40 µg/mL in 1% (v/v) DMF. These treated cells were subsequently incubated for 24 hours at 
27 ºC. The metabolic activity of the cells was then determined by adding 10 µL of CellTiter-
BlueTM reagent to every well and incubated for an additional two hours upon which the 
fluorescence (excitation λ530 nm, emission λ590 nm) was measured on a Thermo Verioskan™ 
spectrophotometer. 
7.2.8 Acute oral toxicity testing of tyrothricin toward adult honeybees  
The oral toxicity study of tyrothricin to honeybees was done at the Agricultural Research 
Council Plant Protection Research Institute, Vredenburg Research Centre (Stellenbosch, 
South Africa) in collaboration with Dr. Mike Allsopp. The oral toxicity of tyrothricin to 
honeybees was evaluated using methodology described in OECD/OCDE Test Guideline (TG) 
213 [58]. A brood frame was removed from a queen-right colony and maintained at 25±2ºC 
and 50% relative humidity. Emerged worker bees were subsequently marked every 24 hours 
using coloured markers and returned to the hive. Subsequently after a period of ten days these 
marked bees were re-captured and ten bees placed in each wooden cage (10 × 8.5 × 5.5cm; 
mesh covered two sides and Perspex the front). These were then fed a feeding solution 
50% (m/v) sucrose in water from a reverse osmosis plant and sterilized by means of 
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autoclave) in a glass tube (50 mm long, 8 mm wide tapering to 2.5 mm), while being 
maintained at 27±2ºC and 52±5% relative humidity to allow the bees to acclimatise to the 
experimental conditions for 24 hours. After which the feeders were removed for a period of 
two hours. Bees were maintained in the dark throughout all of the experimental phases 
barring periods of observation. 
At least four cages were randomly assigned to each of the experimental groups. Three control 
groups received; only feeding solution or feeding solution together with 1% (v/v) DMF 
(dosing vehicle) and a positive control group received 17.5 µg/mL DiM in feeding solution 
and dosing vehicle. Te stock solutions were prepared in 50% DMF (v/v) in analytical grade 
water. These were diluted to concentrations of between 2500 and 30 µg/mL Te ranging over 
eight concentrations dissolved in feeding solution and 1% (v/v) DMF. Feeders containing 
200 µL of each of the respective dosages where then replaced and the feed consumed, as well 
as mortality recorded after four and six hours. After which any unconsumed feed was 
removed and the volume recorded. A fresh feeder was then replaced containing only 
50% (m/v) Suc. Bees which displayed any sub-lethal effects, including lack of mobility, were 
recorded together with mortality and removed every 24 hours until a maximum of 96 hours. 
Bees were subsequently fed a diet of only the mentioned concentration range of Te, together 
with the respective controls, for up to 72 hours. As previously described, feed volume 
consumed, sub-lethal effects and mortality were recorded and bees which had succumbed 
were removed. Mortalities were adjusted relative to those observed in the uninfected controls 
using Abbots correction [59]. 
7.2.9 Delayed toxicity testing and survival in hives after tyrothricin exposure 
Freshly emerged worker honey bees from three different hives were marked and placed in the 
previously described cages, with no more than 300 bees per cage. By means of three 20 mL 
glass feeders per cage, bees from each of the different hives were fed a diet composed of 50% 
Suc and 1% DMF (control), or 50% Suc and 1.5 µg/mL Te dissolved in 1% DMF for 48 
hours. Mortality, sub-lethal effects and volume consumed were recorded for the first six hours 
and every 24 hours thereafter until 48 hours. Bees of the control and experimental groups 
were then lightly sprayed with a water/honey/alcohol solution and returned to the hive from 
which the respective brood frames originated. Bees were then counted after three days and 
weekly thereafter until 28 days. A sample of 10 bees from each experimental group was 
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collected at each counting until 28 days when all the remaining marked bees where collected. 
These bees were stored in an air tight container at -20 C for dissection and analysis. 
7.2.10 Antibacterial activity assays toward foulbrood associated pathogens 
The antibacterial activity assays toward foulbrood associated pathogens were done at the 
Technische Universität Braunschweig (Braunschweig, Germany) in collaboration with 
Hannes Beims. Antimicrobial activity assays were performed against: all four known 
genotypes of P. larvae (ERIC I, DSM 7030; ERIC II, DSM 25430; ERIC III, LMG 16252; 
ERIC IV, LMG 16247) [60], the causative agent of American foulbrood; M. plutonius, the 
causative agent of European foulbrood, as well as the associated secondary invaders P. alvei 
and E. faecalis [61]. 
Single colonies were obtained from freezer stocks and grown on Columbia sheep blood agar 
for 16 hours at 37 °C. A loop of bacteria was used inoculated into 5 mL of BHI (3.7% (m/v) 
BHI, 0.3% (m/v) yeast extract), this pre-culture was cultured at 37 °C while shaking at 
200 rpm for approximately six hours. The pre-culture was then diluted to a final OD of 0.2 at 
600 nm in the described BHI broth. 
Activity assays were performed in triplicate for each strain containing three technical repeats 
of Te. Sterility, growth controls and peptide formulations were prepared at a final EtOH 
concentration of 1.5% (v/v) as previously described. The plates were incubated at 37 °C for 
16 hours on a thermo shaker (Grant-bio, PHMP-4) while shaking at 600 rpm. Only 
M. plutonius was cultivated without shaking at 37 °C and under anaerobic conditions. The 
OD595 was measured in a multiplate reader (Thermo Fischer, VARIOSKAN FLASH) and 
percentage growth inhibition determined [55,57]. 
7.2.11 Toxicity of tyrothricin peptides toward bee larvae  
The toxicity studies against bee larvae were done at the Technische Universität Braunschweig 
(Braunschweig, Germany) in collaboration with Hannes Beims. The in vivo toxicity of 
tyrothricin formulations toward A. mellifera larvae was tested according to the OECD/OCDE 
TG 237 [62]. An apparatus, consisting of a Plexiglas desiccator (NALGENE, 5317-0120), 
containing a dish filled with K2SO4 sutured solution, was placed in an incubator (WiseCube, 
WIS-30R) at 35 °C. Larvae were collected from three different, unrelated colonies of 
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A. mellifera carnica. These were reared in polystyrene grafting cells, which were placed in a 
48-well plate containing pieces of dental roll wetted with 500 µL 15% (v/v) glycerol. Larval 
food (frozen royal jelly, yeast extract, glucose and fructose) was prepared and adjusted 
relative to the various developmental stages of the larvae [62]. Aliquoted dry masses of Te 
were dissolved in 15 µL 99.9% (v/v) DMF and 165 µL of deionised water. An aliquot of 
1.5 mL Diet C (50% (m/v) royal jelly, 2% (m/v) yeast extract, 9% (m/v) glucose, 9% (m/v) 
fructose) [62] was added to 150 µL of the prepared peptide solution. Larvae were fed 33 µL 
of the prepared Diet C on day 4 containing concentrations of 6.17 µg/mL, 18.5 µg/mL, 
55.6 µg/mL, 167 µg/mL or 500 µg/mL of Te. This equated to a single exposure of 0.204, 
0.611, 1.83, 5.5 or 16.5 µg/larva. Controls were performed for: the natural mortality (diets 
without ingredients), for 0.76% (v/v) DMF solvent (as derived above) and for the reference 
chemical insecticide DiM at a concentration of 267 µg/mL, thus 8.8 µg/larva. Three replicates 
containing a minimum of 12 larvae were repeated for each colony for each of the respective 
test conditions. The development of the larvae was assessed and any sub lethal effects were 
recoded as well as the mortality up to day 7, after which the tests were terminated [62]. 
Mortalities were adjusted relative to those observed in the uninfected controls using Abbots 
correction [59]. 
7.2.12 Curing assays of Paenibacillus larvae infected bee larvae  
The curing assays of invested bee larvae were done at the Technische Universität 
Braunschweig (Braunschweig, Germany) in collaboration with Hannes Beims. Rearing of bee 
larvae were performed as previously described [63,64]. At day 1, 1500 spores of P. larvae 
ERIC I (DSM 7030) or ERIC II (DSM 25430) were added to Diet A [62] to infect the larvae 
[65]; barring those which served as uninfected controls. Peptide formulations of Te prepared 
as previously described were fed to cure the infected larvae on day 4 in Diet C [62]. A 
concentration of 55.6 µg/mL (1.83 µg/larva) of Te was used as this concentration was judged 
to not show significant differences in larval survival relative to the respective control. 
Infected control larvae were fed diet C without any additives. Three different, unrelated 
colonies were used in replicates of 36 larvae each. Larvae were inspected for 14 days post-
infection and the mortality recorded every day. Dead individuals were homogenized and 
plated out on blood agar in order to confirm killing by P. larvae using a P. larvae-specific 
16S rRNA-PCR detection [53]. Mortalities were adjusted relative to those observed in the 
Stellenbosch University  https://scholar.sun.ac.za
 7.12 
 
uninfected controls using Abbots correction [59]. The percentage relative mortality was 
plotted against time and compared to describe mortalities of infected larvae [65]. 
7.2.13 Antibacterial activity toward gut microbiota of honey bee larvae  
To exclude any ecological damage after application of the respective peptide formulations on 
bee larvae, their antimicrobial activity was determined toward several members of the gut 
microbiota of A. mellifera [66]. The growth media and cultivation conditions used were as 
described elsewhere (https://www.dsmz.de/). A single indicative activity assay was performed 
toward each strain. Application of Te was as described toward the causative agents of 
foulbrood. 
7.2.14 Data analysis  
The effect of natural mortality observed in bees and their larvae was removed by adjusting the 
mortalities relative to those observed in the uninfected controls using Abbots correction [59] 
by means of the following equation: 
The percentage growth inhibition of the peptide extract in all antimicrobial activity assays 
was determined relative to the mean of the growth control, as previously described by 
Rautenbach et al. [57], using the following equation: 
GraphPad Prism® 4.00 (GraphPad Software, San Diego, USA) was used to plot all graphs as 
well as perform all statistical analysis, except for those obtained by ESMS analysis. 
Antimicrobial activity parameters were determined from these plots included: IC50 
(concentration causing 50% growth inhibition) and ICmax (concentration causing 100% 
growth inhibition). ICmax is directly related to the minimum inhibitory concentration (MIC, 
lowest concentration used where no growth is visually observed), but was calculated from the 
dose response as described by Du Toit and Rautenbach [55]. 
% Mortality 
(Abbots correction) 
= 
         (Mean % mortality due to treatment – Mean % control mortality) 
 
(100 – Mean % control mortality ) 
     % growth inhibition =    100  
100 × (A595 of well – Mean A595 of background) 
 
   (Mean A595 of growth control - Mean A595 of background) 
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The data obtained by means of ESMS was analysed using MassLynx V4.1 (Waters, Miliford, 
USA) to determine the proportion of the different types of oligomers formed. 
7.3 Results and Discussion 
The tyrocidines have shown great promise targeting pathogens in the food and agricultural 
industries [1,2,67,68]. For these peptides to be considered safe to use within these industries, 
particularly in agriculture, their influence on non-target, beneficial honey bees needed to be 
evaluated. 
For this to be achieved the formulation of our tyrothricin extract (Te) for application in a 
honey bee studies was evaluated relative to the purified commercial Trcs mixture (Tc) (refer 
to Chapter 2 for detailed analysis). As EtOH cannot be used as solvent in the toxicity testing 
towards bees, we investigated the use of an alternative solvent, DMF. The influence of 
1.0% DMF on the antimicrobial activity and aggregation of the tyrothricin peptides was 
compared relative to the established 1.5% EtOH solvent used in prior antimicrobial activity 
assays. The influence of two sugars Suc and Glc, present in the feeding solutions used to 
administer the tyrothricin peptides to adult bees and their larvae, was also investigated prior 
to in vivo toxicity studies being performed toward bees and larvae.  
7.3.1 Influence of peptide formulation on aggregation  
Aggregation of the tyrothricin peptides and assembly/oligomerization into higher order 
structures is central to their antimicrobial activity [1,29,31,69,70], however, premature 
aggregation before coming into contact with the membrane targets has a negative influence on 
their antimicrobial activity [71-73]. Te has been shown to contain a natural pigment together 
with linear gramicidins which were co-extracted from the culture extracts (Chapter 4). The 
influence of these co-extracted factors on the aggregation of the tyrothricin peptides was 
evaluated by comparing the aggregation of Te in different environments relative to that of the 
highly cleaned Tc, shown to contain only the tyrocidines and their analogues (Trcs) 
(Chapter 2, [1]). 
The influence of dissolving the tyrothricin peptides in the different solvents, EtOH or DMF, 
on their aggregation into higher order structures was investigated by means of ESMS 
(Fig. 7.1). Analysis of the respective peptide formulations dissolved in the two solvents 
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revealed a difference in the aggregation characteristics of the tyrothricin peptides. In both of 
the peptide formulations the monomeric species of Trcs was the predominant species detected 
when dissolved in EtOH, (Fig. 7.1 A and C). In contrast, when dissolved in DMF the dimeric 
form of Trcs was predominantly detected. Variability in the detected masses of the oligomeric 
structures was observed between Te and Tc reflecting the difference in composition where Tc 
only contains Trcs, Te also contained a small amount of linear gramicidins together with the 
culture pigment (Fig. 7.1, Chapter 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 ESMS spectra of the tyrothricin formulations depicting the aggregation of the 
tyrocidines and their analogues (Trcs) forming monomer, dimers or trimers. Tc 
dissolved in water with 2.5% A EtOH or B DMF or Te dissolved in C EtOH or D 
DMF. Te contains linear gramicidins (Grms) in addition to the tyrocidines and 
their analogues 
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Attempts to characterise the oligomerization of the Trcs in the presence of sugars by ESMS 
where hindered by the suppression of the peptide ion signal by the sugars (data not shown). 
Therefore the influence of the sugars Suc and Glc on the size of the aggregates of the 
tyrothricin peptides dissolved in either EtOH or DMF was investigated further by means of 
DLS (Fig. 7.2). 
Variability was observed in the particle size of Tc and Te in the both of the solvent 
compositions. Tc tended to produced larger aggregates at a greater intensity indicating an 
increased proportion of these aggregates to the total aggregate profile. However, when 
considering the two formulations individually within the two solvents, only minor variability 
is observed in the size of the aggregates (Fig. 7.2 A and B).  
The sugars had a chaotropic effect, causing a disruption of the aggregation of Tc in EtOH and 
decreased the proportion of the aggregates with a diameter of around 220 nm (Fig. 7.2 C). 
The variation in aggregation was more pronounced in the presence of Suc as is evident from 
the decreased intensity signal of the aggregates at 220 nm, concomitantly the diameter of the 
aggregates varied greatly from as low as 33 nm to as large as 825 nm, with the larger 
aggregates as observed in EtOH alone (Fig. 7.2 C). The disruption of the aggregation of Tc in 
the presence of both Glc and Suc also resulted in the presence of a small proportion of 
smaller aggregates with 0.7 to 1 nm diameter (Fig 7.2 C). 
When Tc was dissolved in 2.5% DMF as solvent a more pronounced effect of the sugars 
reducing aggregation was observed producing aggregates within a narrow size window and 
increased intensity (Fig. 7.2 E). In water with 2.5% DMF the majority of the aggregates had a 
mean maximum diameter of approximately 260 nm together with a smaller fraction of 42 nm; 
these aggregates where dispersed over two size windows ranging between 20 nm to 116 nm 
for the smaller aggregates and 116 nm to 540 nm for the larger aggregates. In the presence of 
Suc and Glc, the smaller fraction with an average diameter of 42 nm had a much narrower 
size window ranging between 28 nm and 48 nm, together with even smaller aggregates 
ranging between 3 nm and 12 nm in diameter, indicating a chaotropic effect of the sugars in 
the presence of DMF. In both instances the signal intensity of the larger aggregated obtained 
in the presence of Glc exceeded that of Suc, indicating a large chaotropic effect of Suc on the 
peptide aggregation. 
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Figure 7.2 Comparison of the size of aggregates of Tc (A, C, E) and Te (B, D, F) formed in 
different environments. Size of aggregates formed in water with 2.5% of EtOH or 
DMF solvent and water of A Tc or B Te. In combination with 5% of either 
sucrose or glucose and 2.5% of either EtOH or DMF of Tc in C and D or Te in E 
and F respectively. 
The smaller aggregate size of Te remained fairly consistent in the presence of Suc and Glc 
when dissolved in EtOH with an average aggregate diameter of approximately 70 nm 
(Fig. 7.2 D). As opposed to what was observed in EtOH, the aggregation profile of Te was 
disrupted in the presence of DMF together with Suc and Glc. In the presence of Glc a slight 
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increase in the intensity of aggregates of 32 nm average diameter was observed, while in the 
presence of Suc the intensity of aggregates of the latter diameter decreased concomitantly 
increasing the proportional contribution of larger aggregates between 100 nm and 400 nm as 
well as smaller aggregates of 1 nm average diameter (Fig. 7.2 F). 
The sugars thus had a chaotropic effect on the aggregation of Te when it was dissolved in 
DMF (Fig. 7.2 F) which was not observed when dissolved in EtOH (Fig. 7.2 D). This concurs 
with the altered oligomerization of the peptides in DMF (Fig. 7.1 C and D), attesting to a 
possible conformational change which made the aggregates more accessible to the sugars. 
The aggregate size of Te was consistently smaller than that of Tc when dissolved in only the 
solvent. Only in DMF together with the respective sugars did the aggregate size of Tc 
approach that of Te (Fig. 7.2 E and F). This alludes to the possibility of the culture pigment 
within Te having a chaotropic effect on aggregation similar to what was observed by the 
sugars in Tc. 
7.3.2 Toxicity toward insect cell lines  
Having determined the influence of the respective sugars on the aggregation of the Te and Tc 
formulations, their toxicity alone, as well as in the sugar formulations was determined toward 
Sf9 insect cells. The toxicity of Te, containing linear gramicidin as well as culture pigment, 
was compared to that of Tc, composed of only the Trcs (refer to Fig. 7.1). Only the DMF 
solvent was considered in combination with Suc and Glc as this was the relevant solvent used 
in the in vivo studies performed toward adult honey bees as well as their larvae (Table 7.1). 
Table 7.1 Toxicity of Te and Tc in 1% DMF in different solvent compositions toward 
Spodoptera frugiperda (Sf9) insect cells. 
Peptide formulation 
LCmax 
(µg/mL)±SEM 
Tc  
(n=6) 
11.3±0.25 
Tc + 5% Suc (n=3) 13.2±3.53 
Tc + 5% Glc (n=3) 7.32±0.54$ 
Te  
(n=6) 
18.3±0.98$ 
Te + 5% Suc (n=3) 16.7±1.19$ 
Te + 5% Glc (n=3) 15.1±3.88 
SEM, standard error of the mean. Statistical analysis performed by unpaired Student t-test with $ P<0.001 
relative to Tc, Activity of Te relative to addition of sugars was not statistically significant P>0.05 
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From these data it was evident Te was less toxic than Tc toward Sf9 cells, despite containing 
linear gramicidins. The difference in toxicity of Te in the presence of sugars was not 
statistically significant, however, Glc showed a tendency of augmented toxicity of Tc toward 
the insect cells. 
The culture pigment may also have a modulatory effect on the toxicity of Te. The presence of 
the linear gramicidins has been shown to increase the toxicity of tyrothricin relative to 
tyrocidines alone [41,74] which are found in Tc. However, the opposite was observed in the 
case of Te which displayed less toxicity than Tc toward insect cells (Table 7.1). Taking into 
consideration the fact that Te only contained approximately 75% the peptide content of Tc 
(determined by UPLC-MS analysis, refer to Chapter 4), the toxicity of Te in the presence or 
absence of Suc and Glc was approximately 50% less than that of Tc toward insect cell lines 
despite compensation for the difference in peptide content. Overall the reduction in toxicity of 
Te is attributed to the influence of the culture pigment, which may be acting as a chaotropic 
agent to decrease the formation of toxic oligomers. 
7.3.3 Antimicrobial activity of peptide formulations  
Having observed a change in the aggregation of Te in the different solvents (Fig. 7.1 C and D, 
Fig. 7.2 B), as well as in the presence of sugars when dissolved in DMF (Fig. 7.2F), it was 
investigated whether these changes may have influenced its antimicrobial activity. 
The antimicrobial activity of the Te in either 1.0% DMF or 1.5% EtOH was compared to that 
of the Tc toward A. fumigatus and B. subtilis which served as representative fungi and Gram-
positive bacteria respectively (Table 7.2).  
In both of the solvents the activity of Te was less than that of Tc toward both of the respective 
target organisms. A slight reduction in antimicrobial activity of Te relative to Tc in the two 
respective solvents (Table 7.2) may be attributed to the antagonistic effect of the co-extracted 
linear gramicidins [80]. However, in consideration of the tyrocidine peptide content of Te was 
approximately 75% that of Tc (Chapter 4), this reduction in activity was only truly relevant 
toward A. fumigatus when Te was dissolved in EtOH displaying 66% the activity relative to 
Tc. Te displayed near equivalent activity to that of Tc (if purity is considered) in DMF toward 
A. fumigatus. The antibacterial activity toward B. subtilis in EtOH or DMF increased to 85% 
and 91% respectively relative to Tc, which could indicate higher potency than that of Tc if the 
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75% purity of Te is taken into consideration. However, additional factors such as the 
influence of the culture pigment may have a positive influence on the antimicrobial activity 
which would account for the increased antibacterial activity relative to the peptide content. 
Table 7.2 Activity of the tyrocidine extract (Te) relative to commercial tyrothricin (Tc) in 
different solvent compositions toward representative fungi Aspergillus fumigatus 
and Gram-positive bacteria Bacillus subtilis 
Microbial target 
Peptide complex 
1.5% Ethanol  
ICmax (µg/mL) 
±SEM 
1% DMF 
ICmax (µg/mL) 
±SEM 
Aspergillus fumigatus 
  
Tc 
8.93±1. 3 # c 
(n=7) 
6.77±0.52 # c 
(n=12) 
Te 
12.2±0.48 # c 
(n=37)  
10.3±1.30 # c 
(n=20) 
Bacillus subtilis 
  
Tc 
12.1±1.6 a 
(n=15) 
11.0±0.37 c 
(n=6) 
Te 
13.3±0.42 *a 
(n=50) 
12.9±0.59 * c 
(n=6) 
Statistical analysis performed by means of an unpaired Student t test comparing ethanol vs DMF 
with # P<0.001; * P<0.05 or Tc vs Te a P<0.001; c P<0.05 
With the influence of the two solvents on the antimicrobial activity of Te relative to the 
purified Tc now firmly established, the influence of Suc and Glc on the antimicrobial activity 
of Te in the two the different solvent compositions was evaluated toward the two model 
fungal and bacterial target organisms. The investigation of the influence of these sugars on 
the antimicrobial activity of the tyrothricin peptides is of particular relevance due to their 
ubiquitous presence in not only microbial growth media, but also in environments where 
target pathogens of these peptides reside. The variation of Te activity was compared in the 
different solvent environments relative to that in EtOH alone using the respective ICmax 
values to highlight the influence of the different sugars on antimicrobial activity in the 
different solvent compositions (Fig. 7.3). 
In the two solvents alone, an increase in activity was observed toward the representative fungi 
A. fumigatus when the mentioned peptide formulation was dissolved in DMF, together with a 
marginal decreased in antibacterial activity relative to EtOH (Fig. 7.3). When Te was 
dissolved in EtOH together with the additional 5% (m/v) sugars, the antimicrobial activity 
was greatly decreased (Fig. 7.3). The decrease of antifungal activity was alleviated when the 
peptides were dissolved in DMF where Te regained 97% and 83% activity in the presence of 
Suc and Glc respectively, relative to approximately 25% relative activity observed in EtOH 
Stellenbosch University  https://scholar.sun.ac.za
 7.20 
 
together with both sugars (Fig. 7.3 A). The antibacterial activity of Te in the presence of Suc 
increased to 53% activity when dissolved in DMF in relation to 20% observed when 
dissolved in EtOH. Moreover, the activity of Te increased to 103% when dissolved in DMF 
in the presence of Glc in relation to 27% when dissolved in EtOH (Fig. 7.3 B). Fructose was 
also observed to suppress the antimicrobial activity when Te was dissolved in EtOH and was 
greatly relieved when dissolved in DMF (data not shown). 
Analysis of the aggregation of the tyrothricin peptides into higher order structures in DMF or 
EtOH by ESMS indicated an increase in the prevalence of the dimeric form in DMF relative 
to the monomeric form detected in EtOH (Fig. 7.1). The dimeric form of the tyrocidines is 
proposed be the active amphipathic structure of these cyclodecapeptides that is important in 
their membranolytic mode of action when targeting bacteria [29,31]. Pre-incubation of Te 
together with the various sugars severely suppressed the antimicrobial activity of Te when 
dissolved in EtOH, this was largely relieved when dissolved in DMF. Both Glc and Suc 
reduced the size of the aggregates formed when the peptides where dissolved in DMF, 
indicating an increased chaotropic effect and optimally dimerised antimicrobial formulation 
as shown in Chapters 5 and 6 (Fig. 7.2). 
Increased antimicrobial activity when dissolved in DMF was attributed to the sugars having a 
further chaotropic effect on the aggregates formed in the pre-incubated peptide formulations 
by disrupting the hydrogen bonding networks (refer to Chapter 5) and consequently 
increasing the formation of the more favourable dimeric oligomeric structures [29,31]. The 
chaotropic effect of the sugars is acutely apparent in the Tc peptide formulation. The large 
aggregates formed in EtOH (Fig. 7.2 C) and DMF (Fig. 7.2 E) where disrupted in the 
presence of the sugars as apparent in the decreased signal intensity, increasing the proportion 
of smaller aggregates. However in Te, the sugars only disrupted the aggregation when 
dissolved in DMF (Fig. 7.2 F). The smaller aggregates and increased proportion of dimers as 
indicated by ESMS (Fig. 7.1) correlated with the increased antimicrobial activity observed 
when the peptides where dissolved in DMF together with the sugars relative to its suppression 
of antimicrobial activity by the latter observed when dissolved in EtOH (Fig. 7.3). This was 
particularly evident in the increased antibacterial activity observed in the presence of Glc 
exceeding that observed in either solvent alone (Fig. 7.3 B). 
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The influence of the respective solvents and sugars on the identity of the higher order 
aggregates formed is particularly relevant to the mode of action targeting different pathogens. 
The bacterial membrane is proposed to be targeted by the dimeric oligomers [29,31] formed 
in DMF (Fig. 7.1), which are increased in the presence of Suc and particularly Glc, as 
deduced from the change in aggregation (Fig. 7.2) and antibacterial activity (Fig. 7.3 B). 
However, antifungal activity of the Trcs is probably also dependent on cell wall binding [32]. 
Considering the difference in recovery of antifungal activity in the presence of the two sugars 
(Fig. 7.3 A), it may be due to the fungal target depending on an alternate conformation 
induced by the different sugars to achieve maximal activity. Alternately, this may elude to a 
balance between interaction with the sugars in solution and the fungal cell wall as target cell 
structure [1]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Comparison of the relative activity of Te toward A the representative fungi 
A. fumigatus, and B Gram-positive bacteria B. subtilis. Te was dissolved in either 
1.5% EtOH or 1.0% DMF together with 5% (m/v) of either sucrose (Suc), glucose 
(Glc). ICmax values determined in EtOH were set as 100%. Statistical analysis was 
done using Bonferroni’s Multiple comparison test (One Way ANOVA) with 
## P<0.001; # P<0.05 when comparing formulations (with and without sugars) in 
the two solvents and ** P<0.001; * P<0.05 when comparing the sugar 
formulations relative to the respective solvents alone. 
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7.3.4 In vivo toxicity of the tyrothricin extract toward adult honey bees 
The influence of the formulation of Te in the DMF solvent as well as the influence of 
different sugars on the activity and aggregation was now firmly established. The acute oral 
toxicity of the Te formulation, which was to be utilized within agricultural applications, was 
evaluated toward adult bees using methodology described in OECD guidelines [58]. Due to 
limitations in solubility, fresh preparations of Te were prepared from freeze dried stocks prior 
to feeding experiments commencing at a maximum concentration of 2500 µg/mL. Despite 
using concentrations of approximately 200 times the ICmax observed toward the representative 
target organisms, toxicity was not observed at any of the concentrations of Te when bees were 
exposed to the test compound for a period of up to six hours having consumed 44.70±1.98 µg 
of Te at the highest concentration (data not shown). Due to the low solubility of these 
peptides in water, it was not possible to increase the mass of peptide consumed within the 
given time frame. In an effort to increase the amount of Te consumed, bees were fed a diet of 
50% (m/v) Suc and various Te concentrations for up to 72 hours (Fig. 7.4). The procedure for 
application of the DiM control, however, remained as described in OECD guidelines [58] 
with bees consuming 50% (m/v) Suc spiked with DiM at a concentration of 35 µg/mL for six 
hours where after the diet was replaced with 50% (m/v) Suc only. In conformation of the 
sensitivity of our experimental conditions, after the six hours of exposure bees consumed 
0.48±0.04 µg of DiM (data not shown); consequently near 100% mortality was observed in 
the DiM control within 24 hours (Fig. 7.4 C).  
A maximum concentration of Te at 1500 µg/mL was considered to prevent the influence of 
Te precipitation out of the feeding solution over the extended feeding period. Consumption of 
such high amounts of Te would be highly unlikely in a field application in light of the 
solubility of Te, this was purely performed as an exercise to determine at what concentration 
the peptide became toxic to adult honey bees. A reduction in feed volume consumed was 
observed in all the Te treatments barring the lowest concentration of 50 µg/mL (Fig. 7.4 A). 
Further emphasising how unlikely it would be for bees to consume such extremely high 
tyrothricin concentrations used in our attempt to determine the level of oral toxicity toward 
honey bees. After 48 hours of consuming a diet of only Suc and peptide, with 76 µg 
consumed per bee at 1500 µg/mL Te (Fig. 7.4 B), the percentage mortality was still within the 
levels observed in the control (Fig. 7.4 C). Considering an average mass obtained from 68 
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bees of 66 mg, bees consumed 1200 mg per kg body mass at 48 hours before any significant 
toxicity was observed at 72 hours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 7.4 Consumption of Te by adult African honey bees relative to the 50% Suc, 1% 
DMF and DiM controls. A Volume consumed per bee in the different feeding 
solutions. B Amount of Te in µg consumed per bee in each of the respective Te 
containing feeding solutions. C The relative percentage mortality of bees 
observed in each of the different feeding solutions over the 72 hour feeding period 
corrected relative to the natural mortality in 50% Suc using Abbots correction. 
Statistical analysis were done using Bonferroni’s Multiple comparison test (Two 
Way ANOVA) with # P<0.001; $ P<0.01; * P<0.05 relative to 1% DMF. 
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These data concur with those of numerous others in literature reporting the relative safety of 
the oral consumption of tyrothricin in mammals [38,39,48,75,76]. Oral dosages as high as 
1000 mg per kg body mass were not toxic to mice and rats [39]. While a maximum tolerated 
tyrothricin dosage of 0.8 mg per mouse was found after being successively fed three times a 
day for 10 days [75].  
At 72 hours an increase in mortality in all the conditions tested was observed, barring the 1% 
DMF control. At the 1000 µg/mL and 1500 µg/mL Te concentrations of in excess of 100 µg 
was consumed per bee and a mortality of approximately 25% was reached (Fig. 7.4 B and C). 
The observed toxicity only occurred when the amount of Te consumed was in the excess of 
100 µg/bee (Fig. 7.4 C), the limit amount for a product to be considered safe [58]. It was 
postulated that the increase in mortality may have arisen due the inability of the bees to 
defecate, either as a result of confinement or due to damage to their digestive tract. 
7.3.5 Survival in hives after tyrothricin exposure  
Having observed an increase in mortality after 48 hours in honey bees fed soley a diet spiked 
with Te, this observed toxicity was analysed further in a semi-field trial application. A Te 
concentration of 1500 µg/mL was used, being the highest concentration of Te which could be 
maintained in the feeding solution over the extended feeding exposure to Te. After 48 hours 
(2 days) of caged feeding no difference in survival was observed between the bees fed 
1.500 µg/mL Te relative to the 1% DMF dosing vehicle control where a survival >90% was 
observed (Fig 7.5).  
After returning the bees to their hives of origin, retrieval of the Te fed bees was 25-75% 
greater than the control (Fig. 7.5). However, this difference was only statistically significant 
for day 20 (Fig. 7.5 A), although there were major differences between hives with some hives 
showing >200% retrieval of bees compared to the untreated controls (Fig. 7.5 B). 
Weighing and dissection of bees after caged feeding for 48 hours, as well as those recovered 
from the hives showed no discernible difference between the Te fed bees relative to those of 
the control (data not shown). Thus, even at such extremely high concentrations, consumption 
of tyrothricin by adult bees was safe and may even have been to an advantage to them. 
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Figure 7.5 Comparison of the retrieval of African honey bees fed 1500 µg/mL Te dissolved 
in 50% sucrose feeding solution relative to the 1% DMF control for 2 days then 
returned to their hives of origin. With A showing the average % retrieval 
compared to the control and B the retrieval in the respective hives compared to 
the untreated controls. Statistical analysis was done using student t test. 
7.3.6 Toxicity testing of tyrothricin extract toward bee larvae 
Honey bees progress through four different developmental stages between eggs being laid by 
queen bee and incubation (day 1 to 3), they then develop into larvae (day 4 to 9), progress into 
pre-pupa (day 9 to 12), pupa (day 13 to 20) before finally emerging as adult bees (day 21) 
[77]. As larvae are fed by the adult bees that may have ingested Te, the toxicity of Te needed 
to be determined toward honey bee larvae. 
To remove the influence of natural mortality, the percentage mortality was adjusted relative to 
that observed in the control fed the feeding solution only using Abbots correction [59] 
(Fig. 7.6). A concentration of 55.6 µg/mL (1.8 µg/larva) of Te was found to be the highest 
concentration the bee larvae could tolerate with without any toxicity, as determined relative to 
the percentage mortality observed in the two negative controls (Fig. 7.6). Only a single other 
report of the toxicity of the tyrothricin peptides toward insects exists where a concentration of 
6 µM (7.62 µg/mL) of the purified tyrocidine A analogue was found to be the maximum 
tolerable concentration used in the successful treatment of Candida albicans infections in the 
nematode Caenorhabditis elegans [52]. Our results would seem to suggest that bee larvae 
were considerably more resilient to Te than the nematodes were to the purified single peptide. 
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7.3.7 Activity of peptide formulations toward honey bee pathogens causing 
foulbrood 
In light of the low toxicity of Te toward adult bees, trend of increased survival of bees 
released into hives after being treated with Te and tolerance of the bee larvae to Te at a 
concentration of up to 55.6 g/mL. It was questioned whether these peptides would have any 
potential to combat pathogens affecting honey bee larvae, as it is at these earliest, brood 
developmental stages while still in the hive where honey bees are most sensitive to pathogens 
[78]. The tyrothricin peptides had already displayed potent activity toward the opportunistic 
fungi A. fumigatus (Table 7.2, Fig. 7.3 A), one of the causative agents of stonebrood disease 
or aspergillosis in honey bee larvae [79]. As the next step in this direction the in vitro activity 
of Te was evaluated toward a range of bee pathogens associated with foulbrood (Table 7.3).  
 
 
 
 
 
 
 
 
 
 
Figure 7.6 Bar graph of the relative percentage mortality of Apis mellifera carnica honey bee 
larvae after a single exposure to varied concentrations of Te together with the 
insecticide DiM at day 4. The percentage mortality was adjusted relative to the 
natural mortality observed in feeding solution only using Abbots correction [59]. 
Statistical analysis done using Bonferroni’s Multiple comparison test (One Way 
ANOVA) the relative mortality after exposure to 0.76% DMF feeding vehicle 
was compared to each of the respective treatments at days 5, 6 and 7 # P<0.001; * 
P<0.05. 
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These included a range of different strains of P. larvae, the causative agents of American 
foulbrood [60]; M. plutonius, the causative agent of European foulbrood in honey bees, as 
well as associated secondary invaders P. alvei and E. faecalis [61]. All of the different strains 
of P. larvae where sensitive to Te, ERIC I isolate 25 and 145, as well as ERIC II isolate 1 
where less sensitive. M. plutonius, the secondary invaders P. alvei and E. faecalis, also 
showed high sensitivity toward the peptide formulation. Considering the promising 
antimicrobial activity of Te toward these pathogens in vitro, it begged to question whether Te 
would be able to target these pathogens in vivo.  
Table 7.3 Activity of tyrothricin extract (Te) dissolved in 1.5% ethanol toward honey bee 
pathogens causing foulbrood and associated secondary invaders. 
Bacterial species Strain 
ICmax 
(µg/mL) 
±SEM  
Paenibacillus larvae ERIC I, DSM 7030 (n=2) 6.25±0 
 
ERIC II, DSM 25430 (n=3) 2.73±1.8 
 
ERIC III, LMG 16252 (n=3) 2.08±0.52 
 
ERIC IV, LMG 16247 (n=3) 7.29±2.8 
 
ERIC I, Isolate 11 (n=3) 1.23±0.17 
 
ERIC I, Isolate 15 (n=3) <<0.781 
 
ERIC I, Isolate 24 (n=2) <<0.781 
 
ERIC I, Isolate 25 (n=3) 29.2±11 
 
ERIC I, Isolate 138 (n=3) <<0.781 
 
ERIC I, Isolate 145 (n=3) 21.6±1.7 
 
ERIC II, Isolate 1 (n=3) 25±0 
 
ERIC II, Isolate 3 (n=2) 3.13±0 
 
ERIC II, Isolate 6 (n=3) 1.27±0.41 
 
ERIC II, Isolate 7 (n=3) 3.13±0 
 
ERIC II, Isolate 17 (n=3) <<0.781 
Melissococcus plutonius LMG 20360 (n=3) 12.5±0 
Paenibacillus alvei DSM 29 (n=2) 1.56±0 
Enterococcus faecalis DSM 20376 (n=3) 8.33±2.1 
 
7.3.8 Assessment of the potential of tyrothricin to treat infected bee larvae  
Having established toxicity parameters for Te toward honey bee larvae, a concentration of 
55.6 µg/mL (1.83 µg/larva) was used to establish if the promising in vitro activity toward 
P. larvae could be emulated in vivo. Larvae were infected with spores of either P. larvae 
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reference strains ERIC I (DSM 7030) or ERIC II (DSM 25430) at day 1 and treated with Te at 
the previously mentioned concentration on day 4 (Fig. 7.7). 
It was apparent that the in vivo antimicrobial activity of Te toward P. larvae was not as high 
as had been observed in vitro. Te slowed down the rate at which the infection progressed of 
both strains, but was more effective at slowing down infection of ERIC II (DSM 25430) 
(Fig. 7.7). This was particularly evident at day 5 when there was near 60% mortality in the 
untreated group with Eric II infection and only 13% in the Te treated group (Fig. 7.7 B). 
However, Te on its own had no long term therapeutic or curative effect and a final mortality 
similar to that observed in the infection control was obtained toward both P. larvae reference 
strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7 Curing assays of Apis mellifera carnica honey bee larvae after a single exposure 
of tyrocidine extract (Te) at 55.6 µg/mL (1.83 µg/larva) on day 4 after being pre 
exposed to Paenibacillus larvae spores on day 1 of either A ERIC I (DSM 7030) 
or B ERIC II (DSM 25430) strain. Statistical analysis was done using a Two way 
ANOVA and Bonferroni’s post-test with *** P<0.001 and ** P<0.01. 
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Surviving larvae were also observed to reside for longer within the larval stage resisting 
transition to the pre-pupa stages of development. Moreover, those larvae which succumbed 
while still within the pre-pupa stage of development failed to defecate, correlating with the 
observation in the caged bees (data not shown). Barring a single other report of the maximum 
tolerable concentration the purified tyrocidine A analogue used in the successful treatment of 
C. albicans infections in the nematode C. elegance [52], all the rest of the reports of treatment 
of infections using the tyrothricin peptides are limited to mammalian systems, primarily using 
mouse models. Some authors have reported being able to successfully treat some strains of 
Pneumococcus and Streptococcus infections in mice by the oral administration of tyrothricin 
[75,76]. However, toward other strains of Pneumococcus and Streptococcus it slowed down 
the rate of infection [75]. 
No therapeutic effect was reported in the latter [75] or toward Lactobacillus acidophilus [48], 
despite tyrothricin displaying high antimicrobial activity in vitro [38,48]. The latter is similar 
to what was observed within our own results. While the tyrothricin peptides, Te in particular, 
showed potent in vitro activity against a broad range of bee-pathogens it was ineffective at 
treating pathogens in bee larvae. Therefore, despite any positive effects observed toward adult 
bees, it is not be recommended to use the tyrothricin peptides to treat honey bee pathogens as 
an additive in feeders to treat infected hives. 
7.3.9 Activity of tyrothricin extracts toward beneficial gut microbiota of 
honey bees and larvae  
To negate the any influence Te may have had on the beneficial gut microbiota of honey bees 
[66], exploratory in vitro activity assays were performed toward a range of representative bee 
gut microorganisms (Table 7.4).  
It was apparent from these data that Te does display antimicrobial activity toward the majority 
of the Gram-positive and even some Gram-negative bacteria found in the gut of honey bees 
and larvae. Mice orally treated with tyrothricin, however, were observed to shown no change 
in their intestinal microbiota [38,48]. It is thus questionable whether the observed in vitro 
activity toward the gut microbiota significantly contributes toward the aberration in the 
observed development of the honey bee larvae, particularly when considering the lack of 
in vivo activity observed toward P. larvae. The inability to defecate observed in the larvae, as 
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well as in the adult bees after extended feeding of extremely high concentrations of Te may 
elude to a possible disruption in the mid to hind gut. It was postulated that this may be 
associated with cyclic structure of the peptides in combination their protein-like nature 
making them more resistant to degradation, thus resulting in an immobility of the gut and/or 
constipation.  
Table 7.4 Antimicrobial activity of Te toward a representative sample of the gut microbiota 
of the honey bee 
Bacterial species ICmax 
Gram-positive  
Bacillus megaterium LMG 7127  18.5 
B. pumilus LMG 3455 15.3 
B. subtilis LMG 2099  21.1 
Brevibacillus borstelensis DSM 6347 >100 
Planococcus maritimus DSM 17275 15.9 
Staphylococcus pasteuri DSM 30868 10.3 
Streptomyces griseus DSM 1471 10.8 
Gram-negative  
Comamonas denitrificans LMG 21602 47.9 
Delftia acidovorans LMG 1226 >100 
Gluconobacter oxydans DSM 2003 >100 
Janthinobacterium lividum LMG 2892 >100 
Pedobacter africanus LMG 10345 76.6 
Planomicrobium okeanokoites DSM 15489  >100 
Pseudomonas fluorescens DSM 6147 >100 
Ralstonia Picketti LMG 5342 .>100 
Saccharibacter floricola LMG 23170 19. 3 
Salmonella enterica DSM 11320 >100 
 
7.4 Conclusions 
In light of the promising antimicrobial activity of the tyrocidines to treat pathogens in the 
agricultural and food industries, the safety of utilising these peptides within an agricultural 
environment was assessed by determining their toxicity toward honey bees, which served as a 
corner stone, representative non-target beneficial organism. The culture extracts of 
tyrothricin, Te, which were to be used in the proposed agricultural applications, aggregation 
and antimicrobial activity were investigated in the DMF solvent as well as various sugars 
used to test their toxicity toward honey bees. The parameters obtained from the latter 
formulation were compared to those in EtOH, the solvent used in the application of these 
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peptides. Due to the complex nature of Te it is necessary to study the influence of different 
additives in purified Tc formulation allowing some deductions to be made regarding the 
influence of the culture pigment, as well as the linear gramicidins in Te. 
The formulation of the tyrothricin peptides for application toward honey bees has brought the 
potential of different solvents such as DMF to light. Future work would entail exploring the 
formulation of the tyrothricin peptides in different solvent environments to optimise their 
activity in different applications. In DMF an increase in the prevalence of the dimeric form 
was observed relative to the monomeric form detected in EtOH (Fig 7.1). The dimeric form 
of the tyrocidines is shown be the active form of the peptides in their membranolytic mode of 
action when targeting bacteria [29,31]. Increased antimicrobial activity when dissolved in 
DMF was attributed to the sugars having a further chaotropic effect on the aggregates formed 
in the pre-incubated peptide formulations by disrupting the hydrogen bonding networks (refer 
to Chapter 5) and consequently increasing the formation of the more favourable dimeric 
oligomeric structures [29,31]. Over all, the slight reduction in antimicrobial activity of Te 
relative to Tc in the two respective solvents (Table 7.2) may be attributed to the antagonistic 
effect of the co-extracted linear gramicidins [80] and lower purity of the samples. It was 
however postulated that the culture pigments have a chaotropic effect on aggregation and 
thereby influence the antimicrobial activity and toxicity of Te. Similarly, the culture pigment 
was postulated to also have a modulatory effect on the toxicity of Te, however, this needs to 
be investigated further before definitive conclusions can be made.  
The reduced toxicity of Te toward insect cells supports the very low toxicity of Te observed 
toward adult honey bees. Using concentrations of approximately 200 times the ICmax observed 
toward the representative target organisms, no influence of the peptide was observed toward 
the bees fed for the conventional six hours proposed in the usual toxicity testing [58]. Due to 
the low solubility of these peptides in water, mortality in adult bees only occurred when they 
were exclusively fed Te for extended time periods. These mortalities occurred at extremely 
high concentrations of tyrothricin which would be unattainable by bees foraging within a 
natural environment. Even if bees were to be drenched with the peptide solution during 
application, their low solubility in water would limit the exposure to minute amounts. 
Moreover, due to their hydrophobic nature, these peptides adhere very strongly to surfaces 
[81] and would therefore further limit any exposure that may occur to larvae after application. 
It is therefore concluded that the tyrothricin peptides have a very low toxicity toward honey 
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bees and would be extremely unlikely to cause an adverse effect toward them when applied 
within agricultural applications. 
This study showed the safety of the application of Te in agricultural settings as it was found 
to generally be non-toxic to adult bees, while their larvae were resilient to high levels of the 
Te formulation (Fig. 7.6). The potent in vitro antimicrobial activity observed toward P. larvae 
unfortunately did not result in curing of P. larvae infected bee larvae in in vivo assays 
(Fig. 7.7). Treatment with Te only slowed down the progression of the infection and had little 
or no long term therapeutic effect on its own. Therefore, despite any positive effects observed 
toward adult bees, the use of the tyrothricin peptides as an additive in feeders is not 
recommended to treat hives infected with honey bee pathogens, particularly those affecting 
their larval developmental stages. 
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Chapter 8 
Conclusions and recommendations for future studies 
8.1 Introduction 
The potential cyclodecapeptides produced by Bacillus aneurinolyticus, namely the tyrocidine 
and their analogues (Trcs), to target a broad range of pathogens was recognised through work 
performed by previous members of our group [1-4]. These cyclodecapeptides are shown to be 
able to target a broad range of pathogens, including the malaria virus Plasmodium falciparum 
[2,5,6]. It is their ability to efficiently target Gram-positive bacteria [3,4], and especially fungi 
[7-11], which makes them particularly attractive as so-called green-biocides. However, potent 
antimicrobial activity is found to be dependent on properties of the target cell, as well as those 
of the different cyclodecapeptides [1-4]. 
The goal of the present study was to elucidate the optimal conditions that would allow for the 
large scale production of target-specific subsets of these cyclodecapeptides and economical 
downstream purification of the peptide mixtures and single peptides (Chapters 2-4). The 
produced cyclodecapeptide mixtures/formulations were investigated to elucidate some 
parameters which may allow for optimisation to target different agricultural and/or food 
related pathogens/problem organisms (Chapter 5-6). Initial formulation parameters were 
evaluated together with the relative safety of their application within an agricultural setting by 
determining their in vivo toxicity toward honey bees, as a representative non-target insect 
species (Chapter 7). 
8.2 Summary of findings and future work 
8.2.1 Manipulation of the tyrothricin production profile  
Supplementation of the growth media of the producer organism with Phe or Trp causes a shift 
in its antimicrobial peptide production profile. This was of particular importance as previous 
work by our group had illustrated variable antimicrobial activity of the different 
cyclodecapeptides towards different target organisms [2-7,12]. The more polar Trcs, TrcB 
and TrcC, containing an increased number of Trp residues together with Tyr7 in their 
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structure, were more active toward Gram-positive bacteria [4,5]. Initial studies using the six 
major Trc analogues showed the more non-polar analogue TrcA containing Phe rich moieties 
had greater activity toward the human malaria parasite, Plasmodium falciparum [2]. 
Subsequent studies, using an extended peptide library of the Trcs also showed TpcC, 
containing Trp at all the variable aromatic amino acid positions, to also have high activity [6].  
This shift in cyclodecapeptide production was first characterised by the change in aromatic 
amino acid occupancy of the variable dipeptide unit (position 3 and 4), while also evaluating 
the influence of supplementation of these two amino acids on the growth and total tyrothricin 
production of the producer organism (Chapter 2). Through supplementation with only Phe or 
Trp it was possible to shift the tyrocidine and analogue production profile between two 
extremes in terms of occupancy of the variable dipeptide unit producing two distinct 
cyclodecapeptide subsets, namely the A (Ff) and C (Ww) analogues. Supplementation using 
defined ratios of Phe/Trp resulted in a gradual shift in the occupancy of the variable dipeptide 
unit. 
Subsequently the change in amino acid occupancy at position 7, occupied by Phe, Trp or Tyr, 
was also included in the analysis (Chapter 3). This revealed a shift in the cyclodecapeptide 
production profile toward the predominantly tryptocidines containing Trp7 in Trp 
supplemented culture media. Co-supplementation with Phe allowed a change in the aromatic 
amino acid occupancy of positions 3 and 4, but not 7. Tyr occupied position 7 only at low Trp 
concentrations. Occupancy of position 7 by Phe only occurred at very high Phe/Trp ratios, 
then only contributing to about 25% of the total cyclodecapeptide production. Using these 
data together with kinetic parameters obtained from literature [13], a competitive binding 
model was constructed which eloquently described this shift in cyclodecapeptide production 
(Chapter 3). This model may be used to predict the cyclodecapeptides which will be produced 
with different Phe/Trp ratios in the culture medium, enabling the production of selected 
cyclodecapeptides and tailored mixtures which are aimed at targeting different pathogens. 
The control of cyclodecapeptide production offered by this model may be enhanced through 
the use of a base media which does not contain any background amino acids that can 
influence the peptide production profile. The challenge the latter scenario presents would be 
the appreciable production in such small volumes as to allow for high throughput screening of 
a range of different amino acid concentrations at the same time, as was done in this study. 
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Current work in progress by members of our group has shown potential to expand the amino 
acids used to shift the cyclodecapeptide production profile to include un-natural analogues 
which are also incorporated into the backbone structure by the producer organism.  
8.2.2 Production and purification of the tyrocidines and analogues 
The use of the Trcs as green-biocides is dependent on their production being consistent and of 
sufficient yield and purity. Increased production was achieved in stationary flask cultures 
using optimised production media. Efforts to produce tyrothricin in appreciable amounts by 
aerated submerged culturing in bioreactors were unsuccessful and in general high growth, but 
low tyrothricin production was achieved. The latter was probably because the culturing did 
not lead the induction of tyrothricin synthesis. Tyrothricin synthesis is induced after the 
logarithmic growth phase [14,15,15,16] due to metabolic stress which may include a range of 
factors ranging from oxygen limitation to nutrient starvation [17]. It was concluded that the 
stress signal in flask cultures was oxygen limitation, while sufficient nutrients where still 
available, allowing increased tyrothricin production by the bacterial producers over an 
extended time. In the fast growing submerged cultures, nutrients where depleted before the 
producers where sufficiently induced to produce secondary metabolites. Due to the nature of 
the control of tyrothricin production, high production by submerged culturing is not readily 
achieved using growth media containing a high nutrient values and complex nitrogen sources. 
Successful tyrothricin production within submerged cultures, using defined minimal media 
containing simple nitrogen sources [18-20], is well below that observed in stationary cultures. 
It is thus questionable whether tyrothricin production by submerged culturing would yield 
sufficient product at a cost which would make it feasible for agricultural or industrial 
applications. 
The high tyrothricin yields obtained from the flask cultures contained a proportion of co-
extracted contaminants. Two purification methodologies where developed and/or optimised 
to purify the tyrothricin peptides from the organic solvent extracts obtained from the biomass. 
The first purification methodology (PM1) involved manipulation of the solubility of the 
tyrothricin peptides, its main limitation was the number of arduous handling steps required to 
change solution. Consequently, a second purification methodology (PM2) using column 
chromatography was developed with reduced number of handling steps. Both these 
methodologies yielded a product of increased peptide content containing ~75% (m/m) of 
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tyrocidines. These extracts where utilised successfully in in vivo field trials on a variety of 
plants by members of our group, as well as in vivo toxicity assays toward honey bees and their 
larvae in this study (Chapter 7). These studies indicated the potential of the application of 
these peptides in agricultural applications. Future work would entail upscaling of current 
production and purification methodologies so as to allow for large scale application.  
Using the knowledge gained in shifting the cyclodecapeptide production profile (Chapter 2-
3), greatly eased the downstream purification using selected semi-preparative HPLC 
methodology. Several selected culture extracts were purified further in order to obtain the 
major Trcs for utilisation in more detailed bio-activity and biophysical studies. After a single 
round of purification, more than 330 mg of peptide with purity >90% was obtained (TrcA, 
TrcC, TpcC); while 220 mg of peptide that was >80% enriched in one peptide was used in 
further purifications (TrcB, TpcA, PhcA). TpcB was the only major analogue produced in 
increased quantities which could not be purified due to co-elution with TrcA. Subsequent 
purifications of TpcB have been successful by members of our group using cultures lacking 
TrcA, despite greatly reduced abundance of TpcB in these cultures (personal communication 
W. Laubscher). This illustrated the importance of culture selection in the purification of 
different analogue. However, purification yields obtained in this study greatly exceeded those 
attained by previous members of our group using the commercial tyrocidine extract [5]. 
8.2.3 Structure and oligomerisation relationships of the six major 
cyclodecapeptides 
The relationship between oligomerisation and primary structure was investigated using the six 
major cyclodecapeptides produced under the different culturing conditions in Chapter 5. The 
antibacterial activity of the Trcs is proposed to be reliant on their oligomerisation into active 
dimeric structures which allow for optimal interaction with membrane targets [21,22]. 
Differences in the primary structures of the different cyclodecapeptides, which arise due to 
changes in the identity of the amino acids at the three variable aromatic positions, influenced 
their conformation and character by altering the distribution of different amino acid side 
chains and thereby tweaking the backbone conformation. Ultimately, this determines the 
character of the monomeric peptide in relation to: amphipathicity, surface area occupied by 
charged residues and their ability to partake in non-covalent interactions. This will in turn 
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dictate the conformation of aggregates as well as the propensity to form higher order 
structures [5,12,23-25]. 
A distinct separation was observed between the characteristics of the A and C analogues 
containing Phe3, Phe4 or Trp3, Trp4 respectively in the variable dipeptide unit. Increased 
hydrophobicity was found to be associated with increased dimerization particularly by the A 
(Ff) analogues. TrcB with Trp3, Phe4 as an intermediate between the A and C analogues 
tended to have characteristics of both, or at times did not associate with either of the two 
peptide trends. This was demonstrated by the proportions of higher order structures formed, 
as well as the changes in backbone conformation deduced from the ellipticity ratio within 
different solvent environments in circular dichroism (CD) studies.  
Variation of the aromatic amino acid between Tyr7, Phe7 or Trp7 altered the character of the 
different analogues as shown by the diverse character of the three different A analogues. 
While the C analogues and TrcB containing Trp3 show variable higher ordered structure 
formation, they exemplify a balance of the influence of the three variable aromatic amino 
acids acting to alter the conformation and character of different analogues.  
Glucose was found to have a chaotropic effect on TrcB>PhcA>>TrcA reducing higher 
ordered structure formation detected by CD, which indicated a role of a conformation adopted 
when Phe4 together with Tyr7 or Phe7. The difference in fluorescent yields of the various Trp 
containing Trcs in water or trifluoroethanol, as well as variable influence of glucose on the 
different analogues, indicates a changes in conformation that is the result of an interplay 
between the three variable aromatic residues. Consequently, while there are certain 
similarities in the structures of the different cyclodecapeptides, they each have different 
characteristics determined by their variable structures.  
The concept of “One model fits all” for the tyrothricin-derived cyclodecapeptides, is not 
possible as a consequence of their structural variability. Some adjustments have to be made 
to, for example, the model structure and membrane interaction proposed by Loll et al. [22] for 
dimers of TrcA. Moreover, the observed higher order structure of the cyclodecapeptides in 
this study together with observations in literature [23,25-27] correlate with the model 
proposed by Munyuki et al. [21]. This model proposed that the Trcs can for pore structures 
via oligomerization and we recently directly observed the formation of ion-conducting pores 
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by the Trcs in a variety of model membranes (unpublished results in collaboration with Dr. E. 
Zaitseva, University of Freiburg).  
8.2.4 Oligomerisation-activity relationships of the six major 
cyclodecapeptides 
A shift in the oligomerisation pattern was observed when the single cyclodecapeptides where 
combined into selected co-produced pairs. In single peptides, a tendency of increased 
oligomerization of the more hydrophobic single peptides was observed forming 
predominantly dimers together with larger aggregates up to pentamers. In combinations of the 
co-produced peptide pairs, dimers where the predominant oligomeric species formed with 
trimers being the largest structure detected using ESMS. A general trend of dimer populations 
being composed of heterodimers of the two cyclodecapeptides was observed for all 
combinations; except those involving TrcB where homodimers of the more hydrophobic 
analogue predominated.  
Antibacterial activity towards Bacillus subtilis was largely independent of the variable 
characteristics of the different analogues. This implies that the antibacterial activity could be 
more dependent on the conserved sequence (VOLfP) in these peptides, which coincides with 
the two repeating units in the analogous gramicidin S pentapeptide. In contrast, antifungal 
activity towards Aspergillus fumigatus was related to peptide structure and oligomerization. 
The increased antifungal activity of some of the cyclodecapeptides could also be dependent 
on the cell wall [1]. It was proposed that interaction with hexose moieties in the cell wall -
glucans and chitin [28] may disrupt higher order aggregates formed in an aqueous 
environment. Aggregation of the Trcs is proposed to decrease antimicrobial activity [24-
27,29,30] and the hexose moieties could play a role in the binding and orientation of the 
peptide oligomers, which in turn could act as the seeding units for the active dimer structures 
[21,22] in the formation of pore/channels in the membrane.  
The higher antifungal activity of TrcA and TrcB could be attributed to their optimal balance 
between hydrophobicity and target cell interaction which allowed for the increased formation 
of higher order pore structures in the cell membrane, after initial interaction with the 
carbohydrate moieties in cell wall. The lower antimicrobial activity of TpcA could be 
attributed to its hydrophobicity. Adopting a conformation similar to that proposed for TrcA 
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by Loll et al. [17], the steric bulk of Trp7 may hinder optimal higher order structure formation 
and would account for decreased higher oligomers despite increased dimerization being 
observed. Alternatively, decreased antimicrobial activity may be attributed to tighter 
membrane binding of the indole group through hydrogen bonding to lipid carbonyl groups 
[27]. The TpcA peptide complex may be trapped in a conformation unable to optimally 
interact with other peptides to possibly form a pore/channel like structure and cause 
permeabilization of the cell membrane.  
In order to simulate a scenario that is closer to the natural process we combined peptides that 
were naturally co-produced or co-produced at certain Phe/Trp ratios in the culture media. In 
general, an additive relationship was observed for co-produced peptides in the combinations 
tested. However, a slight antagonistic relationship was observed in combinations containing 
tryptocidines that was not beneficial to the producer organism, which is probably why TpcC 
is almost exclusively produced in Trp-rich media. Overt synergism was observed in 
combinations of TrcA:PhcA and TrcA:TrcB toward the fungal target, and TrcA:TrcB and 
TrcB:TrcC toward the bacterial target. This correlated with the observed characteristics of 
intermediate hydrophobicity and dimerization allowing for active structures which optimally 
interact with the fungal target cell structure. These peptide combinations formed proportions 
of dimeric peptides similar to those seen for the most active analogues TrcA and TrcB. 
Synergism observed in combinations of TrcA:PhcA toward A. fumigatus was possibly due to 
PhcA forming altered heterodimer structure together with reduced homodimers dimers which 
may differ in conformation. 
The natural production profile of the producer organism containing increased TrcA, TrcB and 
TrcC (>40%) supports the synergistic activity observed, indicating an advantage in the natural 
production of these combinations. This study was the first to investigate the interaction and 
possible synergistic influence of peptide pairs from a complex of naturally produced 
cyclodecapeptides. Future work would entail the expansion of the library of analogues tested, 
as well as the range of target organisms, to allow for better correlation of activity to target cell 
structure. 
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8.2.5 Formulation of tyrothricin extracts and in vivo toxicity testing toward 
honey bees 
The observed synergistic action found for the cyclodecapeptides produced in the natural, non-
supplemented production profile supports its use in in vivo studies. The cyclodecapeptide 
mixture was obtained from culture extracts (Te) as described in Chapter 4. Due to the 
potential application in agricultural environments, the toxicity of Te was determined toward 
honey bees and their larvae as an indication of their possible influence on beneficial non-
target insect species. Formulation of Te together with high purity commercial tyrocidine 
mixture (Tc) was evaluated in N,N-Dimethylformamide (DMF) and ethanol (EtOH), the 
solvents used in toxicity tests and agricultural applications respectively. The influence of 
glucose and sucrose, present in honey bee feeding solutions, on the aggregation and 
antimicrobial activity was investigated. 
The size of the aggregates detected by dynamic light scattering for Te were consistently 
smaller than those observed for Tc, which was of high purity. The addition of sugars caused a 
reduction in the size of the aggregates formed by Tc in EtOH, and was particularly 
pronounced when dissolved in DMF. The sugars exerted a chaotropic effect on the 
aggregation of Tc, while a similar effect was induced by DMF on Te. The difference in 
aggregation was attributed to the co-extracted culture pigment in Te causing a similar 
disruption in aggregation. Moreover, the reduction in toxicity of Te, relative to that of Tc, 
toward insect cells may also allude to a role of the culture pigment. However, this aspect will 
be explored in future formulation of the cyclodecapeptides. 
Decreased dimer populations were detected by ESMS when dissolved in EtOH. This most 
likely indicates a difference in conformation adopted by the cyclodecapeptides in the two 
solvent environments. This hypothesis was supported by the opposing influence of the two 
sugars, glucose and sucrose, on the antimicrobial activity of Te when dissolved in the two 
solvents. The addition of the sugars suppressed the antimicrobial activity of Te when 
dissolved in EtOH. This effect was largely relieved when dissolved in DMF, even increasing 
antimicrobial activity. These data supported observations of the chaotropic effect of glucose 
on higher order structure formation and a possible interaction with the cell wall components 
in fungal targets. It is highly likely that the interaction of the Trcs with glucose may depend 
on a balance of interaction with glucose moieties in the target structure and glucose in 
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solution. If too high a concentration of glucose is present in the environment, it may also 
result in reduced antimicrobial activity. The influence of different solvents and sugars on the 
Trcs is an aspect which warrants further investigation in future work.  
No appreciable toxicity was observed for Te toward adult honey bees at the highest 
concentration we could dissolve in the 50% sucrose feeding solution after the six hours 
stipulated in the oral toxicity test guidelines [32]. Furthermore, there was a possible increase 
in survival of the Te treated adult bees in a semi-field trial environment, and potent in vitro 
activity of Te toward a broad array of pathogens causing foul brood in honey bee larvae 
[33,34]. Te formulations unfortunately did not show in vivo activity toward these bee 
pathogens in bee larvae curing assays, although it did significantly delay the onset of 
infection. It is therefore concluded that the tyrothricin peptides have a very low toxicity 
toward honey bees and would be extremely unlikely to cause an adverse effect toward them 
when applied within agricultural applications. 
8.3 Last word  
These cyclodecapeptides show potential for application in agriculture with appreciable high 
natural yields being attainable. They offer an alternate solution to conventional chemical 
agents to treat pathogens in the agricultural and food industries. Optimized formulation of 
these cyclodecapeptides would possibly enhance their potential. Due to their complex nature 
and production as a mixture of cyclodecapeptides, current knowledge regarding their mode(s) 
of antimicrobial action is limited. This is complicated further by changes in primary structure 
resulting in a wide range of different analogues with different properties. In order to harvest 
the potential of the peptides from tyrothricin, a concerted effort must be made in future 
investigations to gain knowledge on their mode of action, toxicity and behavior as mixtures. 
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